{"numRecords":"381","DataElementQueryResults":[{"publicId":"4213348","version":"1","preferredName":"Breast Biopsy Performed Type","preferredDefinition":"The kind of breast biopsy that was carried through to completion.","longName":"BR_BX_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F46B2891-0188-1A27-E040-BB89AD431E41","latestVersionIndicator":"Yes","beginDate":"2014-03-12","endDate":null,"createdBy":"CBROWN","dateCreated":"2014-03-12","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeNote":"3/2/22 jk released as part of quarterly content review and prior reviews with SMEs.  5/29/19 transferred ownership of unused CDE from EA to MCL; edits to Draft New content. 3/24/15 edit to long name, def and question text-tt._3/14/14 Edit DE. cb 3/12/14 Create DE for supporting breast trial. cb","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5260267","version":"2","preferredName":"First Degree Relative Cancer Diagnosis Indicator","preferredDefinition":"A response to indicate if there is an immediate family member (i.e., biological parents, siblings, children) with a history of cancer other than basal/squamous cell skin cancer.","longName":"2436701v1.0:6682528v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B81AB94B-932C-38ED-E053-4EBD850A0AE7","latestVersionIndicator":"Yes","beginDate":"2016-05-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-01-04","modifiedBy":"KNABLEJ","dateModified":"2021-02-25","changeNote":"2/25/21 jk Released, upd Reg Status per SME (KA) review and approval. 1/4/21 jk versioned to upd DEC to link to CDE 3171640 and revised PV list.  1/21/20 jk removed from MCL Biospecimen CSI. 1/29/19 jk released, classified for MCL Core finalization and PCA CSI.  8/5/18 jk upd short name/long/def to reflect concept pref terms.  7/17/18 jk revised MCL Core CSI mapping. 6/20/16 moved to MCL context, added to Core CSI. jk 5/12/16 created for MCL Core data set. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5260652","version":"1","preferredName":"First Menstrual Cycle Age Value","preferredDefinition":"The age (in years) at which participant had their first menstrual period.","longName":"FRST_MENS_CYC_AGE_VAL","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"32AA23EE-81CA-6307-E050-BB89AD432029","latestVersionIndicator":"Yes","beginDate":"2016-05-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-05-12","modifiedBy":"KUMMEROA","dateModified":"2022-12-27","changeNote":"1/31/19 jk classified; added AQT for MCL Core and PCA Specimen tracking CSI. 8/5/18 jk no reuse, upd short name.  7/17/18 jk released per Kristen Anton; chg reg to \"Qualified\"; revised MCL Core CSI mapping. 6/20/16 added to Core CSI. jk 6/14/16 jk moved to MCL context. 5/12/16 new CDE to replace EDRN CDE 2178308v1.0 due to semantic. jk","administrativeNotes":"2022.12.27 AQT, Alt SN added per ticket request CADSR0001837. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5260653","version":"1","preferredName":"Last Menstrual Cycle Age Value","preferredDefinition":"The age (in years) at which participant had their last menstrual period.","longName":"LST_MENS_CYC_AGE_VAL","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"32A9DEB1-946C-04F3-E050-BB89AD43144B","latestVersionIndicator":"Yes","beginDate":"2016-05-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-05-12","modifiedBy":"KUMMEROA","dateModified":"2022-12-27","changeNote":"1/4/21 jk classified in Clinical Core CSI per Dec 2020 Data Dictionary review.  1/31/19 jk classified; added AQT for MCL Core and PCA Specimen tracking CSI. 8/5/18 jk no reuse, upd short name.  7/17/18 jk released per Kristen Anton; chg reg to \"Qualified\"; revised MCL Core CSI mapping. 6/20/16 added to Core CSI. jk  6/14/16 jk moved to MCL context. 5/12/16 new CDE, need age value not category. jk","administrativeNotes":"2022.12.27 AQT, Alt SN added per ticket request CADSR0001837. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5260790","version":"1","preferredName":"eCigarette And Cigarette Use Indicator","preferredDefinition":"A preferred response of yes or no to indicate if a person uses both cigarette and electronic cigarettes (eCigarettes).","longName":"ECIG_USE_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"32ACE2F0-14A2-941C-E050-BB89AD4316DA","latestVersionIndicator":"Yes","beginDate":"2016-05-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-05-12","modifiedBy":"KNABLEJ","dateModified":"2020-01-21","changeNote":"2/14/19 jk AQT for MCL Breast.   8/5/18 jk no reuse, upd short name.  7/17/18 jk released per Kristen Anton; chg reg to \"Qualified\"; revised MCL Core CSI mapping. 6/11/18 jk added application status. 6/13/16 added MCL CSIs. jk 5/12/16 created for MCL-Vanderbilt Lung study. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5260816","version":"1","preferredName":"e-Cigarette Or Vapor Start Use Date","preferredDefinition":"The date on which a person started using electronic cigarettes (eCigarettes) or vapors.","longName":"ECIG_ST_USE_DT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"32AD22F1-1B08-9B21-E050-BB89AD436BE5","latestVersionIndicator":"Yes","beginDate":"2016-05-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-05-12","modifiedBy":"KNABLEJ","dateModified":"2020-01-21","changeNote":"8/5/18 jk no reuse, upd short name.  7/17/18 jk released per Kristen Anton; chg reg to \"Qualified\"; revised MCL Core CSI mapping. 6/11/18 jk added application status. 6/13/16 updated OC to include concept for vapors.  5/12/16 created for MCL-Vanderbilt Lung.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5260820","version":"1","preferredName":"eCigarette Or Vapor Stop Use Date","preferredDefinition":"The date on which a person quit using electronic cigarettes (eCigarettes) or vapors.","longName":"ECIG_END_USE_DT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"32AD22F1-1B7F-9B21-E050-BB89AD436BE5","latestVersionIndicator":"Yes","beginDate":"2016-05-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-05-12","modifiedBy":"KNABLEJ","dateModified":"2020-01-21","changeNote":"1/21/20 jk removed from MCL Biospecimen CSI.  8/5/18 jk no reuse, upd short name. 7/17/18 jk released per Kristen Anton; chg reg to \"Qualified\"; revised MCL Core CSI mapping. 6/11/18 jk added application status. 6/13/16 updated OC to include concept for vapors.  5/12/16 created for MCL-Vanderbilt Lung study. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5300571","version":"2","preferredName":"Relative Diagnosis Age Value","preferredDefinition":"The age (in years) when the patient's relative was first diagnosed.","longName":"REL_DX_AGE_VAL","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"72B057A2-FEB7-5971-E053-F662850A3D63","latestVersionIndicator":"Yes","beginDate":"2016-06-19","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-08-05","modifiedBy":"KNABLEJ","dateModified":"2020-01-22","changeNote":"8/5/18 jk Versioned to change short name to text; sys gen name saved as alt name.  7/17/18 jk revised MCL Core CSI mapping.  4/4/18 jk released for reuse by GDC. 6/19/16 jk created for MCL Core content. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5354656","version":"1","preferredName":"Cyst Lesion Tumor Detection Type","preferredDefinition":"A procedure or systematic course of actions used to detect a cyst, lesion, or malignant neoplasm.","longName":"CYST_LES_TMR_DETECTION_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"381899AF-8155-2528-E050-BB89AD4323B2","latestVersionIndicator":"Yes","beginDate":"2016-07-20","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-07-20","modifiedBy":"KNABLEJ","dateModified":"2020-12-29","changeNote":"12/24/20 jk classified in Clinical Core CSI.  1/22/20 jk removed from MCL Biospecimen CSI per MCL SME. 1/29/19 jk Revised PV Clinical to \"Symptom/Patient detected\" per Oct 2018 meeting discussion. 7/16/18 jk released per Kristen Anton; chg reg to \"Qualified\". 4/30/17 Replaced DEC that includes cyst and lesion; updated VMs. jk  7/20/16 created for MCL Core data set. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5418791","version":"1","preferredName":"Best Overall Lesion Response Date","preferredDefinition":"The date on which the RECIST best overall disease response value (CR, PR, PD, or SD) was recorded.","longName":"BEST_OVR_RESP_DT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A4C7A0E-B739-022B-E050-BB89AD431A58","latestVersionIndicator":"Yes","beginDate":"2016-08-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-17","modifiedBy":"KNABLEJ","dateModified":"2022-03-21","changeNote":"3/21/22 jk Vanderbilt Imaging AI, released as part of quarterly draft content review and prior reviews with SMEs.  8/7/18 LS updated to text short name.6/11/18 jk added application status.  8/17/16 jk created for MCL, reused DEC from associated response value.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5418891","version":"1","preferredName":"Lung Lymph Node Anatomic Location Site","preferredDefinition":"The named locations of, or within, the pair of viscera occupying the pulmonary cavities of the thorax.","longName":"LUNG_LYM_NODE_ANAT_SITE","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A4F336F-0CCA-6966-E050-BB89AD432677","latestVersionIndicator":"Yes","beginDate":"2016-08-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-17","modifiedBy":"KNABLEJ","dateModified":"2022-03-23","changeNote":"3/23/22 jk added \"Application\" RS as part of MCL quarterly content review.  8/7/18 ls update short name. 8/17/16 jk created for MCL Vanderbilt  lung - reuse DEC/VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5418911","version":"2","preferredName":"Patient Age At Biospecimen Collection Value","preferredDefinition":"The age of a patient at the time of gathering biospecimens for testing, diagnostic, propagation, treatment or research purposes.","longName":"PT_AGE_SPEC_COLL_VAL","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"72B0492E-677A-597D-E053-F662850A37F3","latestVersionIndicator":"Yes","beginDate":"2016-08-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-08-05","modifiedBy":"KNABLEJ","dateModified":"2018-08-07","changeNote":"8/5/18 jk Versioned to updated short name to text; sys gen name saved as alt name.  6/11/18 jk added application status. 8/17/16 jk created for MCL Lung Biospeciment content from existing DEC and VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5418953","version":"1","preferredName":"Patient Age At Computed Tomography Scan Value","preferredDefinition":"The age of a patient when an examination of the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis is performed.","longName":"PT_AGE_CT_VAL","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A51CC73-790C-70E0-E050-BB89AD432762","latestVersionIndicator":"Yes","beginDate":"2016-08-18","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-18","modifiedBy":"KNABLEJ","dateModified":"2022-03-23","changeNote":"3/23/22 jk Released as part of MCL quarterly draft content review.  8/7/18 LS updated to text short name.8/17/16 jk created for MCL Lung Biospecimen content from existing DEC and VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5418956","version":"1","preferredName":"Patient Age At Tissue Collection Value","preferredDefinition":"The age of a patient when a sample of anatomical structure consisting of similarly specialized cells and intercellular matrix is collected.","longName":"PT_AGE_TIS_COLL_VAL","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A51CC73-794C-70E0-E050-BB89AD432762","latestVersionIndicator":"Yes","beginDate":"2016-08-18","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-18","modifiedBy":"KNABLEJ","dateModified":"2022-03-21","changeNote":"3/21/22 jk Vanderbilt Imaging AI, released as part of quarterly draft content review and prior reviews with SMEs.  8/7/18 LS updated to text short name.9/26/17 jk classified for Vanderbilt Image Archive project.; 8/17/16 jk created for MCL Lung Biospecimen content from existing DEC and VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5418958","version":"1","preferredName":"Patient Age At Blood Collection Value","preferredDefinition":"The age of a patient when a sample of blood is obtained.","longName":"PT_AGE_BLD_COLL_VAL","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A51C771-741A-8EAD-E050-BB89AD43230C","latestVersionIndicator":"Yes","beginDate":"2016-08-18","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-18","modifiedBy":"KNABLEJ","dateModified":"2022-03-21","changeNote":"3/21/22 jk Vanderbilt Imaging AI, released as part of quarterly draft content review and prior reviews with SMEs.  9/26/17 jk classified for Vanderbilt Image Archive project.; 8/17/16 jk created for MCL Lung Biospecimen content from existing DEC and VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5427594","version":"1","preferredName":"Tissue Sample Collection Follow SOP Indicator","preferredDefinition":"A response of yes/no/unknown to indicate if the gathering of a piece of tissue removed from an organism for examination, analysis, or propagation was collected in accordance with an established procedure.","longName":"TIS_SPEC_COLL_SOP_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A9E8CEE-10FC-EC88-E050-BB89AD432072","latestVersionIndicator":"Yes","beginDate":"2016-08-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-21","modifiedBy":"KNABLEJ","dateModified":"2022-03-02","changeNote":"3/2/22 jk released as part of quarterly content review.  8/7/18 LS updated to text short name.8/21/16 created for MCL Vanderbilt Lung data set. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5427619","version":"1","preferredName":"Tumor Density Type","preferredDefinition":"A characrerisitic of benign or malignant tissue indicating density.","longName":"TM_DENSITY_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A9FBD79-FCC4-3828-E050-BB89AD435E23","latestVersionIndicator":"Yes","beginDate":"2016-08-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-21","modifiedBy":"KNABLEJ","dateModified":"2022-01-07","changeNote":"1/7/22 jk released for reuse by COG.    8/7/18 LS updated to text short name.6/11/18 jk added application status.  8/21/16 created for MCL Lung data set. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5427623","version":"1","preferredName":"Blood Specimen Collection Type","preferredDefinition":"A characterisitic describing when the gathering of a blood occured.","longName":"BLD_SPEC_COLL_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AA0168B-3F5E-3627-E050-BB89AD4336DF","latestVersionIndicator":"Yes","beginDate":"2016-08-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-21","modifiedBy":"KNABLEJ","dateModified":"2022-03-02","changeNote":"3/2/22 jk released as part of quarterly content review. 8/7/18 LS updated to text short name. 6/11/18 jk added application status. 8/21/16 created for MCL Lung data set. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5427651","version":"1","preferredName":"Hemolysis Quality Control Level Category","preferredDefinition":"A characteristic describing the position on a quality scale of the disruption of the erythrocyte membrane causing release of hemoglobin.","longName":"HEMO_QC_LVL_CAT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AA00E47-5597-D929-E050-BB89AD432DD6","latestVersionIndicator":"Yes","beginDate":"2016-08-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-21","modifiedBy":"KNABLEJ","dateModified":"2022-03-02","changeNote":"3/2/22 jk released as part of quarterly content review. 8/7/18 LS updated to text short name.8/21/16 created for MCL Lung data set. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5427655","version":"1","preferredName":"Person Last Known Alive Disease Status","preferredDefinition":"A condition or state of disease for a person when last known alive.","longName":"LST_KNOWN_ALV_STAT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AA00E47-55FD-D929-E050-BB89AD432DD6","latestVersionIndicator":"Yes","beginDate":"2016-08-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-21","modifiedBy":"KNABLEJ","dateModified":"2022-03-21","changeNote":"3/21/22 jk Vanderbilt Imaging AI, released as part of quarterly draft content review and prior reviews with SME.  8/7/18 LS updated to text short name.8/21/16 created for MCL Lung data set. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5431014","version":"1","preferredName":"Primary Pulmonary Disease or Disorder Type","preferredDefinition":"An abnormal condition of the lungs of greatest rank or importance.","longName":"PRI_PULM_DIS_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3ADA2B92-AF85-F541-E050-BB89AD4351EF","latestVersionIndicator":"Yes","beginDate":"2016-08-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-24","modifiedBy":"KNABLEJ","dateModified":"2022-03-21","changeNote":"3/21/22 jk Vanderbilt Imaging AI, released as part of quarterly draft content review and prior reviews with SME.  8/7/18 LS updated to text short name.9/26/17 jk classified for Vanderbilt Image Archive project. 8/24/16 jk created for MCL V-Lung clincial data set.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5434015","version":"1","preferredName":"Primary Adenocarcinoma Differentiation Type","preferredDefinition":"The group based on the cellular characteristic of the primary growth pattern of malignant glandular cells.","longName":"PRI_ADENO_DIFF_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3B2B5731-F5F2-DAC9-E050-BB89AD435C57","latestVersionIndicator":"Yes","beginDate":"2016-08-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-28","modifiedBy":"COLBERTM","dateModified":"2021-09-13","changeNote":"9/7/21 mr Updated PVs, Classified in Lung Core. 9/1/21 mr Added Alt Name, AQT, ref doc per MCL DD. Classified in PCA Lung.  4/25/19 jk released/qualified per review by Sarah M.  4/10/19 jk upd PQT per email; add prior as AQT.  8/7/18 LS updated to text short name. 8/28/16 jk created for MCL V-Lung content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5434051","version":"1","preferredName":"Lung Histology Type","preferredDefinition":"A distinguishable class or grouping based on microscopic characteristics of pulmonary tissues.","longName":"LUNG_HIST_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B2C0215-FE84-30B6-E050-BB89AD433620","latestVersionIndicator":"Yes","beginDate":"2016-08-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-28","modifiedBy":"KNABLEJ","dateModified":"2022-03-17","changeNote":"3/17/22 jk Released, upd Reg Status per prior SME review and approval.  8/7/18 ls updated to text short name.9/27/19 jk classified for MCL Vanderbilt Image Archive project. 8/28/16 jk created for MCL V-Lung content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5434074","version":"1","preferredName":"Absolute DLCO Measurement Result Number","preferredDefinition":"A number to indicate the absolute measurement of carbon monoxide (CO) transfer from inspired gas to pulmonary capillary blood during the test measured in ml/min/mmhg.","longName":"ABS_DLCO_NUM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B2C0215-FEE3-30B6-E050-BB89AD433620","latestVersionIndicator":"Yes","beginDate":"2016-08-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-28","modifiedBy":"KNABLEJ","dateModified":"2022-03-21","changeNote":"3/21/22 jk Vanderbilt Imaging AI, released as part of quarterly draft content review and prior reviews with SME.  8/7/18 ls updated to text short name.6/11/18 jk added application status. 8/28/16 jk created for MCL V-Lung content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5434111","version":"1","preferredName":"Lung Toxic Exposure Type","preferredDefinition":"A distinguishable class of toxic substances usually causing unwanted side effects in the lung.","longName":"LUNG_TOX_EXP_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B2CF2E7-3380-B9B7-E050-BB89AD4312E0","latestVersionIndicator":"Yes","beginDate":"2016-08-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-28","modifiedBy":"KNABLEJ","dateModified":"2022-03-21","changeNote":"3/21/22 jk Vanderbilt Imaging AI, released as part of quarterly draft content review and prior reviews with SME.  8/7/18 ls updated to text short name.  8/28/16 jk created for MCL V-Lung content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5505394","version":"1","preferredName":"Protocol IRB Approved Number","preferredDefinition":"Character value assigned to an IRB approved protocol or clinical trial as its unique identifier.","longName":"PROTO_IRB_NUM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E215483-A6E5-025B-E053-F662850A3FBD","latestVersionIndicator":"Yes","beginDate":"2016-10-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-10-05","modifiedBy":"KNABLEJ","dateModified":"2022-03-23","changeNote":"3/23/22 jk Released as part of MCL quarterly draft content review.  8/7/18 jk updated to text short name. 10/5/16 created for MCL Vanderbilt lung. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5543299","version":"1","preferredName":"Positive Surgical Margin Sum Length Millimeter Measurement","preferredDefinition":"The summed length of the positive margin at the edge of a surgically excised specimen.","longName":"6841509v1.0:5542785v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3FB566F8-CD24-31C6-E053-F662850AAB12","latestVersionIndicator":"Yes","beginDate":"2016-10-25","endDate":null,"createdBy":"UMLLOADER_EDRN","dateCreated":"2016-10-25","modifiedBy":"COLBERTM","dateModified":"2022-03-18","changeNote":"3/18/22 mr Released per DCT and SME.   10/26/21 mr Updated definition.   9/21/21 mr Added alt name, AQT, ref doc, CSI per MCL DD. 7-31-19 tt transferred CDE from EDRN to MCL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5543314","version":"1","preferredName":"Prostate Weight Gram Measurement","preferredDefinition":"The weight in grams of the prostate.","longName":"5528876v1.0:5698242v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FB56954-A169-3713-E053-F662850A2B46","latestVersionIndicator":"Yes","beginDate":"2016-10-25","endDate":"2021-06-17","createdBy":"UMLLOADER_EDRN","dateCreated":"2016-10-25","modifiedBy":"COLBERTM","dateModified":"2021-11-16","changeNote":"7-8-19 tt transferred ownership from EDRN to MCL, updates to Draft New content. 2017-03-07 RR: Added preferred question text","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5581360","version":"1","preferredName":"Current Cyst Lesion Tumor Diagnosis Anatomic Site","preferredDefinition":"The disease location of a cyst, lesion, or atypical neoplastic cells within the body.","longName":"CYST_LES_TMR_DIAG_ANAT_SITE","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"42025D7C-25B5-6343-E053-F662850ADBC5","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"KNABLEJ","dateModified":"2020-12-29","changeNote":"12/23/20 jk classified in Clinical Core CSI.  1/21/20 jk removed from MCL Biospecimen CSI.  2/14/19 jk AQT for MCL Breast. 7/16/18 jk released per Kristen Anton; chg reg to \"Qualified\".  4/30/17 new DEC created to expand scope to include cyst and lesion. jk 11/23/16 created for MCL Core data set based on the NCIt Neoplasm Core terminology set. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5581361","version":"1","preferredName":"Relative First Primary Cancer Diagnosis Anatomic Site","preferredDefinition":"The location of the first original site of cancer origin in a person related by descent rather than by marriage or law.","longName":"REL_FRST_PRI_CA_SITE","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"42019733-BA00-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"KNABLEJ","dateModified":"2020-01-22","changeNote":"8/5/18 jk no reuse, upd short name.  7/17/18 jk released per Kristen Anton; chg reg to \"Qualified\"; revised MCL Core CSI mapping.  11/23/16 created for MCL Core data set based on the NCIt Neoplasm Core terminology set. jk 03-16-2018 Cleaned up acute accent where apostrophe should be in question text. DW","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5581362","version":"1","preferredName":"Relative Subsequent Primary Cancer Diagnosis Anatomic Site","preferredDefinition":"The location of a subsequent original site of cancer origin in a person related by descent rather than by marriage or law.","longName":"REL_SUBSEQ_PRI_CA_SITE","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"42019733-BA18-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"KNABLEJ","dateModified":"2020-01-22","changeNote":"7/17/18 jk released per Kristen Anton; chg reg to \"Qualified\"; revised MCL Core CSI mapping. 11/23/16 created for MCL Core data set based on the NCIt Neoplasm Core terminology set. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589447","version":"1","preferredName":"Oral Route of Administration Current Therapy Indicator","preferredDefinition":"A yes/no response to indicate if an oral steroid is currently being administered as part of a treatment.","longName":"ORAL_STER_CUR_TRMT_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"42F2AEBA-3325-044E-E053-F662850A9C5E","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-12-05","modifiedBy":"KNABLEJ","dateModified":"2022-03-02","changeNote":"3/2/22 jk released as part of quarterly content review.  8/7/18 ls updated to text short name.12/5/16 created for Vanderbilt Lung data set. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589452","version":"1","preferredName":"FEV1 Pre Bronchodilator Percent of Predicted Value","preferredDefinition":"The numerical quantity computed for quantitative evaluation of a forecasted or presumed value against the actual observation value of the volume exhaled before the first second of a forced expiratory maneuver started from the level of total lung capacity.","longName":"FEV1_PRE_BRONCH_PERCT_VAL","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"42F2AEBA-33CF-044E-E053-F662850A9C5E","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-12-05","modifiedBy":"KNABLEJ","dateModified":"2022-03-02","changeNote":"3/2/22 jk released as part of quarterly content review. 8/7/18 ls updated to text short name.6/11/18 jk added application status. 12/5/16 created for Vanderbilt lung data set. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589456","version":"1","preferredName":"FEV1 Post Bronchodilation Percent of Predicted Value","preferredDefinition":"The numerical quantity computed for quantitative evaluation of a forecasted or presumed value against the actual observation value of the volume exhaled after the first second of a forced expiratory maneuver started from the level of total lung capacity.","longName":"FEV1_POST_VAL","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"42F3B009-05B4-722F-E053-F662850ABDA9","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-12-05","modifiedBy":"KNABLEJ","dateModified":"2022-03-02","changeNote":"3/2/22 jk released as part of quarterly content review.  6/11/18 jk added application status. 2/5/16 created for Vanderbilt lung data set. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589457","version":"1","preferredName":"Prior Cancer Diagnosis Year Date","preferredDefinition":"A four digit representation of the calendar year of a prior cancer diagnosis.","longName":"PRIOR_CA_DX_YR_DT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"42F3E265-DD10-0342-E053-F662850A33C0","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-12-05","modifiedBy":"KNABLEJ","dateModified":"2022-03-02","changeNote":"3/2/22 jk released as part of quarterly content review. 12/5/16 created for Vanderbilt lung clinical data set. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5798571","version":"1","preferredName":"MCL Contributing Institution Name","preferredDefinition":"The name of the corporation, foundation or other organization playing a part in the work of the Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions (MCL).","longName":"MCL_CTB_INST_NM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E6A42A6-9553-6EC1-E053-F662850A8C78","latestVersionIndicator":"Yes","beginDate":"2017-04-30","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2017-04-30","modifiedBy":"KNABLEJ","dateModified":"2019-09-29","changeNote":"1/29/19 jk released; PV CUIs pending definitions from MCL.  7/16/18 jk update to capture \"contributing\" organizations that may or may not be funded.  Changed VD to MCL specific list rather than free text representation.  4/30/17 created for MCL Core data set. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5798581","version":"1","preferredName":"Person Education Level Category","preferredDefinition":"A demographic parameter indicating the highest level of education attained by a human being.","longName":"PRSN_EDU_LVL_CAT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4E6B89EA-6905-1DA0-E053-F662850AE081","latestVersionIndicator":"Yes","beginDate":"2017-04-30","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2017-04-30","modifiedBy":"KNABLEJ","dateModified":"2021-02-25","changeNote":"2/25/21 jk Upd Reg Status per SME (KA) Clinical core review and approval.  12/22/20 jk classified in Clinical Core CSI.  1/22/20 jk removed from MCL Biospecimen CSI per MCL SME.   1/28/19 jk released/classified for MCL PCA use.  7/17/18 jk revised MCL Core CSI mapping. 4/30/17 crated for MCL Core data set. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5798603","version":"1","preferredName":"Person Weight Date","preferredDefinition":"The particular day, month and year a person's weight was obtained.","longName":"PRSN_WT_DT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E6BD2C4-71DF-3222-E053-F662850A421A","latestVersionIndicator":"Yes","beginDate":"2017-04-30","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2017-04-30","modifiedBy":"KNABLEJ","dateModified":"2020-01-22","changeNote":"1/22/20 jk removed from MCL Biospecimen CSI per MCL SME. 1/28/19 jk added MCL PCA CSI. 7/17/18 jk revised MCL Core CSI mapping.  11/15/17 jk replaced VD 5798590 with Standard Date VD 2018550; released CDE. 4/30/17 jk created for MCL Core.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5798629","version":"1","preferredName":"Prior Cyst Lesion Tumor Cancer Diagnosis Anatomic Site","preferredDefinition":"The disease location of a prior cyst, lesion, or atypical neoplastic cells within the body.","longName":"PR_CYST_LES_TMR_DIAG_ANAT_SITE","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4E6BCAC6-69C4-0449-E053-F662850A8FD6","latestVersionIndicator":"Yes","beginDate":"2017-04-30","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2017-04-30","modifiedBy":"KNABLEJ","dateModified":"2021-01-06","changeNote":"12/23/20 jk added coding instr, classified in Clinical Core CSI.1/22/20 jk removed from MCL Biospecimen CSI per MCL SME. 1/31/19 jk Core/PCA CSIs. 7/16/18 jk removed dup \"diagnosis\" from CDE long name; released CDE. 4/30/17 new DEC created to expand scope to include cyst and lesion. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5832492","version":"1","preferredName":"Biomarker Laboratory Procedure Performed Indicator","preferredDefinition":"A yes/no response to indicate whether a procedure was performed to determine the presence of measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances).","longName":"BIOMKR_PROC_DT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4FC210F1-A733-1467-E053-F662850A7A03","latestVersionIndicator":"No","beginDate":"2017-05-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2017-05-17","modifiedBy":"KNABLEJ","dateModified":"2021-01-04","changeNote":"1/22/20 jk removed from MCL Biospecimen CSI per MCL SME. 1/31/19 jk classified for MCL PCA Specimen tracking system. 7/16/18 jk released per Kristen Anton; chg reg to \"Qualified\".  6/11/18 jk added application status. 5/17/17 jk Created for MCL Core.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5832492","version":"2","preferredName":"Biomarker Laboratory Procedure Performed Indicator","preferredDefinition":"A response to indicate whether a procedure was performed to determine the presence of measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances).","longName":"3854433v1.0:6682528v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B81B6AB8-F986-493F-E053-4EBD850A53C9","latestVersionIndicator":"Yes","beginDate":"2021-01-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-01-04","modifiedBy":"KNABLEJ","dateModified":"2021-02-25","changeNote":"2/25/21 jk Released per SME (KA) review and approval. 1/4/21 jk Versioned CDE to support Clinical Core DD PVs.  1/22/20 jk removed from MCL Biospecimen CSI per MCL SME. 1/31/19 jk classified for MCL PCA Specimen tracking system. 7/16/18 jk released per Kristen Anton; chg reg to \"Qualified\".  6/11/18 jk added application status. 5/17/17 jk Created for MCL Core.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5833634","version":"1","preferredName":"Disease Detection Method Type","preferredDefinition":"The procedure performed to identify an abnormal condition or atypical variations of structure and function of the body.","longName":"DIS_DETECT_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4FD5B29A-216A-595F-E053-F662850A4DE8","latestVersionIndicator":"Yes","beginDate":"2017-05-18","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2017-05-18","modifiedBy":"KNABLEJ","dateModified":"2021-02-25","changeNote":"2/25/21 jk Upd Reg Status per SME (KA) Clinical core review and approval.  3/7/19 jk per SME, this information not collected in specimen tracking sys - removed CSI.  1/29/19 jk Updated to include PE and Lab test per Oct 2018 F2F meeting discussion; added PCA CSI.  7/17/18 jk added instruction re: collection for incidental detection method.  5/18/17 jk Created for MCL Core","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5833861","version":"1","preferredName":"Last Previous Screening Outcome Date","preferredDefinition":"The date of the latest previous examination or assessment result.","longName":"LAST_PREV_SCR_DT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4FD658E7-4BFA-3209-E053-F662850A1748","latestVersionIndicator":"Yes","beginDate":"2017-05-18","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2017-05-18","modifiedBy":"KNABLEJ","dateModified":"2020-01-21","changeNote":"1/29/19 jk reviewed,PCA CSI added.  7/16/18 jk released per Kristen Anton; chg reg to \"Qualified\".  5/17/17 jk Created for MCL Core.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5833863","version":"1","preferredName":"Last Negative Finding Screening Outcome Date","preferredDefinition":"The date of the last finding of normality following an examination or assessment.","longName":"LAST_NEG_SCR_DT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4FD3E77F-1BAF-2AC6-E053-F662850A31FE","latestVersionIndicator":"Yes","beginDate":"2017-05-18","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2017-05-18","modifiedBy":"KNABLEJ","dateModified":"2020-01-21","changeNote":"1/29/19 jk reviewed, PCA CSI added. 7/16/18 jk released per Kristen Anton; chg reg to \"Qualified\".  5/17/17 jk Created for MCL Core.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5833870","version":"1","preferredName":"Clinical Evaluation Cancer Detected Type","preferredDefinition":"The type of the malignant neoplasm detected based on a clinical assessment of an individual's physical condition.","longName":"CLIN_EVAL_CA_DET_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"4FD6A009-E479-31F2-E053-F662850AF5A8","latestVersionIndicator":"Yes","beginDate":"2017-05-18","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2017-05-18","modifiedBy":"KNABLEJ","dateModified":"2021-02-25","changeNote":"2/25/21 jk Upd Reg Status per SME (KA) Clinical core review and approval.  1/29/19 jk updated DEC/CDE to reflect \"type\" rather than anatomic site.  Released; classified for MCL Core and tracking system.  5/18/17 jk Created for MCL Core","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6113740","version":"1","preferredName":"Experiment Summary Description Text","preferredDefinition":"Text describing the main points of a coordinated set of actions and observations designed to generate data, with the ultimate goal of discovery or hypothesis testing.  Abstract from a publication is acceptable.","longName":"EXP_SUM_TXT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"66D615F5-AF12-193F-E053-F662850A8993","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-07","modifiedBy":"KNABLEJ","dateModified":"2020-10-13","changeNote":"10/13/20 jk per SME, moved from Experiment CSI to Candidate Genomic CDEs CSI. 11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  3/7/18 jk created for MCL Genomics.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6113741","version":"1","preferredName":"Experiment Title Name","preferredDefinition":"The words by which a set of actions and observations, performed to verify or falsify a hypothesis or research, is known.","longName":"EXP_TL_NM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"66D62E14-0C35-7326-E053-F662850A3646","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-07","modifiedBy":"COLBERTM","dateModified":"2022-11-01","changeNote":"3/1/22 jk Designated, added CDS alt name and CSI. 10/13/20 jk per SME, moved from Experiment CSI to Candidate Genomic CDEs CSI. 11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  3/7/18 jk created for MCL Genomics based on Sequence Read Archive (SRA) data element.","administrativeNotes":"11/1/22 Removed CS/CSI for CRDC CDS per CDS submission metatdata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6113755","version":"1","preferredName":"Experiment Created By Name","preferredDefinition":"The name of the person who documents the set of actions and observations to be performed to verify or falsify a hypothesis or research.","longName":"EXP_CBY_NM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"66D615F5-AF3F-193F-E053-F662850A8993","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-07","modifiedBy":"KNABLEJ","dateModified":"2020-10-13","changeNote":"10/13/20 jk per SME, moved from Experiment CSI to Candidate Genomic CDEs CSI.  11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  3/7/18 jk created for MCL Genomics based on Sequence Read Archive (SRA) data element.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6115803","version":"1","preferredName":"Experiment Overall Design Description Text","preferredDefinition":"Text describing the complete set of actions and observations designed to generate data, with the ultimate goal of discovery or hypothesis testing.","longName":"EXP_OVR_DSGN_DESC_TXT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"66D760BF-2A88-01B0-E053-F662850A1C9E","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-07","modifiedBy":"KNABLEJ","dateModified":"2020-10-13","changeNote":"10/13/20 jk per SME, moved from Experiment CSI to Candidate Genomic CDEs CSI. 11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting. 3/7/18 jk created for MCL Genomics data.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6115804","version":"1","preferredName":"File Occurrence Name","preferredDefinition":"The name by which a set of related records (either written or electronic) are known.","longName":"FILE_NM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"66D760BF-2AB2-01B0-E053-F662850A1C9E","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-07","modifiedBy":"JKNABLE","dateModified":"2023-01-24","changeNote":"10/13/20 jk per SME, moved from Experiment CSI to Candidate Genomic CDEs CSI. 10/14/19 jk added LabCAS CSIs.  11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  3/7/18 jk created for MCL Genomics data.","administrativeNotes":"11/1/22 Added CS/CSI for CRDC CDS per CDS metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6115805","version":"1","preferredName":"File Hash Value Identifier","preferredDefinition":"One or more characters using a irreversible unique number generated from a string of text to identify a set of related electronic records.","longName":"FILE_HASH_VAL_ID","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"66D63326-9BA5-732A-E053-F662850A452C","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-07","modifiedBy":"JKNABLE","dateModified":"2023-01-25","changeNote":"10/13/20 jk per SME, moved from Experiment CSI to Candidate Genomic CDEs CSI. 11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  3/7/18 jk created for MCL Genomics data.","administrativeNotes":"1/25/23 removed CDS CDE CSI and alt names; CDS using DSS CDE. jk; \r\n 11/1/22 Added CS/CSI for CRDC CDS per CDS metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6115806","version":"1","preferredName":"Data File Size Value","preferredDefinition":"The numerical quantity documenting the physical magnitude of a set of related electronic records.","longName":"DAT_FILE_SIZ_VAL","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"66D760BF-2AE7-01B0-E053-F662850A1C9E","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-07","modifiedBy":"JKNABLE","dateModified":"2023-01-25","changeNote":"3/1/22 jk Designated, added CDS alt name and CSI. 10/13/20 jk per SME, moved from Experiment CSI to Candidate Genomic CDEs CSI.  11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  3/7/18 jk created for MCL Genomics data.","administrativeNotes":"1/25/23 removed CDS CDE CSI and alt names; CDS using DSS CDE. jk","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6116038","version":"1","preferredName":"Sequencing Data File Category","preferredDefinition":"An identifiable group of related sequencing records based on the content of the data file.","longName":"SEQ_DATA_FILE_CAT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"66DF2319-633F-27C5-E053-F662850A54D8","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-07","modifiedBy":"KNABLEJ","dateModified":"2020-10-13","changeNote":"10/13/20 jk per SME, moved from Experiment CSI to Candidate Genomic CDEs CSI. 11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.   3/7/18 jk created for MCL Genomics data.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6116466","version":"1","preferredName":"Sequencing Data File Type","preferredDefinition":"An identifiable class of related sequencing records based on common qualities of the data file content.","longName":"SEQ_DATA_FILE_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"66D63326-9BDE-732A-E053-F662850A452C","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-07","modifiedBy":"KNABLEJ","dateModified":"2020-10-13","changeNote":"10/13/20 jk per SME, moved from Experiment CSI to Candidate Genomic CDEs CSI. 11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  3/7/18 jk created for MCL Genomics data.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6118265","version":"1","preferredName":"Sample Source MCL Organ Type","preferredDefinition":"The biological organ based on where the sample originates.","longName":"SAMP_SRC_ORG_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"66F1B417-06DA-4D50-E053-F662850ABD86","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-08","modifiedBy":"COLBERTM","dateModified":"2021-12-16","changeNote":"12/16/21 mr Added alt name, alt def, ref doc, coding instructions, MCL Biospecimen CSI per DCT.   10/21/20 jk per SME, moved CDE from Sample CSI to Candidate Genomics CSI; not used in current Core.  8/26/19 jk added AQT-2 for Spec Tracking-Patient Info.  11/19/18 jk Released Core AI per Kristen/Maureen at Oct 2018 Steering Comm meeting.  8/4/18 jk upd short name.  3/8/18 jk created for MCL Genomics.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6118266","version":"1","preferredName":"Sample Organism Type","preferredDefinition":"The organism from which the sample is derived or originated.","longName":"SAMP_ORGN_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66F21B33-C691-4D92-E053-F662850AC802","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-03-08","modifiedBy":"COLBERTM","dateModified":"2023-09-14","changeNote":"3/1/22 jk Designated, added CDS alt name and CSI.  2/14/22 jk chg RS to Application.  3/16/21 jk removed Genomic Core CSI; chg RS to \"Candidate\". 10/21/20 jk per SME, moved CDE from Sample CSI to Candidate Genomics CSI; not used in current Core. 11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  8/4/18 jk upd short name. 3/8/18 jk created for MCL Genomics.","administrativeNotes":"1/18/23 Added CDS alt def per metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6273344","version":"1","preferredName":"Sequencing Library Name","preferredDefinition":"The name by which a collection of double stranded DNA fragments flanked by oligonucleotide sequence adapters to enable their analysis by high-throughput sequencing is known.","longName":"SEQ_LIB_NM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"6BF1DDCF-9D03-5906-E053-F662850A7F67","latestVersionIndicator":"Yes","beginDate":"2018-05-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-11","modifiedBy":"KUMMEROA","dateModified":"2021-03-30","changeNote":"6/3/20 jk AQT added for caps; removed Library CSI, added MCL Genomics Core CSI.  11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  5/11/18 jk created for MCL Genomics based on Sequence Read Archive (SRA) data element.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6273393","version":"1","preferredName":"Sequencing Library Technique Type","preferredDefinition":"The overall strategy for the collection of double stranded DNA fragments flanked by oligonucleotide sequence adapters to enable their analysis by high-throughput sequencing.","longName":"SEQ_LIB_STRAT_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"6BF17142-1FC0-6042-E053-F662850A027C","latestVersionIndicator":"Yes","beginDate":"2018-05-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-11","modifiedBy":"JKNABLE","dateModified":"2024-01-28","changeNote":"3/1/22 jk Designated, added CDS alt name and CSI. 6/3/20 jk AQT added for caps; removed Library CSI, added MCL Genomics Core CSI.  11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  5/11/18 jk created for MCL Genomics based on Sequence Read Archive (SRA) data element.","administrativeNotes":"1/28/24 added CCDI Federation CSI. jk; 9/18/23 Added CCDI alts, CSI. mr; \r\n1/19/23 Added ref doc EXAMPLE; removed general CDS CSI, added CDS|Sequencing CSI; per metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6285979","version":"2","preferredName":"Sequencing Library Biospecimen Sequencing Library Source","preferredDefinition":"The source of a sample collection of double stranded DNA fragments analyzed by high-throughput sequencing.","longName":"SEQ_LIB_SRC","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT MOD","registrationStatus":"Application","id":"11D7BE07-ED67-29E3-E063-731AD00A01ED","latestVersionIndicator":"Yes","beginDate":"2018-05-15","endDate":null,"createdBy":"COLBERTM","dateCreated":"2024-02-20","modifiedBy":"COLBERTM","dateModified":"2024-02-20","changeNote":"3/1/22 jk Designated, added CDS alt name and CSI.  6/3/20 jk AQT added for caps; removed Library CSI, added MCL Genomics Core CSI.  11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  5/15/18 jk created for MCL Genomics based on Sequence Read Archive (SRA) data element.","administrativeNotes":"2/20/24 Versioned in order to delete PVs w no concept codes. mr; \r\n9/18/23 Added CCDI alts, CSI. mr;\r\n1/19/23 Updated CDS alt def, ref doc EXAMPLE; removed general CDS CSI, added CDS|Sequencing CSI; per metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6347743","version":"1","preferredName":"Sequencing Library Creation Method Type","preferredDefinition":"The type of systematic actions performed to select or enrich DNA fragments used in analysis by high-throughput sequencing.","longName":"SEQ_LIB_CREATE_METH_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"70A8FA4C-5279-5E14-E053-F662850A43E1","latestVersionIndicator":"Yes","beginDate":"2018-07-10","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-07-10","modifiedBy":"COLBERTM","dateModified":"2023-09-18","changeNote":"3/1/22 jk Designated, added CDS alt name and CSI. 12/16/21 jk upd LN to remove dup term.  6/3/20 jk AQT added for caps; removed Library CSI, added MCL Genomics Core CSI.  11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  7/10/18 jk created for MCL Genomics based on Sequence Read Archive (SRA) data element.","administrativeNotes":"1/19/23 Added CDS ref doc EXAMPLE; removed general CDS CSI, added CDS|Sequencing CSI; per metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6347744","version":"1","preferredName":"Sequencing Library Feature Strand Type","preferredDefinition":"The direction and/or type of DNA fragment strand(s) used in analysis by high-throughput sequencing.","longName":"SEQ_LIB_STRANDNESS_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"70A9AA42-28E0-79AD-E053-F662850A14EB","latestVersionIndicator":"Yes","beginDate":"2018-07-10","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-07-10","modifiedBy":"KUMMEROA","dateModified":"2021-03-30","changeNote":"6/3/20 jk AQT added for caps; removed Library CSI, added MCL Genomics Core CSI.  11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting. 7/10/18 jk created for MCL Genomics based on Sequence Read Archive (SRA) data element.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6347753","version":"1","preferredName":"DNA Structure Paired-End Sequencing Indicator","preferredDefinition":"A response of yes or no to indicate if a single read DNA sequencing strategy is initiated from each end of a DNA fragment.","longName":"DNA_PR_END_SEQ_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"70A9E11F-6A09-443A-E053-F662850A0113","latestVersionIndicator":"Yes","beginDate":"2018-07-10","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-07-10","modifiedBy":"KUMMEROA","dateModified":"2021-03-30","changeNote":"6/3/20 jk AQT added for caps; removed Library CSI, added MCL Genomics Core CSI.  11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  7/10/18 jk created for MCL Genomics based on Sequence Read Archive (SRA) data element.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6347771","version":"1","preferredName":"Sequencing Library Platform Name","preferredDefinition":"The words used to describe the instrument used to carry out a high-throughput sequencing experiment.","longName":"SEQ_LIB_PLATFORM_NM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"70A7F608-5299-79B5-E053-F662850A3325","latestVersionIndicator":"Yes","beginDate":"2018-07-10","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-07-10","modifiedBy":"COLBERTM","dateModified":"2023-11-01","changeNote":"3/1/22 jk Designated, added CDS alt name and CSI. 10/21/20 jk per SME, moved CDE from Library CSI to Candidate Genomics CSI; not used in current Core. 11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  7/10/18 jk created for MCL Genomics based on Sequence Read Archive (SRA) data element.","administrativeNotes":"1/19/23 Added CDS ref doc EXAMPLE; removed general CDS CSI, added CDS|Sequencing CSI; per metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6352164","version":"1","preferredName":"Sequencing Library Platform Model Name","preferredDefinition":"The words used to describe the specific model of the instrument used to carry out a high-throughput sequencing experiment.","longName":"SEQ_LIB_INSTR_MOD_NM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"70CD2B01-4233-25B7-E053-F662850AD0F6","latestVersionIndicator":"Yes","beginDate":"2018-07-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-07-12","modifiedBy":"COLBERTM","dateModified":"2023-09-18","changeNote":"3/1/22 jk Designated, added CDS alt name and CSI. 6/3/20 jk upd def; removed Library CSI, added MCL Genomics Core CSI. 11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  7/12/18 jk created for MCL Genomics based on Sequence Read Archive (SRA) data element.","administrativeNotes":"1/19/23 Added CDS alt def, ref docs; removed general CDS CSI, added CDS|Sequencing CSI; per metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6352248","version":"1","preferredName":"Sequence Analysis File Data Source Name","preferredDefinition":"The name of the MCL organization who generated the sequencing and provided the computational analysis.","longName":"SEQ_ANALY_DATA_SRC","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"70C24225-ECBC-3344-E053-F662850A8E03","latestVersionIndicator":"Yes","beginDate":"2018-07-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-07-12","modifiedBy":"KNABLEJ","dateModified":"2020-10-21","changeNote":"10/21/20 jk per SME, moved CDE from Library CSI to Candidate Genomics CSI; not used in current Core.  6/3/20 jk upd def per genomic core CDE set.  11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  7/12/18 jk created for MCL Genomics based on Sequence Read Archive (SRA) data element.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6352252","version":"1","preferredName":"Sequencing Run Occurrence Date","preferredDefinition":"The date on which a valid and completed operation of a high-throughput sequencing instrument occurred.","longName":"SEQ_RUN_DT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"70CF0B7C-596A-7B8F-E053-F662850AACCA","latestVersionIndicator":"Yes","beginDate":"2018-07-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-07-12","modifiedBy":"KUMMEROA","dateModified":"2021-03-30","changeNote":"6/3/20 jk added to Genomic Core CSI.  11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting. 7/12/18 jk created for MCL Genomics based on Sequence Read Archive (SRA) data element.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6355706","version":"1","preferredName":"Sample Processed Data File Name","preferredDefinition":"The words by which a sample data file that has been processed is known.","longName":"SAMP_PROC_DFILE_NM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"70D320AE-FC2A-7390-E053-F662850AE2C9","latestVersionIndicator":"Yes","beginDate":"2018-07-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-07-12","modifiedBy":"KNABLEJ","dateModified":"2020-10-21","changeNote":"10/21/20 jk per SME, moved CDE from Sample CSI to Candidate Genomics CSI; not used in current Core. 11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  7/12/18 jk created for MCL Genomics data.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6355716","version":"1","preferredName":"Sample Processed Data Sequencing File Type","preferredDefinition":"The file format of a sequencing sample data file that has been processed.","longName":"SAMP_PROC_SEQ_DFILE_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"70D3B530-14D5-4AD7-E053-F662850A4108","latestVersionIndicator":"Yes","beginDate":"2018-07-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-07-12","modifiedBy":"KNABLEJ","dateModified":"2020-10-21","changeNote":"10/21/20 jk per SME, moved CDE from Sample CSI to Candidate Genomics CSI; not used in current Core. 11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  7/12/18 jk created for MCL Genomics data.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6355737","version":"1","preferredName":"Sample Raw Sequencing Data File Type","preferredDefinition":"The file format of a sequencing sample data file that has not been processed, a raw data file.","longName":"SAMP_RAW_SEQ_DFILE_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"70D4166F-15E0-43A6-E053-F662850AE788","latestVersionIndicator":"Yes","beginDate":"2018-07-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-07-12","modifiedBy":"KNABLEJ","dateModified":"2020-10-21","changeNote":"10/21/20 jk per SME, moved CDE from Sample CSI to Candidate Genomics CSI; not used in current Core. 11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  7/12/18 jk created for MCL Genomics data.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6355738","version":"1","preferredName":"Sample Raw Data File Name","preferredDefinition":"The file format of a sequencing sample data file that has not been processed, a raw data file.","longName":"SAMP_RAW_SEQ_DFILE_NM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"70D38D91-4870-7042-E053-F662850A6D6C","latestVersionIndicator":"Yes","beginDate":"2018-07-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-07-12","modifiedBy":"KNABLEJ","dateModified":"2020-10-21","changeNote":"10/21/20 jk per SME, moved CDE from Sample CSI to Candidate Genomics CSI; not used in current Core. 11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting. 7/12/18 jk created for MCL Genomics data.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6380354","version":"1","preferredName":"Nucleotide Sequence Read Length Number","preferredDefinition":"The number of nucleotides successfully ordered from each side of a nucleic acid fragment obtained after the completion of a sequencing process.","longName":"NUC_SEQ_READ_LEN_NUM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"724F5A1A-BBDC-7CE9-E053-F662850AE714","latestVersionIndicator":"Yes","beginDate":"2018-07-31","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-07-31","modifiedBy":"COLBERTM","dateModified":"2023-02-10","changeNote":"3/1/22 jk Designated, added CDS alt name and CSI. 6/3/20 jk AQT added for caps; removed Library CSI, added MCL Genomics Core CSI.  11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting. 7/31/18 jk created for MCL Genomics based on Sequence Read Archive (SRA) data element.","administrativeNotes":"2/10/23 Removed Used by CRDC. mr;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6380402","version":"1","preferredName":"Sequencing Adapter Name Identifier","preferredDefinition":"One or more characters used to name the sequencing adapter.","longName":"ADP_NM_ID","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"72535A98-BF36-54DB-E053-F662850ABEE1","latestVersionIndicator":"Yes","beginDate":"2018-07-31","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-07-31","modifiedBy":"KUMMEROA","dateModified":"2021-03-30","changeNote":"6/3/20 jk upd def, add AQT; removed Library CSI, added MCL Core CSI.  11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  8/4/18 jk upd short name.  7/31/18 jk created for MCL Genomics based on Sequence Read Archive (SRA) data element.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6380403","version":"1","preferredName":"Sequencing Adapter Nucleotide Sequence Identifier","preferredDefinition":"One or more characters used to identify the base sequence of the sequencing adapter.","longName":"ADP_NUC_SEQ_ID","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"72538EF9-41AC-54DF-E053-F662850AB86A","latestVersionIndicator":"Yes","beginDate":"2018-07-31","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-07-31","modifiedBy":"KUMMEROA","dateModified":"2021-03-30","changeNote":"6/3/20 jk upd def, removed Library CSI; added Genomic Core CSI.  11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  8/4/18 jk upd short name.  7/31/18 jk created for MCL Genomics based on Sequence Read Archive (SRA) data element.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6380404","version":"1","preferredName":"Nucleotide Sequencing Flow Cell Barcode Identifier","preferredDefinition":"A machine-readable representation of information used to identify an optical slide with microliter or picoliter sized wells that each hold a single nucleotide sequencing template.","longName":"NUC_SEQ_FCELL_BRCD_ID","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7253A9FF-36F4-54D7-E053-F662850A71A1","latestVersionIndicator":"Yes","beginDate":"2018-07-31","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-07-31","modifiedBy":"KUMMEROA","dateModified":"2021-03-30","changeNote":"6/3/20 jk add AQT for caps; removed Library CSI, added MCL Core CSI.  11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting. 8/4/18 jk upd short name.  7/31/18 jk created for MCL Genomics based on Sequence Read Archive (SRA) data element.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6380407","version":"1","preferredName":"Assay Kit Sequencing Target Region BED Format Identifier","preferredDefinition":"The procedure and set of reagents to used to conduct a molecular assay which characterizes the content of a specific set of genomic intervals in a tab-delimited text file format (BED file format).","longName":"ASY_KIT_TGT_REG_BED_ID","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7253A9FF-371E-54D7-E053-F662850A71A1","latestVersionIndicator":"Yes","beginDate":"2018-07-31","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-07-31","modifiedBy":"KUMMEROA","dateModified":"2021-03-30","changeNote":"6/3/20 jk Removed Library CSI, added MCL Genomics Core CSI.  11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting. 8/4/18 jk upd short name.  7/31/18 jk created for MCL Genomics based on Sequence Read Archive (SRA) data element.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6381649","version":"1","preferredName":"Sequencing Library Size Selection Range","preferredDefinition":"The difference between minimum and maximum length of the DNA fragments included in the sequencing library.","longName":"SEQ_LIB_SZ_SEL_RG","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"726AA371-5EC2-4218-E053-F662850A087D","latestVersionIndicator":"Yes","beginDate":"2018-08-02","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-08-02","modifiedBy":"KUMMEROA","dateModified":"2021-03-30","changeNote":"6/3/20 jk AQT added for caps; removed Library CSI, added MCL Genomics Core CSI.  11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  8/4/18 jk upd short name; removed dup \"Range\" from LName. 8/2/18 jk created for MCL Genomics based on Sequence Read Archive (SRA) data element.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6437330","version":"1","preferredName":"MCL Human Study Subject Identifier","preferredDefinition":"Unique identifier for patient specifically for MCL study.","longName":"MCL ID","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"76673129-5F33-6894-E053-F662850A1E4B","latestVersionIndicator":"Yes","beginDate":"2018-09-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-09-21","modifiedBy":"COLBERTM","dateModified":"2021-11-17","changeNote":"11/17/21 mr Added CSI for MCL PCA breast; added ref doc.    9/21 mr added CSI for MCL lung, added ref doc per MCL DD. 9/1/21 mr added CSI for PCA Lung, added alt def, added Ref Doc to align with MCL DD. 7/22/21 jk added CSI for PCA Breast, Pancreas. 3/16/21 jk removed Genomic Core CSI; added to genomic candidate CSI.  2/25/21 jk Upd Reg Status per SME (KA) Clinical core review and approval.  12/22/20 jk classified in Clinical Core CSI.  6/4/20 jk added Genomic Core CSI.  1/21/20 jk removed Core CSI per MCL CDE lead.  2/14/19 jk AQT for MCL Breast.  1/28/19 jk released; AQT added for MCL PCA.  9/21/18 jk unique MCL subject/participant ID.  CDE can not be altered.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6626651","version":"2","preferredName":"Biospecimen Acquisition Method Type","preferredDefinition":"Records the method of acquisition or source for the specimen under consideration.","longName":"BIOSP_ACQ_TYP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D92B3322-6BDE-3C2A-E053-4EBD850A646E","latestVersionIndicator":"Yes","beginDate":"2022-03-01","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2022-03-01","modifiedBy":"FINCHAMB","dateModified":"2024-02-06","changeNote":"3/1/22 jk versioned/released to use v2 of VD with updated max length and PVs. 12/17/21 mr Added alt name, AQT, ref doc, MCL Biospecimen CSI.  4/21/21 jk added SRRS CSI.  10/29/19 jk released per MCL SME (Maureen/Kristen) review.   3/27/19 jk removed dup terms from CDE long name.  1/30/2019 smt - created for MCL specimen tracking content.","administrativeNotes":"2/6/24 Added CDS Alt name, def and CSI. BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6626652","version":"1","preferredName":"Biospecimen Acquisition Method Other Specify","preferredDefinition":"Records a text description of the method of acquisition or source for the specimen under consideration, if not on the list provided.","longName":"BIOSP_ACQ_OTHER_TXT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"80CD88E1-C788-4A0C-E053-F662850AE4AD","latestVersionIndicator":"Yes","beginDate":"2019-01-31","endDate":null,"createdBy":"TSESU","dateCreated":"2019-01-31","modifiedBy":"KNABLEJ","dateModified":"2022-02-22","changeNote":"12/17/21 mr Added alt name, AQT, ref doc, MCL Biospecimen CSI per DCT.   10/29/19 jk released per MCL SME (Maureen/Kristen) review.  9/9/19 jk revised PQT to match specimen tracking data entry form.  1/30/19 Created for MCL - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6626659","version":"1","preferredName":"Biospecimen Randomization Or Sequence Identifier","preferredDefinition":"Records a sequence number or randomization identifier assigned to a specimen.","longName":"RANDOM_SEQ_SPEC_ID","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"80CE3D9F-B92E-4A04-E053-F662850AE34B","latestVersionIndicator":"Yes","beginDate":"2019-01-31","endDate":null,"createdBy":"TSESU","dateCreated":"2019-01-31","modifiedBy":"KNABLEJ","dateModified":"2022-03-23","changeNote":"3/23/22 jk Biospecimen CSI removed; if reused in future CDE ownership should be transferred. 10/29/19 jk released per MCL SME (Maureen/Kristen) review. 9/9/19 jk revised per SME review of draft content.  1/30/19 Created for MCL - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6626663","version":"1","preferredName":"Original Biospecimen Storage Processing Temperature Status","preferredDefinition":"The temperature in Celsius of the original specimen prior to final storage processing.","longName":"ORIG_SPEC_STOR_TEMP_STAT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"80CF16F0-D64C-0960-E053-F662850AFFB0","latestVersionIndicator":"Yes","beginDate":"2019-02-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-02-01","modifiedBy":"KNABLEJ","dateModified":"2022-03-23","changeNote":"3/23/22 jk Biospecimen CSI removed; if reused in future CDE ownership should be transferred.  1/22/20 jk added \"in Celsius\" to definition per MCL SME. 10/29/19 jk released per MCL SME (Maureen/Kristen) review.  9/7/19 jk updated per SME review and consistency with format of other questions.  1/30/19 Created for MCL - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6630393","version":"1","preferredName":"Biospecimen Storage Processing Temperature Status","preferredDefinition":"The temperature in Celsius of the specimen during processing from specimen collection to final storage.","longName":"SPEC_STOR_PROC_TEMP_STAT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"80DF994A-ADD0-183F-E053-F662850A2694","latestVersionIndicator":"Yes","beginDate":"2019-02-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-02-01","modifiedBy":"KNABLEJ","dateModified":"2022-03-23","changeNote":"3/23/22 jk Biospecimen CSI removed; if reused in future CDE ownership should be transferred.  1/22/20 jk added \"in Celsius\" to definition per MCL SME.  10/29/19 jk released per MCL SME (Maureen/Kristen) review.  9/7/19 jk updated per SME review; new DEC, revised VD.  1/30/19 Created for MCL - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6630401","version":"1","preferredName":"Biospecimen Original Quantity Storage Unit of Measure","preferredDefinition":"Unit of the quantity of specimen originally stored.","longName":"SPEC_ORIG_QUANT_UOM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"80E474AB-EC99-6783-E053-F662850A92EF","latestVersionIndicator":"Yes","beginDate":"2019-02-02","endDate":null,"createdBy":"TSESU","dateCreated":"2019-02-02","modifiedBy":"KNABLEJ","dateModified":"2022-03-24","changeNote":"3/24/22 jk Biospecimen CSI removed; if reused in future CDE ownership should be transferred.  10/29/19 jk released per MCL SME (Maureen/Kristen) review.  9/10/19 jk revised PQT tper SME review notes. 2/1/19 Created for MCL - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6630402","version":"1","preferredName":"Biospecimen Original Quantity Value","preferredDefinition":"Quantitative value of specimen originally stored.","longName":"SPEC_ORIG_QUANT_VAL","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"80E474AB-ECC0-6783-E053-F662850A92EF","latestVersionIndicator":"Yes","beginDate":"2019-02-02","endDate":null,"createdBy":"TSESU","dateCreated":"2019-02-02","modifiedBy":"KNABLEJ","dateModified":"2022-03-24","changeNote":"3/24/22 jk Biospecimen CSI removed; if reused in future CDE ownership should be transferred.  10/29/19 jk released per MCL SME (Maureen/Kristen) review.  9/10/19 jk removed type from PQT per SME review notes. 8/26/19 jk added coding instruction ref doc.  2/1/19 smt Created for MCL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6631027","version":"1","preferredName":"Specimen Preparation Method Type","preferredDefinition":"Records the method of preparation used for the specimen under consideration.","longName":"SPEC_PRP_MTHD_TYP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"811C6981-0B16-2EC8-E053-F662850A13F7","latestVersionIndicator":"Yes","beginDate":"2019-02-04","endDate":null,"createdBy":"TSESU","dateCreated":"2019-02-04","modifiedBy":"KNABLEJ","dateModified":"2022-03-24","changeNote":"3/24/22 jk Biospecimen CSI removed; if reused in future ownership should be transferred. 10/29/19 jk released per MCL SME (Maureen/Kristen) review.  9/9/19 jk update to reflect revised VD semantics.  2/4/19 Created for MCL - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6631028","version":"1","preferredName":"Specimen Preparation Method Other Specify","preferredDefinition":"Records a text description of method of preparation if the method is not on the list provided.","longName":"PREP_MTHD_OTH_SPEC","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"811682F9-1607-249C-E053-F662850AE373","latestVersionIndicator":"Yes","beginDate":"2019-02-04","endDate":null,"createdBy":"TSESU","dateCreated":"2019-02-04","modifiedBy":"KNABLEJ","dateModified":"2022-03-24","changeNote":"3/24/22 jk Biospecimen CSI removed; if reused in future ownership should be transferred. 12/20/21 mr Added alt name, AQT, alt def, ref doc, MCL Biospecimen CSI per DCT.   10/29/19 jk released per MCL SME (Maureen/Kristen) review.  2/4/19 smt Created for MCL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6631095","version":"1","preferredName":"Tissue Processing Embedding Medium Type","preferredDefinition":"Indication of embedding material used in processing cells or tissue prior to storage.","longName":"EMBED_MATERIAL_TYP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8119B805-4CA9-6D7A-E053-F662850A57AF","latestVersionIndicator":"Yes","beginDate":"2019-02-04","endDate":null,"createdBy":"TSESU","dateCreated":"2019-02-04","modifiedBy":"KNABLEJ","dateModified":"2022-03-24","changeNote":"3/24/22 jk Biospecimen CSI removed; if reused in future ownership should be transferred. 10/29/19 jk released per MCL SME (Maureen/Kristen) review.  2/4/19 Created for MCL - smt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6631097","version":"1","preferredName":"Tissue Processing Embedding Medium Other Specify","preferredDefinition":"Records a text description of an embedding material used, if not on the list provided.","longName":"EMBD_MTRIAL_OTH_SPEC","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8115F5E7-5558-2910-E053-F662850A74A3","latestVersionIndicator":"Yes","beginDate":"2019-02-04","endDate":null,"createdBy":"TSESU","dateCreated":"2019-02-04","modifiedBy":"KNABLEJ","dateModified":"2022-03-24","changeNote":"3/24/22 jk Biospecimen CSI removed; if reused in future ownership should be transferred. 10/29/19 jk released per MCL SME (Maureen/Kristen) review.  2/4/19 smt Created for MCL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6631721","version":"1","preferredName":"Biospecimen Final Storage Date","preferredDefinition":"The date a specimen was ultimately stored.","longName":"SPCFNLSTOR_DT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"812E1B6F-A069-0849-E053-F662850AB935","latestVersionIndicator":"Yes","beginDate":"2019-02-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-02-05","modifiedBy":"KNABLEJ","dateModified":"2022-03-24","changeNote":"3/24/22 jk Biospecimen CSI removed; if reused in future ownership should be transferred. 10/29/19 jk released per MCL SME (Maureen/Kristen) review.  2/5/19 jk created for MCL specimen tracking content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6650904","version":"1","preferredName":"Breast Precancerous Condition Histopathologic Examination Outcome","preferredDefinition":"The result of a precancerous breast tissue examination using light or electron microscopy and employing cytochemical and immunocytochemical stain.","longName":"BREAST_PRE_CA_HISTOPATH_RSLT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"82542321-EBA4-6671-E053-F662850A462A","latestVersionIndicator":"Yes","beginDate":"2019-02-20","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-02-20","modifiedBy":"COLBERTM","dateModified":"2022-03-18","changeNote":"3/18/22 mr Released per DCT and SME.   11/17/21 mr Added 3 PVs; CSI for both MCL PCA breast; AQT, ref doc, alt name, alt def. Per breast DCT.  5/8/19 jk concepts updated for consistency across PCA organ types. 2/20/19 jk created for MCL PCA Breast; classified in Breast and PCA.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6679283","version":"1","preferredName":"Specimen Destination MCL Institution Name","preferredDefinition":"The name of the site that receives or is intended to receive a specimen.","longName":"SPEC_REC_BY_INST_NM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8491665D-2406-357C-E053-F662850A9A00","latestVersionIndicator":"Yes","beginDate":"2019-03-20","endDate":"2019-10-26","createdBy":"KNABLEJ","dateCreated":"2019-03-20","modifiedBy":"COLBERTM","dateModified":"2022-03-21","changeNote":"3/20/22 mr Added note to allow multiple values | separated, per SME.   12/23/21 mr Added alt name, alt def, ref doc, MCL BIospecimen CSI per DCT.   10/26/19 jk Per Kristen, retire and remove from Biospecimen CSI.   10/22/19 jk released per SME review and approval.  3/20/18 jk Created for MCL biospecimen tracking system.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6679292","version":"1","preferredName":"Discrete Neoplasm Identification Quantity Count","preferredDefinition":"The number of discrete tumors that can be identified for resection.","longName":"6679291v1.0:2018392v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"84939621-C3EF-7F21-E053-F662850AE0B9","latestVersionIndicator":"Yes","beginDate":"2019-03-20","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-20","modifiedBy":"COLBERTM","dateModified":"2021-09-15","changeNote":"8/31/21 mr Changed to Qualified/Released per SME. 8/4/21 mr Added alt name and reference document. To match MCL DD. 3/20/19 smt created for MCL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6680610","version":"1","preferredName":"Pancreas Precancerous Condition Histopathologic Examination Grade","preferredDefinition":"The grade of precancerous pancreatic tissue based on microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.","longName":"PAN_PRE_CA_HISTOPATH_GRD","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"84B030D3-777C-0307-E053-F662850AE2AE","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-22","modifiedBy":"COLBERTM","dateModified":"2021-09-15","changeNote":"8/31/21 mr Changed to Qualified/Released per SME. 8/2/21 mr Added alt name, AQT, alternate definition, reference document, and 2 PVs (Unknown/NR) to match MCL DD. 5/8/19 jk updated concepts to match Breast/Lung format.  3/22/19 smt created for MCL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6680631","version":"1","preferredName":"Pancreatic IPMN Pathology Report Epithelial Subtype Category","preferredDefinition":"The Intraductal Papillary Mucinous Neoplasm (IPMN) epithelial cell subtype based on the gross and microscopic examination of a pancreatic neoplasm specimen.","longName":"6680620v1.0:6679119v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"84AED43A-6630-4474-E053-F662850AC59C","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-22","modifiedBy":"COLBERTM","dateModified":"2021-09-15","changeNote":"8/31/21 mr Changed to Qualified/Released per SME. 8/4/21 mr Added Unknown and NR to PVs,  added Alt Name and Reference Document to match MCL DD. 11/14/2019 mrc Changed PQT from IPMN Types requested by Sarah Mazzilli.   5/30/19 jk associated with updated DEC.  3/22/19 smt created for MCL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6680642","version":"1","preferredName":"Neoplasm Excision Anatomic Site","preferredDefinition":"The location of the lesion at the time of resection.","longName":"6680641v1.0:6679135v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"84AED43A-6668-4474-E053-F662850AC59C","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-22","modifiedBy":"COLBERTM","dateModified":"2021-09-15","changeNote":"8/31/21 mr Changed to Qualified/Released per SME. 8/4/21 mr Added Alt Name and Reference Document (MCL template) 3/22/19 smt created for MCL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6680663","version":"1","preferredName":"Neoplasm Focality Type","preferredDefinition":"A term describing benign or malignant tissue growths relative to a central point of origin.","longName":"6680662v1.0:6679145v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"84B17D77-62F5-1C80-E053-F662850A086A","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-22","modifiedBy":"COLBERTM","dateModified":"2021-09-15","changeNote":"8/31/21 mr Changed to Qualified/Released per SME.  8/4/21 mr Added alt name, alt definition, added Unknown and NR to PVs, and added Reference Document.  To match MCL DD. 5/10/19 jk upd CDE definiton per SME review.  3/22/19 smt created for MCL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6680673","version":"1","preferredName":"Mitotic Count Rate","preferredDefinition":"The mitotic rate.","longName":"6680672v1.0:6680666v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"84B06F7E-CF22-1380-E053-F662850AEEBB","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-22","modifiedBy":"COLBERTM","dateModified":"2021-09-15","changeNote":"8/31/21 mr Changed to Qualified/Released per SME. mr Added Unknown and NR to PVs, added alt name added reference document. To match MCL DD. 3/22/19 smt created for MCL 8/4/21","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6680674","version":"1","preferredName":"Malignant Neoplasm Necrosis Status","preferredDefinition":"The necrotic status of the neoplasm.","longName":"2182233v2.0:6679197v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"84B1C637-E568-0976-E053-F662850A69D9","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-22","modifiedBy":"COLBERTM","dateModified":"2021-09-15","changeNote":"8/31/21 mr Changed to Qualfied/Released per SME. 8/4/21 mr Added PVs Absent, Unkown, NR, and Cannot be determined. Added alt name. Added reference document. To match MCL DD. 3/22/19 smt created for MCL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6680700","version":"1","preferredName":"Pancreatic Intraductal Papillary-Mucinous Neoplasm At Excision Grade","preferredDefinition":"The grade of a pancreatic Intraductal Papillary-Mucinous Neoplasm (IPMN) at the time of excision.","longName":"PAN_IPMN_EXC_GRD","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"84B0A2B6-7826-2C83-E053-F662850A6F94","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-22","modifiedBy":"COLBERTM","dateModified":"2021-09-15","changeNote":"8/21/31 mr Changed to Qualified/Released per SME. 8/4/21 mr Added Alt name, AQT, reference documents to match MCL DD. 5/30/19 jk removed type as property to for reuse across CDEs.  3/22/19 smt created for MCL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6680710","version":"1","preferredName":"Pancreatic Duct Final Pathology Type","preferredDefinition":"The final pathology result of the pancreatic duct communication type.","longName":"6680705v1.0:6679323v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"84AF39B9-B8B5-0435-E053-F662850AE574","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-22","modifiedBy":"COLBERTM","dateModified":"2021-09-15","changeNote":"8/31/21 mr Changed to Qualified/Released per SME.  8/4/21 mr Added Not reported; added Alt Name, Alt Def, reference document to match MCL DD. 3/22/19 smt created for MCL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6680715","version":"1","preferredName":"Pancreatic Carcinoma Pathology Treatment Recommendation Name","preferredDefinition":"The recommended treatment of pancreatic carcinoma pathology based on classification of disease.","longName":"6680714v1.0:6680173v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"84B030D3-77A5-0307-E053-F662850AE2AE","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-22","modifiedBy":"COLBERTM","dateModified":"2021-09-15","changeNote":"8/31/21 mr Changed to Qualified/Released per SME. 8/4/21 mr Added Unknown and NR; added Alt Name; added reference document to match MCL DD. 3/22/19 smt created for MCL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6680721","version":"1","preferredName":"Primary Neoplasm Diagnostic Biopsy Accession Number Identifier","preferredDefinition":"A control number composed of one or more characters used to uniquely identify the object among other objects in a collection","longName":"6680213v1.0:7775236v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"84B0838F-8210-6EDB-E053-F662850A505B","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-22","modifiedBy":"COLBERTM","dateModified":"2021-09-15","changeNote":"8/31/21 Changed to Qualified/Released per SME. 8/31/21jk upd to new VD; needed larger max size.   8/4/21 mr Added Alt Name and reference document to match MCL DD. 3/22/19 smt created for MCL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6680725","version":"1","preferredName":"Pathology Immunohistochemical Test Type","preferredDefinition":"The immunohistochemical test type.","longName":"6680724v1.0:6679968v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"84AE7FD6-BF69-2C97-E053-F662850A8AC8","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-22","modifiedBy":"COLBERTM","dateModified":"2021-09-15","changeNote":"8/31/21 mr Changed to Qualified/Released per SME. 8/4/21 mr Added Unknown and NR; added Alt Name; added Reference Document to match MCL DD. 3/22/19 smt created for MCL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6680726","version":"1","preferredName":"Pathology Immunohistochemical Test Outcome","preferredDefinition":"The outcome of the Immunohistochemistry test.","longName":"6680724v1.0:6679284v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"84AF3726-C79E-0836-E053-F662850AB9D9","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-22","modifiedBy":"COLBERTM","dateModified":"2021-09-15","changeNote":"8/31/21 mr Changed to Qualified/Released per SME. 8/4/21 mr Added Unknown and NR; added Alt Name; added Reference Document to match MCL DD. 3/22/19 smt created for MCL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6680727","version":"1","preferredName":"Specimen Histologic Grade","preferredDefinition":"The histology grading of the tumor.","longName":"6681594v1.0:6679286v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"84B0338C-424E-2C8F-E053-F662850AF407","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-22","modifiedBy":"COLBERTM","dateModified":"2021-09-15","changeNote":"8/31/21 mr Changed to Qualified/Released per SME. 8/4/21 mr Added Not reported; added Alt Name; added Reference Document to match MCL DD. 3/22/19 smt created for MCL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6680737","version":"1","preferredName":"Neoplasm Focality Count","preferredDefinition":"The number of benign or malignant tissue growths relative to a central point of origin.","longName":"6680662v1.0:2018392v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"84AED43A-6690-4474-E053-F662850AC59C","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-22","modifiedBy":"COLBERTM","dateModified":"2021-09-15","changeNote":"8/31/21 mr Changed to Qualified/Released per SME. 8/4/21 mr Added alt name, alt def, and reference document. To match MCL DD. 5/9/19 jk upd definition, PQT per discussion w/SME.  3/22/19 smt created for MCL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6686898","version":"1","preferredName":"Clinical Trial Eligibility Criteria Current Enrollment Participation Type","preferredDefinition":"A response to questions necessary to allow a person to participate in a clinical study, as outlined in the study protocol, that address current enrollment in a treatment clinical trial at the time of study registration.","longName":"CLIN_TRL_CUR_ENR_PART_TYPE","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"85CC7702-65EA-26A1-E053-F662850A5544","latestVersionIndicator":"Yes","beginDate":"2019-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-05","modifiedBy":"KNABLEJ","dateModified":"2022-03-10","changeNote":"3/10/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  4/5/19 jk created for Breast planned treatment module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6687032","version":"1","preferredName":"Treatment Plan Neoadjuvant Therapy Sequence Order Number","preferredDefinition":"A number that identifies the order in which neoadjuvant therapy will be administered.","longName":"TRMT_NEOADJ_THRPY_SEQ_ORD_NUM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"85D06403-4E4D-6197-E053-F662850AD089","latestVersionIndicator":"Yes","beginDate":"2019-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-05","modifiedBy":"KNABLEJ","dateModified":"2022-03-11","changeNote":"3/11/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  4/5/19 jk created for Breast planned treatment module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6687036","version":"1","preferredName":"Treatment Plan Surgical Procedure Sequence Order Number","preferredDefinition":"A number that identifies the order in which surgical  therapy will be performed.","longName":"TRMT_SURG_PROC_SEQ_ORD_NUM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"85CC9249-586C-1272-E053-F662850A35A8","latestVersionIndicator":"Yes","beginDate":"2019-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-05","modifiedBy":"KNABLEJ","dateModified":"2022-03-11","changeNote":"3/11/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  4/5/19 jk created for Breast planned treatment module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6687037","version":"1","preferredName":"Treatment Plan Adjuvant Therapy Sequence Order Number","preferredDefinition":"A number that identifies the order in which adjuvant  therapy will be administered.","longName":"TRMT_ADJ_THRPY_SEQ_ORD_NUM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"85CC9C95-9C49-0D7C-E053-F662850AADB7","latestVersionIndicator":"Yes","beginDate":"2019-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-05","modifiedBy":"KNABLEJ","dateModified":"2022-03-11","changeNote":"3/11/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  4/5/19 jk created for Breast planned treatment module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6687038","version":"1","preferredName":"Treatment Plan Radiation Therapy Sequence Order Number","preferredDefinition":"A number that identifies the order in which radiation therapy will be administered.","longName":"TRMT_RAD_THRPY_SEQ_ORD_NUM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"85D0DC29-684E-7497-E053-F662850A7EAE","latestVersionIndicator":"Yes","beginDate":"2019-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-05","modifiedBy":"KNABLEJ","dateModified":"2022-03-11","changeNote":"3/11/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  4/5/19 jk created for Breast planned treatment module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6687039","version":"1","preferredName":"Neoadjuvant Therapy Administered Type","preferredDefinition":"Text term that represents the kind of neoadjuvant therapy being administered.","longName":"NEOADJ_THRPY_ADMIN_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"85CF983E-7D91-7454-E053-F662850AADC6","latestVersionIndicator":"Yes","beginDate":"2019-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-05","modifiedBy":"KNABLEJ","dateModified":"2022-03-11","changeNote":"3/11/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  4/5/19 jk created for Breast planned treatment module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6687041","version":"1","preferredName":"Breast Carcinoma Registry Name","preferredDefinition":"The words by which an official registries of patients diagnosed with breast carcinoma are known.","longName":"BR_CA_REGISTRY_NM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"85D11EF4-BFA7-3E75-E053-F662850AE6F8","latestVersionIndicator":"Yes","beginDate":"2019-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-05","modifiedBy":"KNABLEJ","dateModified":"2022-03-11","changeNote":"3/11/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  4/5/19 jk created for Breast planned treatment module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6689315","version":"1","preferredName":"Lung Precancerous Condition Histopathologic Examination Outcome","preferredDefinition":"The result of a precancerous lung tissue examination using light or electron microscopy and employing cytochemical and immunocytochemical stain.","longName":"LUNG_PRE_CA_HISTOPATH_RSLT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"86234380-DF5A-71E2-E053-F662850A2183","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-09","modifiedBy":"COLBERTM","dateModified":"2021-09-13","changeNote":"9/2/21 mr Added Ref Doc and AQT.  9/1/21 mr Added MIA (minimally invasive adenocarcinoma) and AIS (Adenocarcinoma in situ) as Alt Names to match MCL DD.  5/10/19 jk upd PQT to standardize question per SME.  4/25/19 jk released/qualified per review by Sarah M. 4/9/19 jk created for PCA Lung.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6689326","version":"1","preferredName":"Lung Precancerous Condition Histopathologic Examination Other Specify","preferredDefinition":"A result different than the one(s) previously specified describing the result of a precancerous lung tissue histopathologic examination.","longName":"LUNG_PRE_CA_HISTOPATH_OTHR_SP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"862379F9-D386-66A3-E053-F662850A85E4","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-09","modifiedBy":"COLBERTM","dateModified":"2021-09-13","changeNote":"9/2/21 mr Added AQT, alt name, ref doc to match MCL DD.  4/25/19 jk released/qualified per review by Sarah M. 4/9/19 jk created for PCA Lung.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6689333","version":"1","preferredName":"Lung Location Anatomic Site","preferredDefinition":"The named location of one of a pair of organs in the chest or related structures that supplies the body with oxygen and removes carbon dioxide from the body.","longName":"LUNG_LOC_ANAT_ST","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"861D66C9-23F7-039E-E053-F662850AA67C","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-09","modifiedBy":"COLBERTM","dateModified":"2021-09-13","changeNote":"2/6/20 jk released/qualified post review by MCL SME/Maureen.  4/12/19 jk created for PCA Lung.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6689577","version":"1","preferredName":"Standard Or Guideline Edition Name","preferredDefinition":"The words by which a published document, established by consensus and approved by a recognized body, that provides, for common and repeated use, rules, guidelines or characteristics for activities or their results is known.","longName":"STD_ED_NM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8631A12A-47F4-62B4-E053-F662850A2667","latestVersionIndicator":"Yes","beginDate":"2019-04-10","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-10","modifiedBy":"COLBERTM","dateModified":"2022-03-18","changeNote":"3/18/22 mr Removed MCL PCA Breast CSI per DCT.   10/12/21 mr Removed MCL PCA pancreas CSI per DCT.   9/21/21 mr Added alt name, AQT, ref doc, CSI for MCL prostate. Per MCL DD.   9/13/21 mr Added Uknown and NR. Added alt name, AQT, alt def, ref doc, and CSI. Per MCL DD. 6/7/20 jk added CPTAC ESCA CSI. 2/13/20 jk chg RS to \"Qualified\".  10/31/19 jk released for reuse by CPTAC.  4/10/19 jk Created for PCA-all organs. 4/19/21 ls classified under HNSCC BSLN 4/21/21 ls classified CM bsnl","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690200","version":"1","preferredName":"Lymphocyte Cellular Infiltration Present Status","preferredDefinition":"The presence of normal or pathologic migration and accumulation of lymphocytes within tissue at a particular time.","longName":"LYMPH_CELL_INFL_PRST_STAT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"864475D9-D9A1-5B39-E053-F662850A8EEE","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-11","modifiedBy":"COLBERTM","dateModified":"2021-09-13","changeNote":"9/7/21mr  Added/removed PVs per MCL DD. Added classification info.  9/2/21 mr Added alt name, AQT, ref doc per MCL DD. 2/6/20 jk released/qualified post review by MCL SME/Maureen.  4/9/19 jk created for PCA Lung.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690244","version":"1","preferredName":"Neutrophil Cellular Infiltration Present Status","preferredDefinition":"The presence of normal or pathologic migration and accumulation of neutrophils within tissue at a particular time.","longName":"NEUT_CELL_INFL_PRST_STAT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"864475D9-D9C9-5B39-E053-F662850A8EEE","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-11","modifiedBy":"COLBERTM","dateModified":"2021-09-13","changeNote":"9/2/21 mr Added alt name, AQT, ref doc per MCL DD.  2/6/20 jk released/qualified post review by MCL SME/Maureen.  4/11/19 jk created for PCA Lung.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690245","version":"1","preferredName":"Macrophage Cellular Infiltration Present Status","preferredDefinition":"The presences of normal or pathologic migration and accumulation of macrophages within tissue at a particular time.","longName":"MPHGS_CELL_INFL_PRST_STAT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"86461630-38AE-6318-E053-F662850A9706","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-11","modifiedBy":"COLBERTM","dateModified":"2021-09-13","changeNote":"9/7/21 mr Added alt name, AQT, ref doc to match MCL DD. Classified in Lung PCA and Lung Core. 2/6/20 jk released/qualified post review by MCL SME/Maureen.  4/11/19 jk created for PCA Lung.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690246","version":"1","preferredName":"Plasma Cell Cellular Infiltration Present Status","preferredDefinition":"The presence of normal or pathologic migration and accumulation of plasma cells within tissue at a particular time.","longName":"PLSM_CELL_INFL_PRST_STAT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"86461116-D4F1-49A0-E053-F662850A1053","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-11","modifiedBy":"COLBERTM","dateModified":"2021-09-13","changeNote":"9/7/21 mr Added alt name, AQT, ref doc per MCL DD. Updated PVs in associated VD per MCL DD. Classified in both Lung PCA and Lung Core. 2/6/20 jk released/qualified post review by MCL SME/Maureen. 4/11/19 jk created for PCA Lung.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690803","version":"1","preferredName":"Lung Biopsy Procedure Type","preferredDefinition":"The name of the stepwise set of actions used to remove tissue from the lung for microscopic examination.","longName":"LUNG_BOPSY_PROC_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8656B2F7-2DCF-48A0-E053-F662850A4A84","latestVersionIndicator":"Yes","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"COLBERTM","dateModified":"2021-09-13","changeNote":"9/7/21 mr Added Unknown and NR per MCL DD.  9/2/21 mr Added alt name, alt def, ref doc per MCL DD.  4/25/19 jk released/qualified post review by Sarah M.   4/12/19 jk created for PCA Lung.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6692733","version":"1","preferredName":"Lung Lobe Or Bronchus Location Anatomic Site","preferredDefinition":"The named location of a portion of a lung or bronchus.","longName":"LOBE_BROC_LOC_ANAT_ST","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"86984B07-D088-451B-E053-F662850ACCF8","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-15","modifiedBy":"COLBERTM","dateModified":"2021-09-13","changeNote":"9/7/21 mr Added Unknown and NR; added alt name, AQT, ref doc per MCL DD. Added Lung Core CSI. 2/6/20 jk released/qualified post review by MCL SME/Maureen.  4/15/19 jk created for PCA Lung.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6692738","version":"1","preferredName":"Lung Segmental Bronchus Location Anatomic Site","preferredDefinition":"The lung position on one of the divisions of the lung lobar bronchus that supplies a bronchopulmonary segment.","longName":"LUNG_SEG_BROC_ANAT_ST","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"86984B07-D117-451B-E053-F662850ACCF8","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-15","modifiedBy":"COLBERTM","dateModified":"2021-09-13","changeNote":"9/7/21 mr Added 3 PVs, alt name, AQT, ref doc and Lung Core CSI per MCL DD.  2/6/20 jk released/qualified post review by MCL SME/Maureen.  4/15/19 jk created for PCA Lung.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6692740","version":"1","preferredName":"Lung Subsegmental Bronchus Location Anatomic Site","preferredDefinition":"The named location of the sub-segment within the bronchial tree where it further subdivides into smaller passages.","longName":"LUNG_SUBSEG_BROC_ANAT_ST","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8698F07D-5354-07E9-E053-F662850A851D","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-15","modifiedBy":"COLBERTM","dateModified":"2021-09-13","changeNote":"9/7/21 mr Updated PVs, added alt name, AQT, CSI per MCL DD. 2/6/20 jk released/qualified post review by MCL SME/Maureen.  4/15/19 jk created for PCA Lung.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6692741","version":"1","preferredName":"Adjacent Tumor Histology Type","preferredDefinition":"The type of morphologic characteristics observed by microscope in the tissue next to a benign or malignant tissue growth.","longName":"AJC_TMR_HIST_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"86994680-81C2-0AF2-E053-F662850ACE6E","latestVersionIndicator":"Yes","beginDate":"2019-04-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-15","modifiedBy":"COLBERTM","dateModified":"2021-09-13","changeNote":"9/7/21 mr Updated PVs, added alt name, AQT, ref doc and Lung Core CSI per MCL DD.  4/25/19 jk released/qualified per review by Sarah M. 4/15/19 jk created for MCL PCA Lung pathology content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6702651","version":"1","preferredName":"Molecular Profiling Performed Status","preferredDefinition":"An indication as to whether analysis of the RNA expression pattern in a tissue sample using molecular techniques has been carried through to completion.","longName":"MOL_PROF_PERF_ST","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86D1E64B-3548-6783-E053-F662850A7721","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-18","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeNote":"3/2/22 jk released as part of quarterly content review and prior reviews with SMEs.  4/18/19 jk created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6702668","version":"1","preferredName":"MammaPrint Molecular Risk Assessment Status","preferredDefinition":"The cancer risk assessment for a person based on an in vitro molecular diagnostic test on a breast cancer tumor sample using gene expression profiling.","longName":"MAMMOPRT_RSK_ASSESS_ST","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86CE19BB-91E0-2FA9-E053-F662850AFB08","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-18","modifiedBy":"TYRRELLM","dateModified":"2023-11-09","changeNote":"3/2/22 jk released as part of quarterly content review and prior reviews with SMEs.  4/18/19 jk created for Breast initial diagnosis module.","administrativeNotes":"11.09.2023 Added AQT per request ticket CADSR0003062_mmt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6729514","version":"1","preferredName":"Oncotype DX DCIS Score Result Value","preferredDefinition":"A numeric value assigned based on the gene expression profile in a ductal carcinoma in situ (DCIS) tissue sample.","longName":"ONCO_DX_DCIS_SCR_VAL","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"87478D44-EB94-4285-E053-F662850AC110","latestVersionIndicator":"Yes","beginDate":"2019-04-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-24","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeNote":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.  4/24/19 jk created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6729515","version":"1","preferredName":"Oncotype DX DCIS Score Recurrence Value","preferredDefinition":"A numeric value assigned to the recurrence of the gene expression profile in a ductal carcinoma in situ (DCIS) tissue sample.","longName":"ONCO_DX_DCIS_REC_SCR_VAL","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"874E45E0-F215-6B30-E053-F662850AC919","latestVersionIndicator":"Yes","beginDate":"2019-04-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-24","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeNote":"3/3/22 jk semantics updated, released as part of quarterly content review and prior reviews with SMEs.  4/24/19 jk created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6755557","version":"1","preferredName":"Partial Mastectomy Performed Type","preferredDefinition":"The type of lumpectomy that was carried through to completion.","longName":"PARTL_MAST_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"888FBDA8-71CC-5D97-E053-F662850ACAAC","latestVersionIndicator":"Yes","beginDate":"2019-05-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-10","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/14/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-10-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6755699","version":"1","preferredName":"Mastectomy Performed Type","preferredDefinition":"The type of mastectomy that was carried through to completion.","longName":"MAST_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"McAuley, E. (1992). The role of efficacy cognitions in the prediction of exercise behavior in middle-aged adults. Journal of Behavioral Medicine, 15, 65-88.","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88C6768A-D2C9-61F9-E053-F662850ABF0B","latestVersionIndicator":"Yes","beginDate":"2019-05-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-13","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/14/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.   5-13-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6755884","version":"1","preferredName":"Breast Surgical Procedure Performed Category","preferredDefinition":"The category for the kind of breast surgery that was carried through to completion.","longName":"BRST_SURG_PERF_CAT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88C679B2-FFB3-49B7-E053-F662850A321F","latestVersionIndicator":"Yes","beginDate":"2019-05-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-13","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/14/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-13-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6756365","version":"1","preferredName":"Breast Surgical Procedure Performed Type","preferredDefinition":"The type of breast surgery that was carried through to completion.","longName":"BRST_SURG_PERF_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88DAF11F-353F-6945-E053-F662850A76B2","latestVersionIndicator":"Yes","beginDate":"2019-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-14-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6756366","version":"1","preferredName":"Surgical Procedure Breast Reconstruction Performed Indicator","preferredDefinition":"A response to indicate if mammoplasty was carried through to completion.","longName":"BRST_RCNSTCT_PERF_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88DB0AE2-DE5F-7CD1-E053-F662850A3F20","latestVersionIndicator":"Yes","beginDate":"2019-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-14-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6756371","version":"1","preferredName":"Surgical Procedure Breast Reconstruction Performed Type","preferredDefinition":"The type of mammoplasty that was carried through to completion.","longName":"BRST_RCNSTCT_PERF_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88DC2D27-FF87-05DC-E053-F662850A5EC8","latestVersionIndicator":"Yes","beginDate":"2019-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-14-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6756542","version":"1","preferredName":"Axillary Lymph Node Surgical Procedure Performed Type","preferredDefinition":"The type of axillary lymph node surgery that was carried through to completion.","longName":"ALN_SURG_PERF_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88DCE538-AF04-5D20-E053-F662850A9BC3","latestVersionIndicator":"Yes","beginDate":"2019-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-14-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6756551","version":"1","preferredName":"Tissue Flap Breast Reconstruction Performed Type","preferredDefinition":"The type of flap breast reconstruction that was carried through to completion.","longName":"TFBR_PERF_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88DB0E9C-173A-0226-E053-F662850A1204","latestVersionIndicator":"Yes","beginDate":"2019-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-14-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6756588","version":"1","preferredName":"Concurrent Gynecologic Surgical Procedure Occurrence Indicator","preferredDefinition":"A response to indicate if concurrent gynecologic surgery is happening or occurred.","longName":"CONC_GYN_SGY_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88DE2502-C74F-18AE-E053-F662850AFFA3","latestVersionIndicator":"Yes","beginDate":"2019-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-14-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6756666","version":"1","preferredName":"Concurrent Gynecologic Surgical Procedure Occurrence Type","preferredDefinition":"The type of concurrent gynecologic surgery event.","longName":"CONC_GYN_SGY_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88DE96DC-FD69-2D36-E053-F662850AB7CD","latestVersionIndicator":"Yes","beginDate":"2019-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  ---- Gynecologic Surgery Type","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6756738","version":"1","preferredName":"Accelerated Partial Breast Irradiation Intervention or Procedure Date","preferredDefinition":"The date following a lumpectomy on which a technique to deliver highly effective doses of radiation over a reduced treatment time occurred.","longName":"ACC_P_BA_IRR_PROC_DT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88DF46C5-258B-2E0F-E053-F662850A2FAC","latestVersionIndicator":"Yes","beginDate":"2019-05-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-14","changeNote":"3/14/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5/14/19 jk created for Breast Radiation Therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6756739","version":"1","preferredName":"Accelerated Partial Breast Irradiation Intervention or Procedure Type","preferredDefinition":"The technique used following a lumpectomy to deliver highly effective doses of radiation over a reduced treatment time.","longName":"ACC_P_BA_IRR_PROC_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88DE82BA-0D2E-0DD2-E053-F662850A6FB8","latestVersionIndicator":"Yes","beginDate":"2019-05-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-14","changeNote":"3/14/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5/14/19 jk created for Breast Radiation Therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6756753","version":"1","preferredName":"Malignant Neoplasm Lymphatic Or Vascular Tumor Cell Invasion Indicator","preferredDefinition":"A response which indicates whether there is lymphatic or vascular local spread of tumor cells of a malignant neoplasm through infiltration or destruction of adjacent tissue.","longName":"LVI_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88DFB041-ABE9-5521-E053-F662850AF636","latestVersionIndicator":"Yes","beginDate":"2019-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-14-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6756756","version":"1","preferredName":"Boost Radiation Therapy Device Type","preferredDefinition":"The type of object used to deliver supplemental radiation for treatment of disease or other conditions.","longName":"BOOST_RAD_THPY_DEV_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88E07210-AD25-11E8-E053-F662850A074A","latestVersionIndicator":"Yes","beginDate":"2019-05-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-14","changeNote":"3/14/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5/14/19 jk created for Breast Radiation Therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6756765","version":"1","preferredName":"RT Fractions Total Count","preferredDefinition":"The total number of fractionated radiation doses administered to a patient's treatment field or site.","longName":"RT_FRAC_TOT_CT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88DFD937-701B-0FDC-E053-F662850AA25E","latestVersionIndicator":"Yes","beginDate":"2019-05-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-14","changeNote":"3/14/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5/14/19 jk created for Breast Radiation Therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6756943","version":"1","preferredName":"Breast Ductal Carcinoma In Situ Nipple Involvement Disease Extent Type","preferredDefinition":"A term describing the extent of DCIS involving the nipple.","longName":"DCIS_NIPL_INV_EXT_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88EE016F-F502-34D9-E053-F662850A8A9C","latestVersionIndicator":"Yes","beginDate":"2019-05-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-15","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-15-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6757035","version":"1","preferredName":"Breast Lobular Carcinoma In Situ Histologic Subtype Name","preferredDefinition":"Named histologic subtype of the primary LCIS.","longName":"LCIS_HIST_SUBTP_NM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88EF4CC9-1B38-3095-E053-F662850A3326","latestVersionIndicator":"Yes","beginDate":"2019-05-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-15","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-15-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6757193","version":"1","preferredName":"Biospecimen Breast Lobular Carcinoma In Situ Cell Percentage Value","preferredDefinition":"The numeric value to represent the percentage of LCIS cells in a sample.","longName":"LCIS_CELL_PTG_VAL","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88F001A6-95DA-7A00-E053-F662850A3C3C","latestVersionIndicator":"Yes","beginDate":"2019-05-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-15","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk DEC semantics updated, UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-15-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6757198","version":"1","preferredName":"LCIS Diagnosis Histologic Span Measurement","preferredDefinition":"The measurement of the histologic span for LCIS.","longName":"LCIS_HIST_SPAN_MSRMT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88F0ED4D-E91B-37E5-E053-F662850A377A","latestVersionIndicator":"Yes","beginDate":"2019-05-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-15","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-15-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6757338","version":"1","preferredName":"Breast Carcinoma Treatment Effect Disease Response Outcome","preferredDefinition":"The result of therapy for breast cancer in a patient or group of patients.","longName":"BR_CA_TX_OUTCM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88F252A6-E35A-31FE-E053-F662850AB1A8","latestVersionIndicator":"Yes","beginDate":"2019-05-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-15","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-15-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6757378","version":"1","preferredName":"Patient Stage Readiness Indicator","preferredDefinition":"A response to indicate if the patient is ready for tumor staging.","longName":"PT_STG_READNS_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88F453CC-D63E-54B7-E053-F662850AF899","latestVersionIndicator":"Yes","beginDate":"2019-05-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-15","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-15-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6757384","version":"1","preferredName":"Patient Negation Stage Reason","preferredDefinition":"An explanation for why the patient was not staged.","longName":"PT_NEGN_STG_RSN","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88F49E09-055B-3072-E053-F662850A246D","latestVersionIndicator":"Yes","beginDate":"2019-05-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-15","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-15-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6757524","version":"1","preferredName":"Axillary Lymph Node Largest Metastasis Diameter Centimeter Measurement","preferredDefinition":"Numeric annotation to indicate the largest diameter of lymph node metastases measured in cm.","longName":"ALN_LRG_MET_DIAM_CM_MSRMT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88FFF56D-770E-77B3-E053-F662850A295B","latestVersionIndicator":"Yes","beginDate":"2019-05-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-16","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-16-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6758788","version":"1","preferredName":"Surgical Margin Assessment Status","preferredDefinition":"The state of the margin from a surgically excised specimen at a particular time.","longName":"SX_MARG_ASSESS_STAT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8902F57E-CAFA-6121-E053-F662850AE04A","latestVersionIndicator":"Yes","beginDate":"2019-05-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-16","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-16-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6758868","version":"1","preferredName":"Closest Surgical Margin Range Millimeter Measurement","preferredDefinition":"Annotation used to indicate the range of the surgical margin in closest proximity to the excised tumor, measured in mm.","longName":"CLOS_SX_MARG_MM_MSRMT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89032A13-0CCC-3B04-E053-F662850ABFB2","latestVersionIndicator":"Yes","beginDate":"2019-05-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-16","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-15-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6759374","version":"1","preferredName":"Additional Surgery For Narrow Surgical Margin Planned Occurrence Indicator","preferredDefinition":"A response to indicate if extra surgery for close margins is intended to take place.","longName":"ADD_SX_NARO_MARG_PLAN_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89042730-608D-66A0-E053-F662850A4DDD","latestVersionIndicator":"Yes","beginDate":"2019-05-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-16","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-16-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6759408","version":"1","preferredName":"Additional Surgery For Positive Surgical Margin Planned Occurrence Indicator","preferredDefinition":"A response to indicate if extra surgery for positive margins is intended to take place.","longName":"ADD_SX_POS_MARG_PLAN_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"890604D8-BFDE-4475-E053-F662850A1C12","latestVersionIndicator":"Yes","beginDate":"2019-05-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-16","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-16-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6759598","version":"1","preferredName":"No Surgery For Narrow Surgical Margin Reason","preferredDefinition":"Explanations of the causes for no surgery on the margin in close proximity to the excised tumor.","longName":"NO_SX_NARO_MARG_RSN","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MESA: 2001 Multi-Ethnic Study of Arthrosclerosis, Exam 1, Medical History","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8903EDCB-A5BC-35FF-E053-F662850A00D0","latestVersionIndicator":"Yes","beginDate":"2019-05-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-16","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-16-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6759605","version":"1","preferredName":"No Surgery For Positive Surgical Margin Reason","preferredDefinition":"Explanations of the causes for no surgery on tumor cells at the edge of a surgically excised specimen.","longName":"NO_SX_POS_MARG_RSN","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MESA: 2001 Multi-Ethnic Study of Arthrosclerosis, Exam 1, Medical History","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89077EEA-5985-1F62-E053-F662850A61C4","latestVersionIndicator":"Yes","beginDate":"2019-05-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-16","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-16-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6762777","version":"1","preferredName":"Breast Carcinoma Residual Cancer Burden Index Score","preferredDefinition":"The RCB Index score estimated from routine pathologic sections of the primary breast tumor site and the regional lymph nodes after the completion of neoadjuvant therapy.","longName":"RCB_IND_SC","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8915C021-CFC3-2BB0-E053-F662850AE012","latestVersionIndicator":"Yes","beginDate":"2019-05-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-17","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-17-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6762784","version":"1","preferredName":"Breast Carcinoma Residual Cancer Burden Class Category","preferredDefinition":"The RCB class that uses pre-defined cut-points representing progressively greater extents of residual cancer and indicating a greater risk of recurrence.","longName":"RCB_CLASS_CAT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89166AD0-3D33-27DB-E053-F662850ABF86","latestVersionIndicator":"Yes","beginDate":"2019-05-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-17","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeNote":"3/15/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-17-19 tt created for Breast surgical therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6763213","version":"1","preferredName":"Calcification Present Indicator","preferredDefinition":"A response to indicate if the deposition of calcium is present in the tissue.","longName":"CALCS_PRES_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8951C08E-44A6-47F2-E053-F662850A5357","latestVersionIndicator":"Yes","beginDate":"2019-05-20","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-20","modifiedBy":"KNABLEJ","dateModified":"2022-01-31","changeNote":"1/31/22 jk Released per reuse of EDRN content review.  10/14/19 jk classified for MCL PCA genomic pilot project.  5/20/19 jk created for Initial Diagnosis module; added CSI for diagnosis and surgical therapy.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6763335","version":"1","preferredName":"Laboratory Procedure Estrogen Receptor Finding Outcome","preferredDefinition":"A response which captures the results of the Estrogen Receptor (ER) test.","longName":"LAB_ER_RECPT_FND_OUTCM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8954BDB9-F1B2-6D92-E053-F662850A9426","latestVersionIndicator":"Yes","beginDate":"2019-05-20","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-20","modifiedBy":"TSESU","dateModified":"2022-11-22","changeNote":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.  5/20/19 jk created for Initial Diagnosis module; added CSI for diagnosis and surgical therapy.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6763336","version":"1","preferredName":"Laboratory Procedure Progesterone Receptor Finding Outcome","preferredDefinition":"A response which captures the results of the Progesterone Receptor (PR) test.","longName":"LAB_PR_RECPT_FND_OUTCM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89574476-D754-4FD4-E053-F662850A75C7","latestVersionIndicator":"Yes","beginDate":"2019-05-20","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-20","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeNote":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.  12/2/21 mr Added alt name, AQT, alt def, ref doc, CSI for MCL PCA breast per DCT.   5/20/19 jk created for Initial Diagnosis module; added CSI for diagnosis and surgical therapy.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6763337","version":"1","preferredName":"Therapeutic Procedure Occurrence Schedule Identifier","preferredDefinition":"One or more characters used to describe the schedule for the administration of therapeutic agents.","longName":"TX_OCC_SCH_ID","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8955731D-1E4B-7A8E-E053-F662850A0A95","latestVersionIndicator":"Yes","beginDate":"2019-05-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-20","modifiedBy":"KNABLEJ","dateModified":"2022-03-14","changeNote":"3/14/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-20-19 tt created for Breast systemic therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6763345","version":"1","preferredName":"Laboratory Procedure Breast Carcinoma Receptor Status Type","preferredDefinition":"The type of breast carcinoma testing used to detect the presence or absence of specific receptor molecules on the surface of a cells in a specimen.","longName":"BR_CA_RECT_STAT_LAB_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8955164F-90DE-71E3-E053-F662850A65A9","latestVersionIndicator":"Yes","beginDate":"2019-05-20","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-20","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeNote":"3/3/22 jk semantics updated, released as part of quarterly content review and prior reviews with SMEs.  5/20/19 jk created for Initial Diagnosis module; added CSI for diagnosis and surgical therapy.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6763371","version":"1","preferredName":"Laboratory Procedure HER2 Measurement FISH Dual-ISH Finding Outcome","preferredDefinition":"The lab results for Her2 FISH/Dual ISH.","longName":"LAB_HER2_FISH_DISH_FND_OUTCM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"895912E6-7DEA-18AD-E053-F662850AF823","latestVersionIndicator":"Yes","beginDate":"2019-05-20","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-20","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeNote":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.  5/23/19 edits to CDE/VD; tt. 5/20/19 jk created for Initial Diagnosis module; added CSI for diagnosis and surgical therapy.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6763374","version":"1","preferredName":"Laboratory Procedure HER2 Measurement IHC Test Outcome","preferredDefinition":"The result of HER2 genetic immunohistochemistry analysis.","longName":"LAB_HER2_IHC_TEST_OUTCM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89593FDE-92CB-5ACA-E053-F662850AE06A","latestVersionIndicator":"Yes","beginDate":"2019-05-20","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-20","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeNote":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.  12/3/21 mr Edited VD, def, question text for MCL PCA breast. Added alt name, ref doc, CSI per DCT.  5/23/19 edits/VD; tt. 5/20/19 jk created for Initial Diagnosis module; added CSI for diagnosis and surgical therapy.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6763578","version":"1","preferredName":"Heart Intervention or Procedure Name","preferredDefinition":"The name of the cardiac activity that produces an effect, or that is intended to alter the course of a disease in a patient or population.","longName":"HRT_INT_PROC_NM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"895B349E-47DB-70C6-E053-F662850A4F0E","latestVersionIndicator":"Yes","beginDate":"2019-05-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-21","modifiedBy":"KNABLEJ","dateModified":"2022-03-14","changeNote":"3/14/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs5-21-19 tt created for Breast systemic therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6763733","version":"1","preferredName":"Agent Interruption Administration Indicator","preferredDefinition":"A response which indicates whether there was a time interval during the administration of the active power or cause (substance, physical or biological factor, etc.) that produces a specific effect.","longName":"AGT_INTER_ADM_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89672AE8-C3C9-64E7-E053-F662850A9188","latestVersionIndicator":"Yes","beginDate":"2019-05-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-21","modifiedBy":"KNABLEJ","dateModified":"2022-03-14","changeNote":"3/14/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-21-19 tt created for Breast systemic therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6763766","version":"1","preferredName":"Cancer Progression Local-Regional Diagnosis Indicator","preferredDefinition":"A response to indicate if the patient has a diagnosis of local-regional progression.","longName":"CAPRO_FRST_LOCRGN_DX_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89689C2E-4391-722C-E053-F662850A604A","latestVersionIndicator":"Yes","beginDate":"2019-05-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-21","modifiedBy":"KNABLEJ","dateModified":"2022-03-14","changeNote":"3/14/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs. 5-21-19 tt created for Breast recurrence therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6763780","version":"1","preferredName":"Breast Local-Regional Cancer Progression Anatomic Site","preferredDefinition":"Named locations of or within the body for local-regional breast cancer progression.","longName":"BR_LOC_REG_CAPROG_SITE","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89685864-F7C3-7230-E053-F662850A5D8A","latestVersionIndicator":"Yes","beginDate":"2019-05-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-21","modifiedBy":"KNABLEJ","dateModified":"2022-03-14","changeNote":"3/14/22 jk VD semantics updated, UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-21-19 tt created for Breast recurrence module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6763816","version":"1","preferredName":"Cancer Progression Distant Diagnosis Indicator","preferredDefinition":"A response to indicate if the patient has a diagnosis of distant progression.","longName":"CAPROG_DIST_DX_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"896A6684-E49A-74A7-E053-F662850ACC5C","latestVersionIndicator":"Yes","beginDate":"2019-05-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-21","modifiedBy":"KNABLEJ","dateModified":"2022-03-14","changeNote":"3/14/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-21-19 tt created for Breast recurrence therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6763925","version":"1","preferredName":"Breast Distant Cancer Progression Anatomic Site","preferredDefinition":"Named locations of or within the body for distant breast cancer progression.","longName":"BR_DIST_CAPROG_SITE","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"896B23C6-E418-3037-E053-F662850A5C6A","latestVersionIndicator":"Yes","beginDate":"2019-05-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-21","modifiedBy":"KNABLEJ","dateModified":"2022-03-14","changeNote":"3/14/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-21-19 tt created for Breast recurrence module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6765278","version":"1","preferredName":"Breast Cancer Family History Biological Relative Type","preferredDefinition":"The kind of biological relative(s) with a history of breast cancer.","longName":"BR_CA_FAM_HX_RELTV_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"897F0A47-5A51-1BA9-E053-F662850A20BF","latestVersionIndicator":"Yes","beginDate":"2019-05-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-22","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeNote":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-22-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6765344","version":"1","preferredName":"Genetic Testing Performed Status","preferredDefinition":"The state of execution and completion for genetic analysis.","longName":"GEN_TEST_PERF_STAT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"897F55A3-62D4-1B97-E053-F662850A9DD2","latestVersionIndicator":"Yes","beginDate":"2019-05-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-22","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeNote":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.  11/29/21 mr Added alt name, ref doc, and CSI for MCL PCA breast per DCT.   5-22-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6765607","version":"1","preferredName":"Genetic Testing BRCA1 Gene Finding Outcome","preferredDefinition":"The results of BRCA1 genetic analysis.","longName":"GEN_TEST_BRCA1_OUTCM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"898F34B8-7CAB-2178-E053-F662850AC097","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-23","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeNote":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.  11/30/21 mr Added alt name, ref doc, CSI for MCL PCA breast.   5-23-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6765608","version":"1","preferredName":"Genetic Testing BRCA2 Finding Outcome","preferredDefinition":"The results of BRCA 2 genetic analysis.","longName":"GEN_TEST_BRCA2_OUTCM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"898F43FD-348B-0315-E053-F662850A6C1D","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-23","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeNote":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.  11/30/21 mr Added alt name, ref doc, CSI for MCL PCA breast per DCT.   5-23-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6765611","version":"1","preferredName":"Therapeutic Procedure Occurrence Indicator","preferredDefinition":"A response which indicates whether the administration of therapeutic agents that are intended to alter or stop a pathologic process occurred.","longName":"TX_OCC_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"898F9A43-1C17-02FC-E053-F662850A95FA","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-23","modifiedBy":"KNABLEJ","dateModified":"2022-03-14","changeNote":"3/14/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  5-23-19 tt created for Breast systemic therapy module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6765653","version":"1","preferredName":"Genetic Testing Variant of Unknown Significance Finding Outcome","preferredDefinition":"The results of genetic analysis for an unclassified variant.","longName":"GEN_TEST_VUS_OUTCM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"898FD204-695E-262E-E053-F662850AC223","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-23","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeNote":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.   5-23-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6765654","version":"1","preferredName":"Genetic Counseling Referral Indicator","preferredDefinition":"A response which indicates whether a person was referred for counseling on the genetic risk of disease(s) by an expert in hereditary disorders.","longName":"GEN_CNSEL_REF_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"898FEF46-C678-259F-E053-F662850A17F7","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-23","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeNote":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-23-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6765777","version":"1","preferredName":"Fertility Preservation Interest Indicator","preferredDefinition":"A response to indicate interest in methods that focus on the retention of a woman's reproductive capability.","longName":"FER_PRESV_INTR_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"898FEF46-C6AD-259F-E053-F662850A17F7","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-23","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeNote":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.   5-23-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6765924","version":"1","preferredName":"Major Comorbidity Disease Name","preferredDefinition":"The name of the major coexisting abnormal condition(s) of the body.","longName":"MAJ_COMBID_DZ_NAME","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"899247F6-5AB3-6D3E-E053-F662850AA0E1","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-23","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeNote":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-23-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6766044","version":"1","preferredName":"Breast Carcinoma Current Diagnosis Category","preferredDefinition":"The categorization of breast cancer diagnosed at the present time.","longName":"BR_CA_CURR_DX_CAT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"899136E5-4629-47BD-E053-F662850A4946","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-23","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeNote":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-23-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6769530","version":"1","preferredName":"Breast Imaging Performed Type","preferredDefinition":"The kind of technology or method performed for screening, diagnosis, surgical procedures or therapy that aids in the visualization of the breast(s).","longName":"BR_IMAG_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89A230BE-56F8-64B5-E053-F662850A8A2A","latestVersionIndicator":"Yes","beginDate":"2019-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-24","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeNote":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.  12/3/21 mr Added one PV; added alt name, ref doc, CSI for MCL PCA breast per DCT.   5-24-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6769542","version":"1","preferredName":"Breast Carcinoma Detection Method Type","preferredDefinition":"The means, manner of procedure, or systematic course of actions performed in order to discover or identify breast cancer.","longName":"BR_CA_DET_METH_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89A4DDBB-EF94-52EB-E053-F662850AC933","latestVersionIndicator":"Yes","beginDate":"2019-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-24","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeNote":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.   12/3/21 mr Transferred DEC from EDRN to MCL. Added alt name, ref doc, CSI for MCL PCA breast per DCT.   5-24-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6769982","version":"1","preferredName":"Breast Carcinoma Detection Between Screening Interval Indicator","preferredDefinition":"A response which indicates if breast cancer was discovered or identified between the period of time that separated the systematic examination(s) or assessment(s).","longName":"BR_CA_DET_BT_SCRN_INTVL_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89A6FF03-B12C-335E-E053-F662850A3933","latestVersionIndicator":"Yes","beginDate":"2019-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-24","modifiedBy":"KNABLEJ","dateModified":"2022-03-07","changeNote":"3/7/22 jk released as part of quarterly content review and prior reviews with SMEs.  12/6/21 mr Added alt name, AQT, ref doc, CSI for MCL PCA breast per DCT.   5-24-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6769996","version":"1","preferredName":"Multifocal Breast Carcinoma Present Indicator","preferredDefinition":"A response to indicate if there is breast cancer characterized by the presence of multiple cancerous tumors that originate from the same clone and usually located in the same quadrant of the breast.","longName":"MF_BR_CA_PRES_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89A8B500-77C9-6FC9-E053-F662850A4B36","latestVersionIndicator":"Yes","beginDate":"2019-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-24","modifiedBy":"KNABLEJ","dateModified":"2022-03-07","changeNote":"3/7/22 jk released as part of quarterly content review and prior reviews with SMEs.  12/6/21 mr Added alt name, ref doc, CSI for MCL PCA breast per DCT.   5-24-19 tt created for Breast initial diagnosis and Surgical Therapy modules.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6769999","version":"1","preferredName":"Multicentric Breast Carcinoma Present Indicator","preferredDefinition":"A response to indicate if there is breast cancer characterized by the presence of multiple cancerous tumors that originate from different clones and usually located in different quadrants of the breast.","longName":"MC_BR_CA_PRES_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89A8D938-66C3-7120-E053-F662850AD2C2","latestVersionIndicator":"Yes","beginDate":"2019-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-24","modifiedBy":"TSESU","dateModified":"2022-11-22","changeNote":"3/7/22 jk released as part of quarterly content review and prior reviews with SMEs.  12/6/21 mr Added alt name, ref doc, CSI for MCL PCA breast per DCT.   5-24-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6770018","version":"1","preferredName":"Imaging Procedure Lesion Visible Indicator","preferredDefinition":"A response to indicate if a lesion was perceived by a method of imaging.","longName":"IMAG_LES_VIS_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89A9AFDE-74B3-5B1A-E053-F662850A2EFE","latestVersionIndicator":"Yes","beginDate":"2019-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-24","modifiedBy":"KNABLEJ","dateModified":"2022-03-07","changeNote":"3/7/22 jk semantics updated, released as part of quarterly content review and prior reviews with SMEs.   5-28-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6770315","version":"1","preferredName":"Imaging Procedure Calcification Centimeter Measurement","preferredDefinition":"Annotation used to indicate the size of calcifications on a method of imaging, measured in centimeters.","longName":"IMAG_CALCS_CM_MSRMT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89F3B89D-71D7-1886-E053-F662850ADFDC","latestVersionIndicator":"Yes","beginDate":"2019-05-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-28","modifiedBy":"KNABLEJ","dateModified":"2022-03-07","changeNote":"3/7/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-28-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6770407","version":"1","preferredName":"Imaging Procedure Mass Centimeter Measurement","preferredDefinition":"Annotation used to indicate the size of a mass on a method of imaging, measured in centimeters.","longName":"IMAG_MASS_CM_MSRMT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89F461E6-6835-1874-E053-F662850AFAD9","latestVersionIndicator":"Yes","beginDate":"2019-05-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-28","modifiedBy":"KNABLEJ","dateModified":"2022-03-07","changeNote":"3/7/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-28-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6770650","version":"1","preferredName":"Imaging Technique Lesion Biopsy Indicator","preferredDefinition":"The indicator response as to whether the lesion visualized by an imaging procedure was biopsied.","longName":"IMAG_LES_BX_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89F69C30-CAC3-0F21-E053-F662850A55E5","latestVersionIndicator":"Yes","beginDate":"2019-05-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-28","modifiedBy":"KNABLEJ","dateModified":"2022-03-07","changeNote":"3/7/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-28-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6770668","version":"1","preferredName":"Lesion Biopsy Performed Indicator","preferredDefinition":"The indicator response as to whether a biopsy on the lesion(s) was executed and carried through to completion.","longName":"LES_BX_PERF_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89F3F31E-3273-641F-E053-F662850A1ABA","latestVersionIndicator":"Yes","beginDate":"2019-05-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-28","modifiedBy":"KNABLEJ","dateModified":"2022-03-07","changeNote":"3/7/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-28-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6770705","version":"1","preferredName":"Clinical Decision Imaging Procedure Lesion Follow Up Indicator","preferredDefinition":"The indicator response as to whether there is a clinical judgment to follow the lesion by a method of imaging.","longName":"CL_DEC_IMAG_LES_FU_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89F81B98-9824-52FB-E053-F662850AE128","latestVersionIndicator":"Yes","beginDate":"2019-05-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-28","modifiedBy":"KNABLEJ","dateModified":"2022-03-07","changeNote":"3/7/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-28-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6770735","version":"1","preferredName":"BIRADS Mammography Breast Density Category","preferredDefinition":"The category that describes the relative amount of different tissues present in the breast on a mammogram based on the updated 2015 edition of the American College of Radiology's Breast Imaging Reporting and Data System (BI-RADS) reporting guidelines.","longName":"BIRADS_MAMMO_BR_DENS_CAT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89F968F8-83EA-7030-E053-F662850A6655","latestVersionIndicator":"Yes","beginDate":"2019-05-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-28","modifiedBy":"KNABLEJ","dateModified":"2022-03-07","changeNote":"3/7/22 jk released as part of quarterly content review and prior reviews with SMEs.  12/6/21 mr Added alt name, ref doc, CSI for MCL PCA breast per DCT.   5-28-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6770853","version":"1","preferredName":"PET And CT Scan Occurrence Indicator","preferredDefinition":"The indicator response as to whether a PET/CT occurred.","longName":"PETCT_OCC_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A06B349-86D7-7A81-E053-F662850A9602","latestVersionIndicator":"Yes","beginDate":"2019-05-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-29","modifiedBy":"KNABLEJ","dateModified":"2022-03-07","changeNote":"3/7/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-29-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6770871","version":"1","preferredName":"Imaging Procedure Metastatic Neoplasm Present Indicator","preferredDefinition":"An indicator response for the presence of metastatic disease on the imaging procedure.","longName":"IMAG_MET_DZ_PRES_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A05CC0C-8659-7A98-E053-F662850AB643","latestVersionIndicator":"Yes","beginDate":"2019-05-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-29","modifiedBy":"KNABLEJ","dateModified":"2022-03-07","changeNote":"3/7/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-29-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6771065","version":"1","preferredName":"Breast Calcification Histologic Classification Type","preferredDefinition":"Text term to identify the kind of calcifications by their combined microscopic physical features of cells and their surrounding extracellular environment in breast tissue.","longName":"BR_CALC_HIST_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A1A0DBC-52BE-7994-E053-F662850A8233","latestVersionIndicator":"Yes","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"KNABLEJ","dateModified":"2022-03-07","changeNote":"3/7/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-30-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6771087","version":"1","preferredName":"Invasive Lobular Breast Carcinoma Histologic Classification Subtype Type","preferredDefinition":"The histologic subtype for an infiltrating lobular carcinoma of the breast.","longName":"ILC_HIST_SUBTP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A19C823-6ECB-799A-E053-F662850A6C0A","latestVersionIndicator":"Yes","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-30-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6771219","version":"1","preferredName":"Breast DCIS Nuclear Grade Category","preferredDefinition":"The nuclear grade category used to classify Breast DCIS.","longName":"DCIS_NUC_GRAD_CAT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A1DD4A5-0967-1496-E053-F662850AD292","latestVersionIndicator":"Yes","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  10/14/19 jk classified for MCL PCA genomic pilot project.  5-30-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6771252","version":"1","preferredName":"Breast DCIS Histologic Subtype Classification Type","preferredDefinition":"The histologic subtype of a breast carcinoma entirely confined to the mammary ducts.","longName":"DCIS_HIST_SUBTP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A1DD4A5-098F-1496-E053-F662850AD292","latestVersionIndicator":"Yes","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  10/14/19 jk classified for MCL PCA genomic pilot project.  5-30-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6772150","version":"1","preferredName":"Biopsy Clip Placement Indicator","preferredDefinition":"A response to indicate if a marker was used to identify the site of a biopsy.","longName":"BX_CLIP_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A1C8499-0AE2-0A8F-E053-F662850AE1E7","latestVersionIndicator":"Yes","beginDate":"2019-05-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-30","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-30-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6773176","version":"1","preferredName":"Breast Biopsy Guidance Method Type","preferredDefinition":"The means or manner of procedure in directing a biopsy needle into an area of interest within the breast.","longName":"BR_BX_GUID_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A31B3E4-D5B1-6D68-E053-F662850A323E","latestVersionIndicator":"Yes","beginDate":"2019-05-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-31","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-31-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6773374","version":"1","preferredName":"Laboratory Procedure Oncotype DX Breast Cancer Assay Estrogen Receptor Status Finding Outcome","preferredDefinition":"The result of an Oncotype DX breast cancer estrogen receptor assay, a diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early-stage breast cancer.","longName":"LAB_ONCODX_ER_OUTCM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A338697-A914-0EBE-E053-F662850AFDCC","latestVersionIndicator":"Yes","beginDate":"2019-05-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-31","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-31-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6773375","version":"1","preferredName":"Laboratory Procedure Oncotype DX Breast Cancer Assay Progesterone Receptor Status Finding  Outcome","preferredDefinition":"The result of an Oncotype DX breast cancer progesterone receptor assay, a diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early-stage breast cancer.","longName":"LAB_ONCODX_PR_OUTCM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A33ADDA-730B-0ECB-E053-F662850AB27E","latestVersionIndicator":"Yes","beginDate":"2019-05-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-31","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-31-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6773376","version":"1","preferredName":"Laboratory Procedure Oncotype DX Breast Cancer Assay HER2 Finding Outcome","preferredDefinition":"The result of an Oncotype DX breast cancer HER2 assay, a diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early-stage breast cancer.","longName":"LAB_ONCODX_HER2_OUTCM","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A33C64A-FD78-6D78-E053-F662850A4309","latestVersionIndicator":"Yes","beginDate":"2019-05-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-31","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-31-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6773479","version":"1","preferredName":"Breast Carcinoma Preventive Intervention Indicator","preferredDefinition":"The indicator response as to whether the patient has a history of therapeutic interventions to decrease the chances of getting breast cancer.","longName":"BR_CA_PREVN_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A338697-A96B-0EBE-E053-F662850AFDCC","latestVersionIndicator":"Yes","beginDate":"2019-05-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-31","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-31-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6774541","version":"1","preferredName":"MRI Non-mass Like Enhancement Centimeter Measurement","preferredDefinition":"Annotation used to indicate the size of an area of enhancement on MRI that does not belong to a 3D mass or have distinct features of a mass, measured in centimeters.","longName":"MRI_NMLE_CM_MSRMT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A828489-DBC7-559D-E053-F662850AFBCA","latestVersionIndicator":"Yes","beginDate":"2019-06-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-04","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  6-4-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6774571","version":"1","preferredName":"Clinical Breast Examination Performed Indicator","preferredDefinition":"The indicator response as to whether an exam of the breast performed by a health care provider was carried through to completion.","longName":"CBE_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A835B2B-BB25-4863-E053-F662850ACB1E","latestVersionIndicator":"Yes","beginDate":"2019-06-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-04","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  6-4-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6774715","version":"1","preferredName":"Imaging Technique Clockface or Region Identifier","preferredDefinition":"The location identifier based on clockface numbering for an imaging procedure.","longName":"IMAG_CLOCK_ID","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A86D5AF-3326-0777-E053-F662850AC376","latestVersionIndicator":"Yes","beginDate":"2019-06-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-04","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk semantics updated, released as part of quarterly content review and prior reviews with SMEs.  6-4-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6776737","version":"1","preferredName":"Breast Neoplasm Distance From Nipple Centimeter Measurement","preferredDefinition":"Annotation used to indicate the distance from the neoplasm of the breast to the nipple, measured in centimeters.","longName":"BR_NEOPLM_DIST_FR_NIPL_MSRMT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AF94689-AA68-5CA0-E053-F662850A813D","latestVersionIndicator":"Yes","beginDate":"2019-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-10","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  6-10-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6776757","version":"1","preferredName":"Breast Carcinoma Extent Centimeter Measurement","preferredDefinition":"Annotation used to indicate the extent of breast cancer, measured in centimeters.","longName":"BR_CA_EXT_CM_MSRMT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AF8B82E-737F-0ABC-E053-F662850A02BF","latestVersionIndicator":"Yes","beginDate":"2019-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-10","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  6-10-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6776763","version":"1","preferredName":"Breast Palpable Lymph Node Laterality Anatomic Site","preferredDefinition":"The side of the breast where a lymph node is capable of being handled, or touched, or felt.","longName":"BR_PALP_LN_LAT_SITE","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AFB9FE4-D239-49D2-E053-F662850A089A","latestVersionIndicator":"Yes","beginDate":"2019-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-10","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk semantics updated, released as part of quarterly content review and prior reviews with SMEs.  6-10-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6776778","version":"1","preferredName":"Regional Matted Lymph Nodes Present Indicator","preferredDefinition":"The indicator response for the presence of lymph nodes that feel connected.","longName":"REG_MATT_LN_PRES_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AFCB026-5118-3DFF-E053-F662850AC730","latestVersionIndicator":"Yes","beginDate":"2019-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-10","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  6-10-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6777407","version":"1","preferredName":"Breast Palpable Lymph Node Anatomic Site","preferredDefinition":"The named location(s) of or within the body where the breast lymph node is capable of being handled, or touched, or felt.","longName":"BR_PALP_LN_ANAT_SITE","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AFD85B6-FBF6-1E81-E053-F662850A2511","latestVersionIndicator":"Yes","beginDate":"2019-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-10","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  6-10-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6779514","version":"1","preferredName":"Fixed Lymph Node Chest Wall Present Indicator","preferredDefinition":"The indicator response for the presence of lymph nodes attached to the chest wall.","longName":"FIXD_LN_IND","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B00B7CC-FCB5-29FB-E053-F662850A1010","latestVersionIndicator":"Yes","beginDate":"2019-06-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-11","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  6-11-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6779556","version":"1","preferredName":"Breast Carcinoma Clinical Calculated Stage","preferredDefinition":"The clinical stage for breast cancer determined by mathematical or logical methods based on the patient's combined T, N, and M categories.","longName":"BR_CLN_CALCUD_STG","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B0D8CAF-287D-6359-E053-F662850A21F9","latestVersionIndicator":"Yes","beginDate":"2019-06-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-11","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  6-11-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6780819","version":"1","preferredName":"Malignant Neoplasm Personal Medical History Anatomic Site","preferredDefinition":"The cancer location(s) of or within the body as recorded in the patient's medical history.","longName":"CA_PMH_SITE","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B36FF14-5ACE-54D0-E053-F662850A7956","latestVersionIndicator":"Yes","beginDate":"2019-06-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-13","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  6-13-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6780839","version":"1","preferredName":"Invasive Breast Carcinoma Scarff-Bloom-Richardson Grading System Calculated Grade","preferredDefinition":"The grade for invasive breast cancer determined by mathematical or logical methods, based on the grading system that was the precursor of the Nottingham system.","longName":"IBC_SBR_CALCD_GR","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B36BC6F-7F35-3A39-E053-F662850AC4C5","latestVersionIndicator":"Yes","beginDate":"2019-06-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-13","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  6-13-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6781088","version":"1","preferredName":"Computed Tomography Performed Anatomic Site","preferredDefinition":"The named location(s) of or within the body for the CT carried through to completion.","longName":"CT_SITE","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B3B3321-F30D-332F-E053-F662850A5BEF","latestVersionIndicator":"Yes","beginDate":"2019-06-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-13","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk released as part of quarterly content review and prior reviews with SMEs.  6-13-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6781099","version":"1","preferredName":"Breast Disease Histology Classification Type","preferredDefinition":"The identifiable class of breast disease based on the abnormal morphologic characteristics in tissues.","longName":"BR_DZ_HIST_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B49812E-C1C3-3D57-E053-F662850AACCB","latestVersionIndicator":"Yes","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  6-14-19 tt created for Breast initial diagnosis and surgical therapy modules.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6782231","version":"1","preferredName":"Invasive Ductal Breast Carcinoma Histologic Classification Subtype Type","preferredDefinition":"The histologic subtype for the most common type of invasive breast carcinoma.","longName":"IDC_HIST_SUBTP_TP","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B4B6666-ADAD-355C-E053-F662850ABC74","latestVersionIndicator":"Yes","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  6-14-19 tt created for Breast initial diagnosis and surgical therapy modules.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6782255","version":"1","preferredName":"Laboratory Procedure KI67 Measurement Positive Cell Count Result","preferredDefinition":"The outcome of lab tests to determine the amount of Ki-67 positive cells present in a sample.","longName":"KI67_RSLT","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B4BA627-E65F-47EB-E053-F662850A3131","latestVersionIndicator":"Yes","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-08","changeNote":"3/8/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  12/8/21 mr Added alt name, alt def, AQT, ref doc, and CSI for MCL PCA breast per DCT.   6-14-19 tt created for Breast initial diagnosis and surgical therapy modules.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6788831","version":"1","preferredName":"Anchor Date Occurrence Type","preferredDefinition":"The date used as the base date from which all other dates within a cohort or data set are derived.","longName":"6788470v1.0:6788749v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8BDAF7E5-19D1-02E7-E053-F662850AB405","latestVersionIndicator":"Yes","beginDate":"2019-06-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-06-21","modifiedBy":"COLBERTM","dateModified":"2021-11-17","changeNote":"11/17/21 mr Added CSI for MCL PCA breast (both). Added ref doc, AQT per DCT.  9/21 mr added CSI for MCL prostate. Added ref doc per MCL DD. 9/1/21 mr Added CSI for PCA -> Lung.  8/2/21-mr-Added AQT. 2/25/21 jk Upd Reg Status per SME (KA) Clinical core review and approval. 12/22/20 jk classified in Clinical Core CSI.  6/21/19 jk created for offset date content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6815891","version":"1","preferredName":"Prostate Carcinoma Local Disease Extent Category","preferredDefinition":"The category assigned to describe the location of the carcinoma within and around the prostate gland.","longName":"6815884v1.0:6815886v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8D5A16D2-5542-58FA-E053-F662850A932B","latestVersionIndicator":"Yes","beginDate":"2019-07-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-10","modifiedBy":"COLBERTM","dateModified":"2022-03-18","changeNote":"3/18/22 mr Released per DCT and SME.   10/13/21 mr Updated definition.   9/29/21 mr Updated PVs, added alt name, ref doc. Per MCL DD.  7-10-19 tt created for prostate content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6831681","version":"1","preferredName":"Extraprostatic Extension Extranodal Involvement Indicator","preferredDefinition":"Indicator for the identification of extranodal prostatic extension.","longName":"6831615v1.0:6059598v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8E884D86-9FDE-139A-E053-F662850A9FC8","latestVersionIndicator":"Yes","beginDate":"2019-07-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-25","modifiedBy":"COLBERTM","dateModified":"2022-03-18","changeNote":"3/18/22 mr Released per SME and DCT.   9/29/21 mr Updated VD to Y/N/Unk/NR indicator. Added alt name, AQT, ref doc, CSI. Per MCL DD.   7-25-19 tt created for prostate content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6834776","version":"1","preferredName":"Lymph Node Laterality Anatomic Site","preferredDefinition":"Side of the body for the location of lymph node(s).","longName":"6833042v1.0:6833084v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8ED4E7C4-FB72-3B97-E053-F662850AE6E9","latestVersionIndicator":"Yes","beginDate":"2019-07-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-29","modifiedBy":"COLBERTM","dateModified":"2022-03-18","changeNote":"3/18/22 mr Released per SME and DCT.   9/29/21 mr Added alt name, AQT, alt def, ref doc per MCL DD.   7-29-19 tt created for prostate content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6835490","version":"1","preferredName":"Metastatic Carcinoma Lymph Node Present Count","preferredDefinition":"The number of lymph nodes with carcinoma that has spread from the original site of growth to other anatomic sites.","longName":"6835481v1.0:2018392v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8ED6C214-83F3-6022-E053-F662850A6ADC","latestVersionIndicator":"Yes","beginDate":"2019-07-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-29","modifiedBy":"COLBERTM","dateModified":"2022-03-18","changeNote":"3/18/22 mr Released per DCT and SME. 9/21/21 mr Added alt name, AQT, ref doc, CSI for prostate PCA. Per MCL DD. 7-29-19 tt created for prostate content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6836206","version":"1","preferredName":"Metastatic Carcinoma Pelvic Lymph Node Present Finding Outcome","preferredDefinition":"The findings following an examination of pelvic lymph nodes for the presence of carcinoma that has spread from the original site of growth to other anatomic sites.","longName":"6835481v1.0:6682734v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8ED7BDCB-90B6-324D-E053-F662850A1A21","latestVersionIndicator":"Yes","beginDate":"2019-07-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-29","modifiedBy":"COLBERTM","dateModified":"2022-03-18","changeNote":"3/18/22 mr Released per DCT and SME.   11/4/21 mr Updated DEC OC from lymph node to pelvic lymph node and updated definition accordingly.   10/26/21 mr Added alt name, AQT, ref doc, CSI for MCL PCA prostate. Per DCT.   7-29-19 tt created for prostate content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6863673","version":"1","preferredName":"Biospecimen Precancerous Condition Other Specify","preferredDefinition":"Records a text description of the pre-cancerous specimen type if not on the list provided.","longName":"6810162v1.0:2666713v2.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9108308D-20D5-048F-E053-F662850AF21A","latestVersionIndicator":"Yes","beginDate":"2019-08-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-08-26","modifiedBy":"COLBERTM","dateModified":"2021-12-16","changeNote":"12/16/21 mr Added alt name, alt def, ref doc, MCL biospecimen CSI per DCT.   10/29/19 jk released per MCL SME (Maureen/Kristen) review.   10/28/19 jk added to LabCAS PCA Pilot CSI due to addition of \"other\" to Precancer type CDEs. 9/9/19 jk revised PQT to match specimen tracking data entry form.  8/26/19 jk created for MCL specimen tracking-specimen information.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6864730","version":"2","preferredName":"Biospecimen Precancerous Condition MCL Type","preferredDefinition":"The classification of pre-cancerous cells found in the specimen being study by the Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions (MCL).","longName":"6810162v1.0:6863672v2.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4C70D2B-FD95-0D47-E053-4EBD850A5F7A","latestVersionIndicator":"Yes","beginDate":"2022-01-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"COLBERTM","dateModified":"2022-02-11","changeNote":"2/11/22 mr Updated system def with def from v1.0. 1/4/22 mr Versioned to 2.0 to sync with new VD version 2.0. 10/29/19 jk released per MCL SME (Maureen/Kristen) review. 9/7/19 jk 2 PVs added; chg to Application. 8/26/19 jk created for MCL specimen tracking-specimen information.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6921892","version":"1","preferredName":"Biospecimen Source Laboratory Identifier","preferredDefinition":"A unique sequence of alphanumeric characters used to identify the specimen at it's point of origin.","longName":"6921888v1.0:2728596v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9220532D-5AFF-1AC4-E053-F662850A3AE6","latestVersionIndicator":"Yes","beginDate":"2019-09-09","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-09","modifiedBy":"FINCHAMB","dateModified":"2024-02-06","changeNote":"3/24/22 jk Biospecimen CSI removed; if reused in future ownership should be transferred. 10/29/19 jk released per MCL SME (Maureen/Kristen) review.  9/9/19 jk created for MCL specimen tracking system.","administrativeNotes":"1/25/23 removed CDS CDE CSI and alt names; new CDS CDE created. jk","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6931076","version":"1","preferredName":"Biospecimen Fixation Time Value","preferredDefinition":"A numerical quantity which captures the length of time it takes for chemical preservation of a biospecimen's structural and/or molecular features.","longName":"6930779v1.0:3872712v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92730413-1C11-6665-E053-F662850A596E","latestVersionIndicator":"Yes","beginDate":"2019-09-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-13","modifiedBy":"KNABLEJ","dateModified":"2022-02-22","changeNote":"2/17/22 JK Designated for reuse by HTAN/SRRS Biospecimen upload DCT, Alt Name, AQT, HTAN/SRRS CSIs. 12/20/21 mr Added alt name, AQT, alt def, ref doc, MCL Biospecimen CSI per DCT.   10/29/19 jk released per MCL SME (Maureen/Kristen) review.   9/13/19 jk created for MCL specimen tracking system.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6931077","version":"1","preferredName":"Biospecimen Fixation Time Unit of Measure","preferredDefinition":"The unit of measure associated with the numerical quantity which captures the length of time it takes for chemical preservation of a biospecimen.","longName":"6930779v1.0:6630388v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9271166D-9811-3385-E053-F662850A24AF","latestVersionIndicator":"Yes","beginDate":"2019-09-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-13","modifiedBy":"KNABLEJ","dateModified":"2022-03-24","changeNote":"3/24/22 jk Biospecimen CSI removed; if reused in future ownership should be transferred.  10/29/19 jk released per MCL SME (Maureen/Kristen) review.  9/13/19 jk created for MCL specimen tracking system.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6931105","version":"1","preferredName":"Tissue Processor Manufacturer Name","preferredDefinition":"The words by which the manufacturer of the tissue processor is known.","longName":"6930998v1.0:5406151v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9273B2DD-79F0-6FFB-E053-F662850ABD64","latestVersionIndicator":"Yes","beginDate":"2019-09-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-13","modifiedBy":"KNABLEJ","dateModified":"2022-03-24","changeNote":"3/24/22 jk MCL Biospecimen CSI removed; if reused in future ownership should be transferred. 10/29/19 jk released per MCL SME (Maureen/Kristen) review. 9/13/19 jk created for MCL specimen tracking system.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6931106","version":"1","preferredName":"Tissue Processor Protocol Name","preferredDefinition":"The words by which the protocol used for the tissue processor is known.","longName":"6931000v1.0:5406151v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9274C62D-66D2-7C53-E053-F662850A73EC","latestVersionIndicator":"Yes","beginDate":"2019-09-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-13","modifiedBy":"KNABLEJ","dateModified":"2022-03-24","changeNote":"3/24/22 jk MCL Biospecimen CSI removed; if reused in future ownership should be transferred. 10/29/19 jk released per MCL SME (Maureen/Kristen) review. 9/13/19 jk created for MCL specimen tracking system.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6931108","version":"1","preferredName":"Tissue Processor Total Time Value","preferredDefinition":"The total processing time using an automated system to process tissue specimens for examination through fixation, dehydration, and infiltration.","longName":"6931009v1.0:3872712v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92741945-539B-1425-E053-F662850A8F9A","latestVersionIndicator":"Yes","beginDate":"2019-09-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-13","modifiedBy":"KNABLEJ","dateModified":"2022-03-24","changeNote":"3/24/22 jk MCL Biospecimen CSI removed; if reused in future ownership should be transferred.  10/29/19 jk released per MCL SME (Maureen/Kristen) review.  9/13/19 jk created for MCL specimen tracking system.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6931109","version":"1","preferredName":"Tissue Processor Total Time Unit of Measure","preferredDefinition":"The unit of measure for the total processing time using an automated system to process tissue specimens for examination through fixation, dehydration, and infiltration.","longName":"6931009v1.0:6630388v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92752A0E-774B-0F05-E053-F662850AD42E","latestVersionIndicator":"Yes","beginDate":"2019-09-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-13","modifiedBy":"KNABLEJ","dateModified":"2022-03-24","changeNote":"3/24/22 jk Biospecimen CSI removed; if reused in future ownership should be transferred. 10/29/19 jk released per MCL SME (Maureen/Kristen) review.  9/13/19 jk created for MCL specimen tracking system.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6931110","version":"1","preferredName":"Tissue Processing Paraffin Type Descriptive Text","preferredDefinition":"Free text to describe the type of paraffin used in processing the biospecimen (i.e. Manufacturer and Catalog #).","longName":"6931069v1.0:2181231v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9274C62D-670F-7C53-E053-F662850A73EC","latestVersionIndicator":"Yes","beginDate":"2019-09-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-13","modifiedBy":"KNABLEJ","dateModified":"2022-03-24","changeNote":"3/24/22 jk MCL Biospecimen CSI removed; if reused in future ownership should be transferred. 9/13/19 jk created for MCL specimen tracking system.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6931111","version":"1","preferredName":"Tissue Processing Paraffin Melting Point Value","preferredDefinition":"The melting point in Celsius of the paraffin used in processing the biospecimen.","longName":"6931072v1.0:3872712v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9273BCF3-ABFE-7013-E053-F662850A2F57","latestVersionIndicator":"Yes","beginDate":"2019-09-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-13","modifiedBy":"KNABLEJ","dateModified":"2022-03-24","changeNote":"3/24/22 jk MCL Biospecimen CSI removed; if reused in future ownership should be transferred. 1/22/20 jk added \"in Celsius\" to definition per MCL SME.  10/29/19 jk released per MCL SME (Maureen/Kristen) review.  9/13/19 jk created for MCL specimen tracking system.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6931115","version":"1","preferredName":"Tissue Processor Microwave Processing Indicator","preferredDefinition":"A response of yes, no, or unknown to indicate if microwave processing was used in the fixation, dehydration, and infiltration of the biospecimen.","longName":"6931114v1.0:6682528v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92755CB0-1E3F-092E-E053-F662850AC2F4","latestVersionIndicator":"Yes","beginDate":"2019-09-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-13","modifiedBy":"KNABLEJ","dateModified":"2022-03-24","changeNote":"3/24/22 jk MCL Biospecimen CSI removed; if reused in future ownership should be transferred.   10/29/19 jk released per MCL SME (Maureen/Kristen) review. 9/13/19 jk created for MCL specimen tracking system.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6944379","version":"1","preferredName":"Data Collection Identifier","preferredDefinition":"One or more characters which identifies a data collection used for testing or research purposes.","longName":"6943519v1.0:5251428v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93628F78-DECB-1942-E053-F662850A7C3E","latestVersionIndicator":"Yes","beginDate":"2019-09-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-25","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  9/25/19 jk created for LabCas data collection and PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6944383","version":"1","preferredName":"Data Collection Name","preferredDefinition":"The words which identify a data collection used for testing or research purposes.","longName":"6943521v1.0:5406151v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9365C759-3447-7B96-E053-F662850AD5BA","latestVersionIndicator":"Yes","beginDate":"2019-09-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-25","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  9/25/19 jk created for LabCas data collection and PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6944391","version":"1","preferredName":"Data Collection Description Text","preferredDefinition":"The words which provides an explanation of the data collection used for testing or research purposes.","longName":"6943523v1.0:6847557v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93673772-DBC8-044B-E053-F662850A373C","latestVersionIndicator":"Yes","beginDate":"2019-09-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-25","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  9/25/19 jk created for LabCas data collection and PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6944407","version":"1","preferredName":"Data Collection Discipline Occupation or Discipline Type","preferredDefinition":"The field of study(s) associated with the data collection.","longName":"6943528v1.0:6944403v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9367C2C7-FDA2-3B8C-E053-F662850A2EF4","latestVersionIndicator":"Yes","beginDate":"2019-09-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-25","modifiedBy":"COLBERTM","dateModified":"2023-02-01","changeNote":"3/1/22 jk Designated, added CDS alt name and CSI.  9/25/19 jk created for LabCas data collection and PCA-Genomic pilot project.","administrativeNotes":"2/1/23 Removed CRDC CDS CSI, used by, alt name. Recommend for future use CDE 11160683, a CRDC std. mr","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6944578","version":"1","preferredName":"Data Collection Analytical Methods Text","preferredDefinition":"The words which describe the process by which a data collection is tested or used for research purposes.","longName":"6944562v1.0:6847557v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9367D25E-6BFB-3213-E053-F662850A03F6","latestVersionIndicator":"Yes","beginDate":"2019-09-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-25","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  9/25/19 jk created for LabCas PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6950458","version":"1","preferredName":"Data Collection Aim Text","preferredDefinition":"The words which describe the goal intended to be attained for testing or research purposes.","longName":"6950442v1.0:6847557v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"938A1E3B-0E03-39DB-E053-F662850A4C70","latestVersionIndicator":"Yes","beginDate":"2019-09-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-27","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  9/27/19 jk created for LabCas PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6951298","version":"1","preferredName":"Data Collection User Privilege Category","preferredDefinition":"The category of data access level which are allowed by a user.","longName":"6950275v1.0:6950451v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93B418A0-9B10-4C45-E053-F662850AC76A","latestVersionIndicator":"Yes","beginDate":"2019-09-29","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-29","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review. 9/29/19 jk created for LabCas PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6951299","version":"1","preferredName":"Data Collection Authorized Username Identifier","preferredDefinition":"One or more characters used to identify the designated user account name that has access to data used for testing or research purposes.","longName":"6945946v1.0:5251428v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93B4DF01-BE09-4C2A-E053-F662850ADB07","latestVersionIndicator":"Yes","beginDate":"2019-09-29","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-29","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  9/29/19 jk created for LabCas PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6951300","version":"1","preferredName":"Data Collection Lead Principal Investigator Identifier","preferredDefinition":"One or more characters used to identify the investigator who is responsible for all aspects of the data used for testing or research purposes.","longName":"6943615v1.0:5251428v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93B50AE7-ABD6-4C34-E053-F662850A4F49","latestVersionIndicator":"Yes","beginDate":"2019-09-29","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-29","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  9/29/19 jk created for LabCas PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6951303","version":"1","preferredName":"Data Collection Species Type","preferredDefinition":"The name that describes a organism group from which the cells used in the data collection originated.","longName":"6951302v1.0:6951316v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93B50AE7-AC0A-4C34-E053-F662850A4F49","latestVersionIndicator":"Yes","beginDate":"2019-09-29","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-29","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  9/29/19 jk created for LabCas PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6951309","version":"1","preferredName":"Data Set Description Text","preferredDefinition":"The words which provides an explanation of the collection of related data records used for testing or research purposes.","longName":"2866614v1.0:6847557v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93C6C865-0FBF-5E29-E053-F662850A7B5E","latestVersionIndicator":"Yes","beginDate":"2019-09-30","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-30","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  9/30/19 jk created for LabCas data collection and PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6951310","version":"1","preferredName":"Data Set Identifier","preferredDefinition":"One or more characters which identifies the data set used for testing or research purposes.","longName":"2726871v1.0:5251428v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93C6BC42-24B0-6537-E053-F662850AA6B2","latestVersionIndicator":"Yes","beginDate":"2019-09-30","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-30","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review and prior reviews with SME.  9/30/19 jk created for LabCas data collection and PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6951311","version":"1","preferredName":"Data Set Name","preferredDefinition":"The words which identify the data set used for testing or research purposes.","longName":"6951308v1.0:5406151v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93C6BC42-24DE-6537-E053-F662850AA6B2","latestVersionIndicator":"Yes","beginDate":"2019-09-30","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-30","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  9/30/19 jk created for LabCas data collection and PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6951330","version":"1","preferredName":"Data Set Experiment Design Text","preferredDefinition":"The words which provides an explanation of the methodology/experimental design used for the collection of related data records..","longName":"6951329v1.0:6847557v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93C7F7B9-842A-2010-E053-F662850AAFB9","latestVersionIndicator":"Yes","beginDate":"2019-09-30","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-30","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  9/30/19 jk created for LabCas data collection and PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6953373","version":"1","preferredName":"Data Set Protocol Title Name","preferredDefinition":"The words used as the official descriptive name of a document which describes the rules used to perform an activity on a collection of related data records.","longName":"6953367v1.0:6379856v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93E0F5A1-8EE8-2011-E053-F662850A5E74","latestVersionIndicator":"Yes","beginDate":"2019-10-01","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-01","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  12/17/21 jk change VD for larger max size.  10/9/19 jk Revised for upd DEC. 10/1/19 jk created for LabCas data collection and PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6953390","version":"1","preferredName":"Sequence Analysis Polymerase Chain Reaction Cycle Count","preferredDefinition":"The quantity of recurring rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase in a sample used for testing.","longName":"6953370v1.0:6272433v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"93E10E78-45B0-7DFC-E053-F662850AA427","latestVersionIndicator":"Yes","beginDate":"2019-10-01","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-01","modifiedBy":"KNABLEJ","dateModified":"2021-03-17","changeNote":"6/3/20 jk - chg VD to supoort Number(4) per MCL upload specs; add 3SEQ CSI.  10/16/19 jk upd LN to reflect revised DEC post SME review.  10/1/19 jk created for LabCas data collection and PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6953431","version":"1","preferredName":"Pooled Sample Sequencing Library Count","preferredDefinition":"The quantity of double stranded DNA fragments flanked by oligonucleotide sequence adapters in a mix of specimens from multiple sources.","longName":"6953430v1.0:7001795v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"93DE284A-DFC9-2186-E053-F662850AA0A3","latestVersionIndicator":"Yes","beginDate":"2019-10-01","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-01","modifiedBy":"KNABLEJ","dateModified":"2021-03-17","changeNote":"3/17/21 jk Released, upd Reg Status per SME (KA) review and approval.  6/3/20 jk chg VD to support Number(3); added SEQ3 CSI.  10/1/19 jk created for LabCas data collection and PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6953436","version":"1","preferredName":"Data Set Data Custodian Name","preferredDefinition":"The name of the person responsible and held accountable for a collection of related data records.","longName":"6953435v1.0:5406151v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93DE2AAD-64A4-3813-E053-F662850AE77C","latestVersionIndicator":"Yes","beginDate":"2019-10-01","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-01","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  10/9/19 jk upd for revised DEC.  10/1/19 jk created for LabCas data collection and PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6953437","version":"1","preferredName":"Data Set Data Custodian Email Address Text","preferredDefinition":"The email of the person responsible and held accountable for a collection of related data records.","longName":"6953435v1.0:2484074v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93E1A6D4-6F56-7E00-E053-F662850A7ECF","latestVersionIndicator":"Yes","beginDate":"2019-10-01","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-01","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk added \"Qualified\" RS as part of MCL quarterly content review. 10/9/19 jk upd for revised DEC. 10/1/19 jk created for LabCas data collection and PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6953476","version":"1","preferredName":"Malignant Neoplasm Invasive Lesion Category","preferredDefinition":"The category of a tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.","longName":"6953474v1.0:6953471v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93DE284A-DFF6-2186-E053-F662850AA0A3","latestVersionIndicator":"Yes","beginDate":"2019-10-01","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-01","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  10/1/19 jk created for LabCas data collection and PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6953493","version":"1","preferredName":"Tissue Dissection Region Cell Quantity Count","preferredDefinition":"The number of cells within a specified area or portion of a biological sample.","longName":"6953479v1.0:2018392v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93DE2AAD-6502-3813-E053-F662850AE77C","latestVersionIndicator":"Yes","beginDate":"2019-10-01","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-01","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  10/16/19 jk upd to reflect revised DEC post SME review.  10/1/19 jk created for LabCas data collection and PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6953494","version":"1","preferredName":"Tissue Dissection Region Cellularity Measurement Percentage Value","preferredDefinition":"The degree, quality, or condition of cells that are present within an area or portion of a biological sample.","longName":"6953482v1.0:6757345v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93E3AE5E-83E9-5B04-E053-F662850ADF25","latestVersionIndicator":"Yes","beginDate":"2019-10-01","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-01","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  10/16/19 jk upd LN to reflect revised DEC post SME review.  10/1/19 jk created for LabCas data collection and PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6953495","version":"1","preferredName":"Tissue Dissection Region Histology Type","preferredDefinition":"The class of cells identifiable based on their structure and arrangement within an area or portion of a biological sample.","longName":"6953485v1.0:6997707v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93E300B9-0859-59C5-E053-F662850A2B53","latestVersionIndicator":"Yes","beginDate":"2019-10-01","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-01","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  10/16/19 jk upd LN to reflect revised DEC post SME review.  10/1/19 jk created for LabCas data collection and PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6974943","version":"1","preferredName":"Data Source Study Site MCL Institution Name","preferredDefinition":"Text which identifies the organization or facility which  provided the data and related information.","longName":"6974940v1.0:6356234v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9480BA07-BC25-7FA8-E053-F662850AA011","latestVersionIndicator":"Yes","beginDate":"2019-10-09","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-09","modifiedBy":"COLBERTM","dateModified":"2023-03-08","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  10/9/19 jk created for LabCas data collection and PCA-Genomic pilot project.","administrativeNotes":"3/8/23 Removed PCDC CSI, alts. mr;\r\n2/16/23 Decided semantics were not right for re-use by PCDC, will retire 2.0 and un-retire 1.0. mr;\r\n2/13/23 Versioned to generalize for use by PCDC and other non-MCL orgs. mr","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6974944","version":"1","preferredName":"Data Source Investigator Name","preferredDefinition":"The name of the person authorized to provide the data and related information.","longName":"6974942v1.0:5406151v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9480C3E2-6743-7F8E-E053-F662850AA8D5","latestVersionIndicator":"Yes","beginDate":"2019-10-09","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-09","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  10/9/19 jk created for LabCas data collection and PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6983162","version":"1","preferredName":"File Type Descriptive Text","preferredDefinition":"Text that provides a description of a particular kind of set of related records.","longName":"2915631v1.0:2181231v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"94E49BE1-A3D8-2CA7-E053-F662850A4D1D","latestVersionIndicator":"Yes","beginDate":"2019-10-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-14","modifiedBy":"JKNABLE","dateModified":"2023-02-10","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review and prior reviews with SME.   10/14/19 jk created for MCL LabCAS File and PCA genomic pilot project collections.","administrativeNotes":"11/7/22 added CDS Alt Name. jk; 11/1/22 Added CS/CSI for CRDC CDS per CDS metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6983172","version":"1","preferredName":"File Description Text","preferredDefinition":"The words that describe the content of a set of related data records.","longName":"2830112v1.0:6847557v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"94E41BF3-F8C1-2CB7-E053-F662850A84C2","latestVersionIndicator":"Yes","beginDate":"2019-10-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-14","modifiedBy":"COLBERTM","dateModified":"2022-11-01","changeNote":"3/1/22 jk Released for reuse; Designated, added CDS alt name and CSI. 10/14/19 jk created for MCL LabCAS File and PCA genomic pilot project collections.","administrativeNotes":"11/1/22 Removed CS/CSI for CRDC CDS per CDS submission metatdata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6986561","version":"1","preferredName":"Data Collection Precancerous Condition MCL Type","preferredDefinition":"The classification of pre-cancerous cells found in a specific collection of data being study by the Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions (MCL).","longName":"6984231v1.0:6863672v2.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"94E3FB57-319E-2CBB-E053-F662850AFC6A","latestVersionIndicator":"Yes","beginDate":"2019-10-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk CDE updated for versioned VD, released as part of quarterly draft content review.  10/14/19 jk created for MCL PCA genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6986562","version":"1","preferredName":"Data Set Precancerous Condition MCL Type","preferredDefinition":"The classification of pre-cancerous cells found in a specific data set being study by the Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions (MCL).","longName":"6983217v1.0:6863672v2.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"94E4FC8A-48FC-6C3B-E053-F662850A2198","latestVersionIndicator":"Yes","beginDate":"2019-10-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk CDE updated for versioned VD, released as part of quarterly draft content review.  10/14/19 jk created for MCL PCA genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6986569","version":"1","preferredName":"File Precancerous Condition MCL Type","preferredDefinition":"The classification of pre-cancerous cells found in a specific file being study by the Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions (MCL).","longName":"6984724v1.0:6863672v2.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"94E3FB57-31D4-2CBB-E053-F662850AFC6A","latestVersionIndicator":"Yes","beginDate":"2019-10-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk CDE updated for versioned DEC/VD, released as part of quarterly draft content review.  10/14/19 jk created for MCL PCA genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6986854","version":"1","preferredName":"Malignant Neoplasm Necrosis Breast Type","preferredDefinition":"The type of necrosis affecting atypical neoplastic cells within the breast.","longName":"2182233v2.0:6986729v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"94E65BD6-A958-7F50-E053-F662850A76DE","latestVersionIndicator":"Yes","beginDate":"2019-10-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review and prior reviews with SME.   10/14/19 jk created for MCL PCA genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6999248","version":"1","preferredName":"Tissue Dissection Region Area Square Micrometer Measurement","preferredDefinition":"The size of a specified area or portion of a biological sample measured in µm2.","longName":"6996289v1.0:6997669v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95087165-2976-5636-E053-F662850A857D","latestVersionIndicator":"Yes","beginDate":"2019-10-16","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-16","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  10/16/19 jk created for MCL PCA genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6999494","version":"1","preferredName":"Tissue Dissection Method Type","preferredDefinition":"The type of tissue dissection procedure or systematic course of actions performed.","longName":"6996291v1.0:6999487v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"950A0CBD-D8F8-231E-E053-F662850A978B","latestVersionIndicator":"Yes","beginDate":"2019-10-16","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-16","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  10/16/19 jk created for MCL PCA genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6999504","version":"1","preferredName":"Tissue Dissection Method Other Specify","preferredDefinition":"The type of tissue dissection procedure or systematic course of actions performed which is different than the ones previously specified.","longName":"6996291v1.0:6832577v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"950A197B-5E89-4595-E053-F662850A9B85","latestVersionIndicator":"Yes","beginDate":"2019-10-16","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-16","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review. 10/16/19 jk created for MCL PCA genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6999512","version":"1","preferredName":"Tissue Dissection Region Histology Other Specify","preferredDefinition":"The class of cells identifiable based on their structure and arrangement within an area or portion of a biological sample which is different than the ones previously specified.","longName":"6953485v1.0:6832577v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"950A2445-543F-090C-E053-F662850AF2F1","latestVersionIndicator":"Yes","beginDate":"2019-10-16","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-16","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  10/16/19 jk created for MCL PCA genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6999971","version":"1","preferredName":"Sequence Analysis Input Sample Type","preferredDefinition":"The type of substance or portion of material obtained for use in the computational analysis performed to determine the similarities between nonidentical proteins or molecules of DNA or RNA.","longName":"6999950v1.0:6999933v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"950C8640-0726-0228-E053-F662850A61C8","latestVersionIndicator":"Yes","beginDate":"2019-10-16","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-16","modifiedBy":"KNABLEJ","dateModified":"2021-03-17","changeNote":"3/17/21 jk Released, upd Reg Status per SME (KA) review and approval. 10/16/19 jk created for MCL PCA genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6999992","version":"1","preferredName":"Sequence Analysis Indexed Sequencing Type","preferredDefinition":"The type of sequencing method used to add a unique identifier sequence to samples during library preparation allowing multiple libraries to be pooled and processed together.","longName":"6999954v1.0:6999914v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"950CA148-BEF8-02A9-E053-F662850AEE77","latestVersionIndicator":"Yes","beginDate":"2019-10-16","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-16","modifiedBy":"KNABLEJ","dateModified":"2021-03-17","changeNote":"3/17/21 jk Released, upd Reg Status per SME (KA) review and approval.  6/3/20 jk added SEQ3 CSI.  10/16/19 jk created for MCL PCA genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6999993","version":"1","preferredName":"Sequence Analysis Indexed Sequencing Other Specify","preferredDefinition":"The type of sequencing method which is different than the one(s) previously specified used to add a unique identifier sequence to samples during library preparation allowing multiple libraries to be pooled and processed together.","longName":"6999954v1.0:2666713v2.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"950CA77C-0B52-7DD3-E053-F662850A3CF4","latestVersionIndicator":"Yes","beginDate":"2019-10-16","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-16","modifiedBy":"KNABLEJ","dateModified":"2021-03-17","changeNote":"3/17/21 jk Released, upd Reg Status per SME (KA) review and approval. 6/3/20 jk upd PQT, chg'd VD to NCI Standard Other Specify; added SEQ3 CSI.   10/16/19 jk created for MCL PCA genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7000347","version":"1","preferredName":"Tissue Block Creation Year Date","preferredDefinition":"The particular year a preserved specimen was embedded in support material.","longName":"6996228v1.0:6841661v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"950A4FD4-002B-187E-E053-F662850A133E","latestVersionIndicator":"Yes","beginDate":"2019-10-16","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-16","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review.  10/29/19 jk upd LN to match C25436 synonym added for MCL.  10/16/19 jk created for MCL PCA genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7000349","version":"1","preferredName":"Tissue Block Preservation Method Type","preferredDefinition":"The type of preservation procedure utilized to save a specimen by embedding it in support material to maintain the cells and tissues in a viable state.","longName":"6996230v1.0:6953490v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"950A4FD4-0053-187E-E053-F662850A133E","latestVersionIndicator":"Yes","beginDate":"2019-10-16","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-16","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeNote":"3/22/22 jk LabCas AI, released as part of quarterly draft content review. 10/29/19 jk upd LN to match C25436 synonym added for MCL.  10/16/19 jk created for MCL PCA genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7028299","version":"1","preferredName":"Tissue Processor Processing Indicator","preferredDefinition":"A response of yes, no, or unknown to indicate if a tissue processor was used to prepare the biospecimen.","longName":"6931006v1.0:6682528v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"95C52DDF-E6A4-64BC-E053-F662850A39AB","latestVersionIndicator":"Yes","beginDate":"2019-10-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-26","modifiedBy":"KNABLEJ","dateModified":"2022-03-24","changeNote":"3/24/22 jk MCL Biospecimen CSI removed; if reused in future ownership should be transferred.  10/29/19 jk released per MCL SME (Maureen/Kristen) review. 10/26/19 jk created for MCL specimen tracking system.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7072105","version":"1","preferredName":"Birth Date Days From Anchor Date Count","preferredDefinition":"Number of days between the date used for index and the date from a person's birth represented as a calculated negative number of days.","longName":"7072104v1.0:7069460v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9909F1FB-F31A-0190-E053-F662850A05E8","latestVersionIndicator":"Yes","beginDate":"2019-12-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-06","modifiedBy":"KNABLEJ","dateModified":"2021-02-25","changeNote":"2/25/21 jk Upd Reg Status per SME (KA) Clinical core review and approval. 12/22/20 jk classified in Clinical Core CSI.  4/17/20 jk replaced date CDE with offset date CDE. 1/27/10 jk released per MCL SME.  12/12/19 jk added PQT per discussion with SME.  12/6/19 jk created for calculated birth offset date value.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7147699","version":"1","preferredName":"Informed Consent Form Signed Days From Anchor Date Count","preferredDefinition":"The number of calendar days from the data set base date to the date on which an individual signed the procedure  consent document.","longName":"7147296v1.0:7069460v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CBD6841-33AD-2FCE-E053-F662850AD081","latestVersionIndicator":"Yes","beginDate":"2020-01-22","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-22","modifiedBy":"KNABLEJ","dateModified":"2020-01-27","changeNote":"1/27/10 jk released per MCL SME.  1/22/20 jk offset date CDE created for MCL Core data variable.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7147703","version":"1","preferredName":"Participant Enrollment Days From Anchor Date Count","preferredDefinition":"The number of calendar days from the data set base date to the date of participant enrollment.","longName":"7147300v1.0:7069460v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"Upper Gastrointestinal CDE Disease Committee","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CBD860B-4B0E-4943-E053-F662850A7A6B","latestVersionIndicator":"Yes","beginDate":"2020-01-22","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-22","modifiedBy":"KNABLEJ","dateModified":"2022-01-28","changeNote":"1/28/22 jk updated for dup enrollment CDEs (7544688, 7147703) in MCL Core; this CDE replaces 7544688. 1/27/10 jk released per MCL SME.  1/22/20 jk offset date CDE created for MCL Core data variable.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7147704","version":"1","preferredName":"Person Body Weight Days From Anchor Date Count","preferredDefinition":"The number of calendar days from the data set base date to the date on which a participant's weight was obtained.","longName":"7147318v1.0:7069460v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9CBDA46C-A5EE-4937-E053-F662850A061E","latestVersionIndicator":"Yes","beginDate":"2020-01-22","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-22","modifiedBy":"KNABLEJ","dateModified":"2021-02-25","changeNote":"2/25/21 jk Upd Reg Status per SME (KA) Clinical core review and approval.  1/27/10 jk released per MCL SME.  1/22/20 jk offset date CDE created for MCL Core data variable.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7147705","version":"1","preferredName":"Diagnosis Date Days From Anchor Date Count","preferredDefinition":"The number of calendar days from the data set base date to the date on which a participant's disease was diagnosed.","longName":"7147303v1.0:7069460v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CBD6841-33D7-2FCE-E053-F662850AD081","latestVersionIndicator":"Yes","beginDate":"2020-01-22","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-22","modifiedBy":"KNABLEJ","dateModified":"2020-04-17","changeNote":"4/17/20 jk replaced date CDE with offset date CDE. 1/27/20 jk released per MCL SME.   1/22/20 jk offset date CDE created for MCL Core data variable.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7147706","version":"1","preferredName":"Disease or Disorder Detection Days From Anchor Date Count","preferredDefinition":"The number of days between the date used for anchor/index and the date the lesion or tumor was detected.","longName":"7147305v1.0:7069460v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9CBDA46C-A61D-4937-E053-F662850A061E","latestVersionIndicator":"Yes","beginDate":"2020-01-22","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-22","modifiedBy":"COLBERTM","dateModified":"2021-12-03","changeNote":"12/3/21 mr Added AQT, ref doc, CSI for MCL PCA breast per DCT.   2/25/21 jk Upd Reg Status per SME (KA) Clinical core review and approval.  1/27/10 jk released per MCL SME.  1/22/20 jk offset date CDE created for MCL Core data variable.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7147707","version":"1","preferredName":"Last Previous Screening Days From Anchor Date Count","preferredDefinition":"The number of days between the date used for anchor/index and the date of last previous cancer screening.","longName":"7147307v1.0:7069460v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9CBD6841-33FF-2FCE-E053-F662850AD081","latestVersionIndicator":"Yes","beginDate":"2020-01-22","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-22","modifiedBy":"COLBERTM","dateModified":"2021-12-10","changeNote":"12/10/21 mr Added alt name, AQT, alt def, ref doc, CSI for MCL PCA breast per DCT.  2/25/21 jk Upd Reg Status per SME (KA) Clinical core review and approval.  1/27/10 jk released per MCL SME.  1/22/20 jk offset date CDE created for MCL Core data variable.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7147709","version":"1","preferredName":"Last Negative Finding Screening Days From Anchor Date Count","preferredDefinition":"The number of days between the date used for anchor/index and the date of last negative cancer screening.","longName":"7147309v1.0:7069460v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9CBBBEA1-54D4-2BE1-E053-F662850A4DA4","latestVersionIndicator":"Yes","beginDate":"2020-01-22","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-22","modifiedBy":"COLBERTM","dateModified":"2021-12-03","changeNote":"12/3/21 mr Added alt name, AQT, alt def, ref doc, CSI for MCL PCA breast per DCT.  2/25/21 jk Upd Reg Status per SME (KA) Clinical core review and approval.  1/27/10 jk released per MCL SME.  1/22/20 jk offset date CDE created for MCL Core data variable.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7147710","version":"1","preferredName":"Electronic Cigarette Or Personal Vaporizer Start Use Days From Anchor Date Count","preferredDefinition":"The number of calendar days from the data set base date to the date on which the participant started using a battery-powered electronic device designed to atomize a nicotine-containing liquid solution for inhalation.","longName":"7147312v1.0:7069460v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CBBBEA1-54FC-2BE1-E053-F662850A4DA4","latestVersionIndicator":"Yes","beginDate":"2020-01-22","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-22","modifiedBy":"KNABLEJ","dateModified":"2020-01-27","changeNote":"1/27/10 jk released per MCL SME.  1/22/20 jk offset date CDE created for MCL Core data variable.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7147711","version":"1","preferredName":"Electronic Cigarette Or Personal Vaporizer Cessation Days From Anchor Date Count","preferredDefinition":"The number of calendar days from the data set base date to the date on which the participant stopped using a battery-powered electronic device designed to atomize a nicotine-containing liquid solution for inhalation.","longName":"7147315v1.0:7069460v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CBDA7EA-B550-493F-E053-F662850ACAA7","latestVersionIndicator":"Yes","beginDate":"2020-01-22","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-22","modifiedBy":"KNABLEJ","dateModified":"2020-01-27","changeNote":"1/27/10 jk released per MCL SME.  1/22/20 jk offset date CDE created for MCL Core data variable.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7247313","version":"1","preferredName":"Biospecimen Pathologic Examination CAP Grade","preferredDefinition":"The result of a pathological examination utilizing the College of American Pathologists (CAP) assessment scale.","longName":"6687939v1.0:6687929v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A35CE4F8-03A7-0F95-E053-F662850A2716","latestVersionIndicator":"Yes","beginDate":"2020-04-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-04-15","modifiedBy":"COLBERTM","dateModified":"2022-03-18","changeNote":"3/18/22 mr Released per SME and DCT.   11/18/21 mr Updated VD, added CSI, alt def, ref doc per MCL PCA breast DCT. 4/15/20 jk created for PCA Breast.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7247339","version":"1","preferredName":"Breast Biopsy Assessment Breast Laterality Category","preferredDefinition":"The side of the body from which the breast tissue specimen was removed for microscopic examination.","longName":"7247338v1.0:7841448v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A36A10F2-DA7C-5AB6-E053-F662850A3130","latestVersionIndicator":"Yes","beginDate":"2020-04-16","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-04-16","modifiedBy":"COLBERTM","dateModified":"2022-03-01","changeNote":"3/1/22 mr Released per SME.   11/19/21 mr Created new VD to add PV & increase length. Added AQT, ref doc, CSI. Updated definition from machine-generated. Per MCL PCA breast DCT. 4/16/20 jk created for MCL PCA Breast content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7247343","version":"1","preferredName":"Breast Biopsy Assessment Anatomic Site Quadrant Name","preferredDefinition":"The breast quadrant or structure from which the breast tissue specimen was removed for microscopic examination.","longName":"7247338v1.0:3290583v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A36A4471-8153-7B4E-E053-F662850A007A","latestVersionIndicator":"Yes","beginDate":"2020-04-16","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-04-16","modifiedBy":"COLBERTM","dateModified":"2022-03-18","changeNote":"3/18/22 mr Released per SME and DCT.   11/19/21 mr Added alt name, CSI, ref doc per MCL PCA Breast DCT.  4/16/20 jk created for MCL PCA Breast content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7248868","version":"1","preferredName":"Histopathologic Examination Lesion Size Measurement","preferredDefinition":"The measured size of a lesion as a result of a histological examination of the tissue characteristics and abnormalities.","longName":"7248843v1.0:7248856v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A380A568-83CC-5CA8-E053-F662850AE9DA","latestVersionIndicator":"Yes","beginDate":"2020-04-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-04-17","modifiedBy":"COLBERTM","dateModified":"2022-03-18","changeNote":"3/18/22 mr Released per DCT and SME.   12/14/21 mr Updated with revised VD.   11/19/21 mr Added coding instructions, ref doc, alt name, CSI per MCL PCA breast DCT. 4/15/20 jk created for PCA Breast.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7248869","version":"1","preferredName":"Histopathologic Examination Necrosis Present Indicator","preferredDefinition":"A response to indicate if necrosis is present in a lesion as determined by the histological examination of the tissue.","longName":"7248846v1.0:6682528v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A3807F66-4E2C-03C8-E053-F662850A854A","latestVersionIndicator":"Yes","beginDate":"2020-04-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-04-17","modifiedBy":"COLBERTM","dateModified":"2022-03-18","changeNote":"3/18/22 mr Released per SME and DCT.   11/19/21 mr Added CSI, alt name, ref doc per MCL PCA breast DCT.  4/15/20 jk created for PCA Breast.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7248870","version":"1","preferredName":"Histopathologic Examination Necrosis Category","preferredDefinition":"The category of necrosis present in a lesion as determined by a histological examination of the tissue","longName":"7248849v1.0:7248852v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A380D3FD-5B69-01AA-E053-F662850A3947","latestVersionIndicator":"Yes","beginDate":"2020-04-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-04-17","modifiedBy":"COLBERTM","dateModified":"2022-03-18","changeNote":"3/18/22 mr Released per DCT and SME.   11/19/21 mr Added CSI, alt name, AQT, ref doc per MCL PCA breast DCT.  4/17/20 jk created for PCA Breast.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7318162","version":"1","preferredName":"Sequence Analysis Indexed Sequencing Text","preferredDefinition":"The sequencing string, or pair of strings in case of dual index, of ACGT (the four types of bases found in DNA) enabling 96 different samples on a single flow cell.","longName":"6999954v1.0:7318161v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A72F07D9-FD02-4D12-E053-4EBD850A099B","latestVersionIndicator":"Yes","beginDate":"2020-06-03","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-03","modifiedBy":"KNABLEJ","dateModified":"2021-03-17","changeNote":"3/17/21 jk Released, upd Reg Status per SME (KA) review and approval. 12/22/20 jk added coding note.  6/3/20 jk created for MCL Genomic SEQ3 CDE set.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7318199","version":"1","preferredName":"Sequence Analysis File Data Source Number","preferredDefinition":"A numeral or string of numerals identifying the MCL organization which generated the sequencing.","longName":"6352170v1.0:7318194v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7330894-9F30-1DEF-E053-4EBD850A9C57","latestVersionIndicator":"Yes","beginDate":"2020-06-03","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-03","modifiedBy":"KNABLEJ","dateModified":"2022-03-23","changeNote":"3/23/22 jk Released as part of MCL quarterly draft content review.  6/3/20 jk created for MCL Genomic Core CDE set.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7318266","version":"1","preferredName":"Sequence Analysis File Batch Identifier","preferredDefinition":"One or more characters used to identify samples in a specific sequencer run.","longName":"7318265v1.0:5251428v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A733854F-C767-144E-E053-4EBD850AF29C","latestVersionIndicator":"Yes","beginDate":"2020-06-03","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-03","modifiedBy":"KNABLEJ","dateModified":"2022-03-23","changeNote":"3/23/22 jk Released as part of MCL quarterly draft content review.  6/3/20 jk created for MCL Genomic Core CDE set.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7318689","version":"1","preferredName":"MCL Biospecimen Identifier","preferredDefinition":"A sequence of letters, numbers, or other characters that uniquely identifies a biospecimen obtained for research purposes.  The MCL biospecimen identifier which is comprised of the MCL participant identifier and a unique specimen number (ex. MCL75_001_10100).","longName":"7318688v1.0:8014356v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A74A8C64-C6C6-6571-E053-4EBD850AFEC9","latestVersionIndicator":"Yes","beginDate":"2020-06-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-04","modifiedBy":"COLBERTM","dateModified":"2022-03-23","changeNote":"3/23/22 mr Added LabCAS CSI.   3/21/22 mr Released per SME.   2/3/22 jk Upd data to use MCL specific format VD.  12/13/21 mr Added AQT, alt def, ref doc, coding instructions and CSI for MCL Biospecimen per DCT.  2021-3-29 ak Removed Reference Doc \"MCL-Template Field Name\" specimen_id and added as alt name.  10/16/20 jk added MCL Biospecimen CSI; MCL Template label. 6/4/20 jk Derived CDE to capture specimen sample identifier.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7537144","version":"1","preferredName":"Alcohol History Indicator","preferredDefinition":"The response indicating whether a patient has ever consumed alcohol.","longName":"2179379v1.0:7537142v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B7170FC6-4DD1-0132-E053-4EBD850AD0DE","latestVersionIndicator":"Yes","beginDate":"2020-12-22","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-12-22","modifiedBy":"COLBERTM","dateModified":"2023-09-15","changeNote":"2/25/21 jk Released, upd Reg Status per SME (KA) review and approval. 12/22/20 jk created for Clinical Core data set.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7539706","version":"1","preferredName":"Household Income Category","preferredDefinition":"The response indicating the category to designate the total income of a household.","longName":"2185514v1.0:7539671v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B726FAAB-4D39-4740-E053-4EBD850AF5EA","latestVersionIndicator":"Yes","beginDate":"2020-12-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-12-23","modifiedBy":"KNABLEJ","dateModified":"2021-02-25","changeNote":"2/25/21 jk Released, upd Reg Status per SME (KA) review and approval. 12/22/20 jk created for Clinical Core data set.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7539714","version":"1","preferredName":"Prior Cancer Diagnosis Indicator","preferredDefinition":"The response indicating whether a person has been diagnosed with cancer.","longName":"2010134v4.0:7537142v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B6FB648D-2030-0CC0-E053-4EBD850A6220","latestVersionIndicator":"Yes","beginDate":"2020-12-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-12-23","modifiedBy":"HARTLEYG","dateModified":"2021-11-30","changeNote":"10/1/21 mr Added AQT, ref doc, CSI per MCL prostate DD.   9/14/21 mr Added alt name, AQT, alt def, ref doc, CSI. Per MCL lung DD. 2/25/21 jk Released, upd Reg Status per SME (KA) review and approval. 12/22/20 jk created for Clinical Core data set.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7544287","version":"1","preferredName":"Biospecimen Collected Indicator","preferredDefinition":"A response to indicate whether or not a biospecimen such as cellular molecules, cells, or tissue was collected.","longName":"3192115v1.0:6682528v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B806A863-1AB2-1A82-E053-4EBD850A626F","latestVersionIndicator":"Yes","beginDate":"2021-01-03","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-01-03","modifiedBy":"KNABLEJ","dateModified":"2021-02-25","changeNote":"2/25/21 jk Released, upd Reg Status per SME (KA) review and approval. 1/3/21 jk created for MCL Clinical Core data set.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7544297","version":"1","preferredName":"Alcohol Consumption Average Per Day Count","preferredDefinition":"The average number of alcoholic beverages a  participant consumes per day.","longName":"7544296v1.0:6272433v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B80906C7-4FF5-15C2-E053-4EBD850AFC75","latestVersionIndicator":"Yes","beginDate":"2021-01-03","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-01-03","modifiedBy":"KNABLEJ","dateModified":"2021-02-25","changeNote":"2/25/21 jk Released, upd Reg Status per SME (KA) review and approval. 1/3/21 jk created for Clinical Core data set per Dec 2020 Data Dictionary review.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7544298","version":"1","preferredName":"Cigarette Average Daily Use Count","preferredDefinition":"The average number of cigarettes a participant smoked per day.","longName":"2593548v1.0:7001795v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B809B0F3-BCA3-2B12-E053-4EBD850A6CCF","latestVersionIndicator":"Yes","beginDate":"2021-01-03","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-01-03","modifiedBy":"TSESU","dateModified":"2022-06-02","changeNote":"2/25/21 jk Upd Reg Status per SME (KA) Clinical core review and approval.  1/14/21 jk released for reuse by CCTG.  1/3/21 jk created for Clinical Core data set per Dec 2020 Data Dictionary review.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7544306","version":"1","preferredName":"Tobacco Use Smoking Device Type","preferredDefinition":"The specific type of tobacco product used by the participant.","longName":"7544305v1.0:7544301v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B80AAD0D-15C4-624E-E053-4EBD850AEBAF","latestVersionIndicator":"Yes","beginDate":"2021-01-03","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-01-03","modifiedBy":"KNABLEJ","dateModified":"2021-02-25","changeNote":"2/25/21 jk Released, upd Reg Status per SME (KA) review and approval. 1/3/21 jk created for Clinical Core data set per Dec 2020 Data Dictionary review.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7544665","version":"1","preferredName":"Vital Status Reference Point Day From Anchor Date Count","preferredDefinition":"The number of days between the date used for index and the reference date for determination of vital status.","longName":"7539717v1.0:7069460v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B82B1193-9CCD-753C-E053-4EBD850A8D9C","latestVersionIndicator":"Yes","beginDate":"2021-01-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-01-05","modifiedBy":"KNABLEJ","dateModified":"2021-02-25","changeNote":"2/25/21 jk Released, upd Reg Status per SME (KA) review and approval. 1/5/21 jk created for Clinical Core data set per Dec 2020 Data Dictionary review.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7544666","version":"1","preferredName":"Participant Age Day From Anchor Date Year Count","preferredDefinition":"The patient's age (in years) on the reference or anchor date used during date obfuscation.","longName":"7539719v1.0:2185961v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B82B1193-9D1D-753C-E053-4EBD850A8D9C","latestVersionIndicator":"Yes","beginDate":"2021-01-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-01-05","modifiedBy":"KNABLEJ","dateModified":"2021-02-25","changeNote":"2/25/21 jk Released, upd Reg Status per SME (KA) review and approval. 1/5/21 jk created for Clinical Core data set per Dec 2020 Data Dictionary review.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7544668","version":"1","preferredName":"Baseline Menstrual History Indicator","preferredDefinition":"A response which indicates whether or not participant's menstrual periods have stopped.","longName":"2015069v1.0:6682528v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B82BD730-B22A-7E8D-E053-4EBD850A55C5","latestVersionIndicator":"Yes","beginDate":"2021-01-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-01-05","modifiedBy":"KNABLEJ","dateModified":"2021-02-25","changeNote":"2/25/21 jk Released, upd Reg Status per SME (KA) review and approval. 1/5/21 jk created for Clinical Core data set per Dec 2020 Data Dictionary review.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7544687","version":"1","preferredName":"Informed Consent Form Signed Day Count","preferredDefinition":"Number of days between the date used for anchor/index and date the informed consent was signed.","longName":"2014057v1.0:7069460v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B82CFC95-28F5-76FB-E053-4EBD850ADE51","latestVersionIndicator":"Yes","beginDate":"2021-01-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-01-05","modifiedBy":"KNABLEJ","dateModified":"2021-02-25","changeNote":"2/25/21 jk Released, upd Reg Status per SME (KA) review and approval. 1/5/21 jk created for Clinical Core data set per Dec 2020 Data Dictionary review.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7782009","version":"1","preferredName":"Biospecimen Collected Prior To Therapeutic Procedure Type","preferredDefinition":"The type of therapeutic agents received before the body specimen was collected.","longName":"7781972v1.0:7782006v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CBF89ED8-72CC-7E38-E053-4EBD850AD069","latestVersionIndicator":"Yes","beginDate":"2021-09-14","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-14","modifiedBy":"COLBERTM","dateModified":"2021-11-19","changeNote":"11/19/21 mr Released for MCL PCA lung.  10/1/21 mr Added AQT, ref doc, CSI per MCL prostate DD.  9/15/21 mr Edited DEC and VD concept codes; edited CDE definition, all in consultation with jk. 9/14/21 mr Created for MCL Lung.  Added alt name, AQT, alt def, ref doc, CSI.  Per MCL lung DD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7782023","version":"1","preferredName":"Biospecimen Histologic Grade","preferredDefinition":"A position on a scale of severity which indicates the degree of abnormality of cancer cells, a measure of differentiation, and the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type.","longName":"6953488v1.0:7782022v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CBF9D248-FE1E-78BA-E053-4EBD850ABC21","latestVersionIndicator":"Yes","beginDate":"2021-09-14","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-14","modifiedBy":"COLBERTM","dateModified":"2021-11-19","changeNote":"11/19/21 mr Released for MCL PCA lung.  9/14/21 mr Created for MCL Lung.  Added alt name, alt def, ref doc, CSI. Per MCL DD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7788950","version":"1","preferredName":"Prostate Carcinoma Histologic Type","preferredDefinition":"The type of structural pattern of cancer cells used to define a diagnosis of prostate carcinoma.","longName":"7788937v1.0:7788939v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CD02136B-D205-6C75-E053-4EBD850A2967","latestVersionIndicator":"Yes","beginDate":"2021-09-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-27","modifiedBy":"COLBERTM","dateModified":"2022-02-25","changeNote":"2/25/22 mr Released per SME.   9/27/21 mr Created for MCL prostate per MCL DD. 9/28/21 mr Added alt name, AQT, ref doc per MCL DD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7789388","version":"1","preferredName":"Prostate Carcinoma Histologic Subtype","preferredDefinition":"The subtype of prostate carcinoma defined by the microscopic physical features of cells and their surrounding extracellular environment.","longName":"7789310v1.0:7789349v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CD11D9C9-1885-3D40-E053-4EBD850A768A","latestVersionIndicator":"Yes","beginDate":"2021-09-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-28","modifiedBy":"COLBERTM","dateModified":"2022-02-25","changeNote":"2/25/22 mr Released per SME.   10/26/21 mr Edited definition.   10/13/21 Modified PVs per MCL PCA prostate DCT.   9/28/21 mr Created for MCL prostate.  Added alt name, AQT, ref doc, per MCL DD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7789408","version":"1","preferredName":"Prostate Gland Precancerous Condition Histopathologic Examination Outcome","preferredDefinition":"The subtype of prostate carcinoma defined by the microscopic and cytologic tissue abnormality characteristics.","longName":"7789396v1.0:7789403v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CD13802F-0DA5-1A66-E053-4EBD850A409B","latestVersionIndicator":"Yes","beginDate":"2021-09-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-28","modifiedBy":"COLBERTM","dateModified":"2022-02-24","changeNote":"2/24/22 mr Released per SME.   10/26/21 mr Edited definition.  10/13/21 mr Edited definition.   9/28/21 mr Created for MCL prostate per MCL DD.  Added ref doc, CSI.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7796037","version":"1","preferredName":"Gleason Score for Prostate Cancer Grading System Category","preferredDefinition":"Defined characteristics based on the Gleason grading system for prostatic carcinoma that distills grade groups of prostate cancer down to the lowest number of grades, each with a unique prognosis.","longName":"2547911v2.0:7796036v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CDB2B21E-BCD7-1D3C-E053-4EBD850AE1DF","latestVersionIndicator":"Yes","beginDate":"2021-10-06","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-06","modifiedBy":"COLBERTM","dateModified":"2022-02-25","changeNote":"2/25/22 mr Released per SME.   10/13/21 mr Updated with v2 of the DEC to correct issue with long name and property. Also updated definition.   10/6/21 mr Created for MCL PCA prostate per DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7796122","version":"1","preferredName":"Gleason Score for Prostate Cancer Tertiary Gleason Pattern Number","preferredDefinition":"A value capturing the percentage of the tumor displaying the third most prevalent grade of cancer cells, occupying less than 5% of the tumor.","longName":"2782937v1.0:5699360v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CDB459AB-FA74-2075-E053-4EBD850A83B2","latestVersionIndicator":"Yes","beginDate":"2021-10-06","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-06","modifiedBy":"COLBERTM","dateModified":"2022-02-24","changeNote":"2/24/22 mr Released per SME.   10/21/21 mr Updated definition and long name.  10/13/21 mr Updated definition.  10/6/21 mr Created for MCL PCA prostate per DCT. Repurposed draft new EDRN VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7797155","version":"1","preferredName":"Biospecimen Tumor Mass Extent Category","preferredDefinition":"The category assigned to describe the range or magnitude of a malignant pathologic structure.","longName":"6832602v1.0:7796129v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CDC46318-61A0-1533-E053-4EBD850A2016","latestVersionIndicator":"Yes","beginDate":"2021-10-07","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-07","modifiedBy":"COLBERTM","dateModified":"2022-02-25","changeNote":"2/25/22 mr Released per SME.   10/26/21 mr Edited definition.   10/7/21 mr Created for MCL PCA prostate, per DCT. Added alt name, ref doc.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7797496","version":"1","preferredName":"Nodule Dominant Location Prostate Gland Anatomic Site","preferredDefinition":"The anatomic location within the prostate of the primary lump, swelling or collection of tissue.","longName":"6831639v1.0:7797477v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CDD8E429-E7E4-29A0-E053-4EBD850A79FE","latestVersionIndicator":"Yes","beginDate":"2021-10-08","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-08","modifiedBy":"COLBERTM","dateModified":"2022-02-24","changeNote":"2/24/22 mr Released per SME.   10/26/21 mr Edited concepts on 2 PVs. Added ref doc and alt name.   10/13/21 mr Updated definition.   10/8/21 mr Created for MCL PCA prostate per DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7797499","version":"1","preferredName":"Nodule Secondary Location Prostate Gland Anatomic Site","preferredDefinition":"The anatomic location within the prostate of the less prominent lump, swelling or collection of tissue.","longName":"7794824v1.0:7797477v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CDDC91EF-3A8A-0D50-E053-4EBD850A37BE","latestVersionIndicator":"Yes","beginDate":"2021-10-08","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-08","modifiedBy":"COLBERTM","dateModified":"2022-02-25","changeNote":"2/25/22 mr Released per SME.   10/26/21 mr Added ref doc, alt name.   10/13/21 mr Updated definition.   10/8/21 mr Created for MCL PCA prostate per DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7797502","version":"1","preferredName":"Extraprostatic Extension Location Prostate Gland Anatomic Site","preferredDefinition":"The anatomic site of the prostatic carcinoma that has invaded the prostatic capsule and has spread to nearby tissues or distant anatomic sites.","longName":"7797501v1.0:7797477v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CDDCCE73-0ED5-5A5D-E053-4EBD850A2AEF","latestVersionIndicator":"Yes","beginDate":"2021-10-08","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-08","modifiedBy":"COLBERTM","dateModified":"2022-02-24","changeNote":"2/24/22 mr Released per SME.   10/26/21 mr Added alt name, ref doc. Edited definition.  Per DCT.   10/13/21 mr Updated definition.   10/8/21 mr Created for MCL PCA prostate per DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7798672","version":"1","preferredName":"Prostate Gland Precancerous Condition Histopathologic Examination Category","preferredDefinition":"The subcategory of prostate carcinoma defined by the microscopic and cytologic tissue abnormality characteristics.","longName":"7789396v1.0:7798522v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CEB87A68-7CCE-0213-E053-4EBD850AC57D","latestVersionIndicator":"Yes","beginDate":"2021-10-19","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-19","modifiedBy":"COLBERTM","dateModified":"2022-02-25","changeNote":"2/25/22 mr Released per SME.   10/16/21 mr Edited definition.   10/19/21 mr Created for MCL PCA prostate per DCT. Added ref doc and alt name.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7798801","version":"1","preferredName":"Seminal Vesicle Tumor Cell Invasion Type","preferredDefinition":"The type of local spread of prostate tumor cells through infiltration or destruction of seminal vesicle tissue.","longName":"2011997v4.0:7798792v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CEBBD20F-F4A8-6638-E053-4EBD850A0942","latestVersionIndicator":"Yes","beginDate":"2021-10-19","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-19","modifiedBy":"COLBERTM","dateModified":"2022-02-24","changeNote":"2/24/22 mr Released per SME.   10/21/21 mr Updated long name and definition.  10/19/21 mr Created for MCL PCA prostate per DCT.  10/20 mr  Added alt name, ref doc.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7799720","version":"1","preferredName":"Primary Gleason Score For Prostate Cancer Category","preferredDefinition":"The Primary Gleason score as defined by the most prevalent Gleason pattern in a prostate biopsy or prostatectomy specimen.","longName":"2782935v1.0:7799719v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CEF68F75-CD0A-0CC0-E053-4EBD850A86AA","latestVersionIndicator":"Yes","beginDate":"2021-10-22","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-22","modifiedBy":"COLBERTM","dateModified":"2022-02-25","changeNote":"2/25/22 mr Released per SME.   10/26/21 mr Added ref doc, alt name, CSI per DCT.  10/22/21 mr Created for MCL PCA prostate.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7801425","version":"1","preferredName":"Prostate Gland Additional Uninvolved Anatomy Finding Type","preferredDefinition":"The type of added, extra or further molecular evidence, or absence of evidence, of prostate disease.","longName":"7801424v1.0:7801012v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CF81F25D-12E5-3360-E053-4EBD850A7898","latestVersionIndicator":"Yes","beginDate":"2021-10-29","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-29","modifiedBy":"COLBERTM","dateModified":"2022-02-25","changeNote":"2/25/22 mr Released per SME.   11/4/21 mr Updated VD.   10/29/21 mr Created for MCL PCA prostate. Added alt name, ref doc, CSI per DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7802650","version":"1","preferredName":"Pelvic Lymph Node Number Examined Count","preferredDefinition":"The numeric count of pelvic lymph nodes.","longName":"7802645v1.0:2182209v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CFF61B0B-10AE-55CB-E053-4EBD850A1A7D","latestVersionIndicator":"Yes","beginDate":"2021-11-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-11-04","modifiedBy":"COLBERTM","dateModified":"2022-02-25","changeNote":"2/22/25 mr Released per SME.   12/15/21 mr Added origin MCL.   11/4/21 mr Created for MCL PCA prostate.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7836931","version":"1","preferredName":"Positive Surgical Margin Characteristic Prostate Gland Anatomic Site","preferredDefinition":"The specific anatomic location and characteristics of the tumor cells found at the edge of the surgical excision site in the prostate.","longName":"7836928v1.0:7797477v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D0D66697-F4E2-7769-E053-4EBD850A9131","latestVersionIndicator":"Yes","beginDate":"2021-11-15","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-11-15","modifiedBy":"COLBERTM","dateModified":"2022-02-24","changeNote":"2/24/22 mr Released per SME.   12/15/21 mr Added origin MCL.   11/15/21 mr Created for MCL PCA prostate per DCT.  Added CSI, alt name, ref doc.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7847914","version":"1","preferredName":"Laboratory Procedure Estrogen Receptor Status Genetic Testing Outcome","preferredDefinition":"The result of Estrogen Receptor (ER) genetic analysis.","longName":"6763347v1.0:7847910v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D2314152-9406-219A-E053-4EBD850A38D4","latestVersionIndicator":"Yes","beginDate":"2021-12-02","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-12-02","modifiedBy":"COLBERTM","dateModified":"2022-02-25","changeNote":"2/25/22 mr Released per SME.   12/15/21 mr Added origin MCL.   12/2/21 mr Created for MCL PCA breast. Added alt name, ref doc, and CSI for MCL PCA breast per DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7847934","version":"1","preferredName":"Laboratory Procedure HER2 Measurement in situ Hybridization Positive Negative Finding Outcome","preferredDefinition":"The result of HER2 genetic in situ hybridization analysis.","longName":"7847171v1.0:6682734v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D240755A-17DA-7EC1-E053-4EBD850A4197","latestVersionIndicator":"Yes","beginDate":"2021-12-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-12-03","modifiedBy":"COLBERTM","dateModified":"2022-02-25","changeNote":"2/25/22 mr Released per SME.   12/15/21 mr Added origin MCL.   12/3/21 mr Created for MCL PCA breast. Added alt name, ref doc, CSI per DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7848480","version":"1","preferredName":"Laboratory Procedure Estrogen Receptor Status Percentage Value","preferredDefinition":"The result of Estrogen Receptor (ER) genetic analysis, percentage of cells demostrating nuclear positivity.","longName":"6763347v1.0:2903088v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D27C099D-43FB-357C-E053-4EBD850ABC01","latestVersionIndicator":"Yes","beginDate":"2021-12-06","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-12-06","modifiedBy":"COLBERTM","dateModified":"2022-02-25","changeNote":"2/25/22 mr Released per SME.   12/15/21 mr Added origin MCL.   12/6/21 mr Created for MCL PCA breast per DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7977780","version":"1","preferredName":"Histopathologic Examination Lesion Size Pathologic Primary Tumor TNM Finding Code","preferredDefinition":"The size code assigned to a lesion as a result of a histological examination of the tissue characteristics and abnormalities.","longName":"7248843v1.0:7977725v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D32096F6-E0CF-33B7-E053-4EBD850AC1E0","latestVersionIndicator":"Yes","beginDate":"2021-12-14","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-12-14","modifiedBy":"COLBERTM","dateModified":"2022-02-25","changeNote":"2/25/22 mr Released per SME.   12/14/21 mr Created for MCL PCA breast per DCT. See CDE 7248868 for measurement DE.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7990898","version":"1","preferredName":"Biospecimen Storage Processing Elapsed Time Minute Duration","preferredDefinition":"The duration of time in minutes between biospecimen collection, through processing procedure, to final storage.","longName":"6920694v1.0:3431119v2.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D3AB54B1-718B-0AED-E053-4EBD850AE01B","latestVersionIndicator":"Yes","beginDate":"2021-12-21","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-12-21","modifiedBy":"COLBERTM","dateModified":"2022-03-21","changeNote":"3/21/22 mr Released per SME.   2/25/22 mr Awaiting SME review.   12/21/21 mr Created for MCL Biospecimen.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7991821","version":"1","preferredName":"Study Protocol Occurrence Identifier","preferredDefinition":"A unique sequence of alphanumeric characters used to identify or name a study protocol.","longName":"8010792v1.0:5251428v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D3BE6331-CBFA-63B4-E053-4EBD850A40AA","latestVersionIndicator":"Yes","beginDate":"2021-12-22","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-12-22","modifiedBy":"COLBERTM","dateModified":"2022-03-21","changeNote":"3/21/22 mr Released per SME.   2/24/22 mr Awaiting SME review.   2/22/22 mr Added alt name, alt def, ref doc, explanatory note per MCL Biospecimen DCT.   12/22/21 mr Created for MCL BIospecimen per DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8003356","version":"1","preferredName":"Biospecimen Excision Biologic Sample Preservation Procedure Elapsed Time Minute Duration","preferredDefinition":"The duration of time between biospecimen collection to processing or preservation, measured in minutes.","longName":"8003355v1.0:3431119v2.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D57E2D9C-246D-4F17-E053-4EBD850A7C6B","latestVersionIndicator":"Yes","beginDate":"2022-01-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-13","modifiedBy":"COLBERTM","dateModified":"2022-03-21","changeNote":"3/21/22 mr Released per SME.   2/24/22 mr Awaiting SME review.   1/13/22 mr Created for MCL Biospecimen.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8003363","version":"1","preferredName":"Biospecimen Ischemia Time Minute Duration","preferredDefinition":"The duration of time between biospecimen blood supply separation to processing or preservation, measured in minutes.","longName":"8003362v1.0:3431119v2.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D57AE1F3-C39D-1759-E053-4EBD850A6DEC","latestVersionIndicator":"Yes","beginDate":"2022-01-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-13","modifiedBy":"COLBERTM","dateModified":"2022-03-21","changeNote":"3/21/22 mr Released per SME.   2/24/22 mr Awaiting SME review.   1/13/22 mr Created for MCL Biospecimen.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8003688","version":"1","preferredName":"Collection Date Days From Anchor Date Count","preferredDefinition":"Time interval between the participant's index date and the date the specimen was collected, measured in days.","longName":"8010789v1.0:7069460v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D58D9B10-FAFB-2958-E053-4EBD850A5EF6","latestVersionIndicator":"Yes","beginDate":"2022-01-14","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-14","modifiedBy":"COLBERTM","dateModified":"2022-03-21","changeNote":"3/21/22 mr Released per SME.   2/25/22 mr Awaiting review by SME.   1/14/22 mr Created for MCL Biospecimen.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8003953","version":"1","preferredName":"Molecular Specimen Type Other Specify","preferredDefinition":"Text description that represents the kind of molecular specimen analyte, if not on the list provided.","longName":"2513648v1.0:2666713v2.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D5DC68ED-1F39-79DD-E053-4EBD850A788E","latestVersionIndicator":"Yes","beginDate":"2022-01-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-18","modifiedBy":"COLBERTM","dateModified":"2022-03-21","changeNote":"3/21/22 mr Released per SME.   2/25/22 mr Awaiting review by SME.   1/18/22 mr Created for MCL Biospecimen.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8004170","version":"1","preferredName":"Protocol Identifier Version Number","preferredDefinition":"A string of numbers that uniquely identifies a specific version of a study protocol.","longName":"8004169v1.0:6951332v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D5DCA4B7-9016-7777-E053-4EBD850A539F","latestVersionIndicator":"Yes","beginDate":"2022-01-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-18","modifiedBy":"COLBERTM","dateModified":"2022-03-21","changeNote":"3/21/22 mr Released per SME.   2/24/22 mr Awaiting review by SME.   1/18/22 mr Created for MCL BIospecimen.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8008780","version":"1","preferredName":"Final Storage Date Days From Anchor Date Count","preferredDefinition":"The number of days between the date used for index and the date the specimen was placed into ultimate storage.","longName":"8008766v1.0:7069460v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D5F2DF21-4F60-1188-E053-4EBD850A2880","latestVersionIndicator":"Yes","beginDate":"2022-01-19","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-19","modifiedBy":"COLBERTM","dateModified":"2022-03-21","changeNote":"3/21/22 mr Released per SME.   2/24/22 mr Awaiting review by SME.   1/19/22 mr Created for MCL BIospecimen.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8010206","version":"1","preferredName":"Shipping Date Days From Anchor Date Count","preferredDefinition":"Number of days from the anchor/index date to the date the specimen was shipped.","longName":"8010197v1.0:7069460v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D5F4E61A-AC55-5C2C-E053-4EBD850A6149","latestVersionIndicator":"Yes","beginDate":"2022-01-19","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-19","modifiedBy":"COLBERTM","dateModified":"2022-03-21","changeNote":"3/21/22 mr Released per SME.   2/25/22 mr Awaiting review by SME.   1/19/22 mr Created for MCL Biospecimen.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8018441","version":"1","preferredName":"Biospecimen Storage Method Other Specify","preferredDefinition":"The method used to store a biospecimen after preservation or before another protocol is performed, if not on the list provided.","longName":"8017352v1.0:2666713v2.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D6A8F344-1D66-1B37-E053-4EBD850A2044","latestVersionIndicator":"Yes","beginDate":"2022-01-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-28","modifiedBy":"COLBERTM","dateModified":"2022-03-21","changeNote":"3/21/22 mr Released per SME.   2/24/22 mr Awaiting SME review.   1/28/22 mr Created for MCL Biospecimen per DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8026566","version":"1","preferredName":"Biospecimen Parent Specimen MCL Identifier","preferredDefinition":"A sequence of letters, numbers, and other characters which uniquely identifies the parent biospecimen in the MCL identifier format. Parents can be another biospecimen or a research participant.","longName":"7789415v1.0:8014356v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"HTAN:Human Tumor Atlas Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D71DB393-10E1-4F58-E053-4EBD850A8CE8","latestVersionIndicator":"Yes","beginDate":"2022-02-03","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2022-02-03","modifiedBy":"COLBERTM","dateModified":"2022-03-21","changeNote":"3/21/22 mr Released per SME.   2/3/22 jk created for MCL Biospecimen DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8026572","version":"1","preferredName":"Biospecimen Adjacent Specimen MCL Identifier","preferredDefinition":"One or more sequences of letters, numbers, and other characters in the MCL identifier format (ex. MCL75_001_10100) that uniquely identifies a biospecimen that was next to the one obtained for research purposes.","longName":"8024839v1.0:8014356v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D7209E8B-7345-08C6-E053-4EBD850A5E7D","latestVersionIndicator":"Yes","beginDate":"2022-02-03","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2022-02-03","modifiedBy":"COLBERTM","dateModified":"2022-03-21","changeNote":"3/21/22 mr Released per SME.   2/3/22 jk created for HTAN Biospecimen DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8027563","version":"1","preferredName":"Biospecimen Local Data Source Identifier","preferredDefinition":"A sequence of letters, numbers, or other characters that uniquely identifies the person or authoritative body who provided the biospecimen for research purposes.","longName":"8027562v1.0:7344497v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D7209E8B-738D-08C6-E053-4EBD850A5E7D","latestVersionIndicator":"Yes","beginDate":"2022-02-03","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2022-02-03","modifiedBy":"COLBERTM","dateModified":"2022-03-23","changeNote":"3/23/22 mr Added alt name, alt def, AQT, ref doc, per DCT.   3/21/22 mr Released per SME.   2/3/22 jk created for MCL Biospecimen DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8028962","version":"1","preferredName":"Biospecimen Preservation Procedure Type","preferredDefinition":"Text term that represents the method used to maintain the sample or biospecimen in a viable state.","longName":"8026554v1.0:8028961v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D76F3967-5364-07C9-E053-4EBD850A9D4C","latestVersionIndicator":"Yes","beginDate":"2022-02-07","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-02-07","modifiedBy":"COLBERTM","dateModified":"2023-09-22","changeNote":"3/21/22 mr Released per SME.   2/25/22 mr Awaiting SME review.   2/7/22 mr Created for MCL BIospecimen per DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8038058","version":"1","preferredName":"Biospecimen Preservation Procedure Other Specify","preferredDefinition":"Records a text description of method of preparation if the method is not on the list provided.","longName":"8026554v1.0:2666713v2.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D7BFF518-9954-444B-E053-4EBD850AD1B7","latestVersionIndicator":"Yes","beginDate":"2022-02-11","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-02-11","modifiedBy":"COLBERTM","dateModified":"2022-03-21","changeNote":"3/21/22 mr Released per SME.   2/24/22 mr Awaiting SME review.   2/11/22 mr Created for MCL Biospecimen per DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8120269","version":"1","preferredName":"Biospecimen Stain Type","preferredDefinition":"The name of the dye or other coloring material used in microscopy to make biological sample structures visible.","longName":"8119796v1.0:8119914v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB1033E7-6CA1-4CC9-E053-4EBD850A9CD8","latestVersionIndicator":"Yes","beginDate":"2022-03-25","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-03-25","modifiedBy":"COLBERTM","dateModified":"2023-09-22","changeNote":"4/28/22 mr Released per SME.   3/25/22 mr Created for MCL path imaging per DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8120281","version":"1","preferredName":"Biospecimen Stain MCL Site Identifier","preferredDefinition":"The identifier of the MCL site at which the staining was performed.","longName":"8119796v1.0:8119803v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB0A7F5B-412F-4B45-E053-4EBD850AEF5E","latestVersionIndicator":"Yes","beginDate":"2022-03-25","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-03-25","modifiedBy":"COLBERTM","dateModified":"2022-04-28","changeNote":"4/28/22 mr Released per SME.   3/25/22 mr Created for MCL path imaging per DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8120292","version":"1","preferredName":"Biospecimen Stain Date","preferredDefinition":"The date the biospecimen was stained.","longName":"8119796v1.0:8120251v1.0","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB0DA372-D041-5AD1-E053-4EBD850A316F","latestVersionIndicator":"Yes","beginDate":"2022-03-25","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-03-25","modifiedBy":"COLBERTM","dateModified":"2022-04-28","changeNote":"4/28/22 mr Released per SME.   3/25/22 mr Created for MCL path imaging per DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10115621","version":"1","preferredName":"Endobronchial Nodule Yes No Unknown Data Not Available Indicator","preferredDefinition":"A small lump, swelling or collection of tissue entirely contained within a bronchus. It may obstruct the airway, but does not breach the bronchial wall.","longName":"10115620v1.00:6682528v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DE1C3524-939D-5D7B-E053-731AD00A6C0A","latestVersionIndicator":"Yes","beginDate":"2022-05-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-03","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/3/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10118309","version":"1","preferredName":"Nodule Axial Location Anatomic Site","preferredDefinition":"The position, site, or location within the body where a nodule can be found, relative to an axis.","longName":"10115624v1.00:10116413v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DE1DD1B6-D60A-5D79-E053-731AD00A650C","latestVersionIndicator":"Yes","beginDate":"2022-05-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-03","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/3/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10135107","version":"1","preferredName":"Subpleural Nodule Yes No Unknown Data Not Available Indicator","preferredDefinition":"The position of a nodule with respect to the pleural surface.","longName":"10135043v1.00:6682528v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DDE5F7A4-5B1A-5D7D-E053-731AD00AA191","latestVersionIndicator":"Yes","beginDate":"2022-05-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-04","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/4/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10139869","version":"1","preferredName":"Nodule Consistency Type","preferredDefinition":"Text term to represent the description of the  radiologic consistency of a nodule.","longName":"10139858v1.00:10139860v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DE345AFA-AD79-5D75-E053-731AD00AC2B1","latestVersionIndicator":"Yes","beginDate":"2022-05-05","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-05","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/5/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10146917","version":"1","preferredName":"Image Series and Image Identifier","preferredDefinition":"One or more text strings used to identify and name a particular image in a series or set of images.","longName":"10139638v1.00:5251428v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DDE5F7A4-688D-5D7D-E053-731AD00AA191","latestVersionIndicator":"Yes","beginDate":"2022-05-09","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-09","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/12/22 mr Updated DEC.  \r\n5/9/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10147188","version":"1","preferredName":"Nodule Margin Conspicuity Type","preferredDefinition":"The category of radiologic visibility of a nodule's margins.","longName":"10146922v1.00:10146925v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DDE5F7A4-699D-5D7D-E053-731AD00AA191","latestVersionIndicator":"Yes","beginDate":"2022-05-09","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-09","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/9/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10147919","version":"1","preferredName":"Primary Nodule Margin Type","preferredDefinition":"The category of the radiologic margin type that is most prevalent in the nodule.","longName":"10147192v1.00:10147199v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DDE5A4E5-4B57-5E37-E053-731AD00A299D","latestVersionIndicator":"Yes","beginDate":"2022-05-09","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-09","modifiedBy":"COLBERTM","dateModified":"2022-06-03","changeNote":null,"administrativeNotes":"6/3/22 mr Added AQT for MCL Lung Imaging Atlas per CRF.\r\n5/9/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10147922","version":"1","preferredName":"Secondary Nodule Margin Type","preferredDefinition":"The second most prevalent category of radiologic margin type in the nodule.","longName":"10147921v1.00:10147199v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DDE5F7A4-7230-5D7D-E053-731AD00AA191","latestVersionIndicator":"Yes","beginDate":"2022-05-09","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-09","modifiedBy":"COLBERTM","dateModified":"2022-06-03","changeNote":null,"administrativeNotes":"6/3/22 mr Added AQT per MCL Lung Imaging Atlas.  \r\n5/9/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10156183","version":"1","preferredName":"Nodule Lobar Location Bronchial Anatomic Site","preferredDefinition":"A text term to describe the location of a nodule within the lung.","longName":"8177603v1.00:6690563v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DEAED41F-24B1-5D71-E053-731AD00A2B4D","latestVersionIndicator":"Yes","beginDate":"2022-05-11","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-11","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/11/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10156508","version":"1","preferredName":"Nodule Axial Longest Diameter Millimeter Measurement","preferredDefinition":"The measurement, in millimeters, of the longest possible length of a straight line passing through a nodule.","longName":"10135173v1.00:5542785v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DEBD4660-EF71-1FBB-E053-731AD00A3827","latestVersionIndicator":"Yes","beginDate":"2022-05-11","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-11","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/11/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10169242","version":"1","preferredName":"Nodule Axial Minimum Diameter Millimeter Measurement","preferredDefinition":"The measurement, in millimeters, of the shortest possible length of a straight line passing through a nodule.","longName":"10137024v1.00:5542785v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DEBD4661-2646-1FBB-E053-731AD00A3827","latestVersionIndicator":"Yes","beginDate":"2022-05-12","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-12","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/12/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10169243","version":"1","preferredName":"Part-Solid Nodule Longest Diameter Millimeter Measurement","preferredDefinition":"The measurement, in millimeters, of the longest possible length of a straight line passing through a part-solid nodule.","longName":"10137027v1.00:5542785v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DEBD4661-2648-1FBB-E053-731AD00A3827","latestVersionIndicator":"Yes","beginDate":"2022-05-12","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-12","modifiedBy":"COLBERTM","dateModified":"2022-06-03","changeNote":null,"administrativeNotes":"6/3/22 mr Added AQT per MCL Lung Imaging Atlas CRF. \r\n5/11/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10176560","version":"1","preferredName":"Nodule Shape Type","preferredDefinition":"A text description of the radiologic shape of a nodule.","longName":"10148699v1.00:10148702v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DEAED41F-49C4-5D71-E053-731AD00A2B4D","latestVersionIndicator":"Yes","beginDate":"2022-05-12","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-12","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/12/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10206516","version":"1","preferredName":"Nodule Internal Feature Cavitation Yes No Unknown Data Not Available Indicator","preferredDefinition":"The response indicating the formation of bubbles in a fluid within the nodule itself.","longName":"10206501v1.00:6682528v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DED70430-9F33-2FBF-E053-731AD00A19BF","latestVersionIndicator":"Yes","beginDate":"2022-05-16","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-16","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/16/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10206519","version":"1","preferredName":"Nodule Internal Feature Eccentric Morphology Calcification Yes No Unknown Data Not Available Indicator","preferredDefinition":"The response indicating the position of calcium deposits within the nodule.","longName":"10206518v1.00:6682528v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DED5C7E9-433C-2222-E053-731AD00AECE0","latestVersionIndicator":"Yes","beginDate":"2022-05-16","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-16","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/16/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10206613","version":"1","preferredName":"Nodule Internal Feature Airway Obstruction Yes No Unknown Data Not Available Indicator","preferredDefinition":"The response indicating whether the airway that enters the nodule is blocked inside the nodule.","longName":"10206612v1.00:6682528v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DED70430-9F37-2FBF-E053-731AD00A19BF","latestVersionIndicator":"Yes","beginDate":"2022-05-16","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-16","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/16/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10207284","version":"1","preferredName":"Nodule External Feature Vascular Convergence Yes No Unknown Data Not Available Indicator","preferredDefinition":"The response indicating whether a blood vessel was moving toward a nodule to form a connection.","longName":"10207276v1.00:6682528v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DED70430-A1D8-2FBF-E053-731AD00A19BF","latestVersionIndicator":"Yes","beginDate":"2022-05-16","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-16","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/16/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10216286","version":"1","preferredName":"Nodule External Feature Septal Stretching Yes No Unknown Data Not Available Indicator","preferredDefinition":"The response indicating whether septal stretching lines are present in the environment immediately surrounding the nodule.","longName":"10216275v1.00:6682528v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DED6273D-07F9-221E-E053-731AD00A8FB3","latestVersionIndicator":"Yes","beginDate":"2022-05-16","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-16","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/16/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10230796","version":"1","preferredName":"Nodule Internal Feature Lung Cyst Like Space Yes No Unknown Data Not Available Indicator","preferredDefinition":"The response indicating the presence of cyst-like spaces within a lung nodule.","longName":"10230795v1.00:6682528v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DF254FDB-10C7-0788-E053-731AD00A68DE","latestVersionIndicator":"Yes","beginDate":"2022-05-17","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-17","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/17/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10231336","version":"1","preferredName":"Nodule Internal Feature Intra Nodule Bronchiectasis Yes No Unknown Data Not Available Indicator","preferredDefinition":"The response indicating whether segmental, irreversible dilation of the bronchial tree, leading to obstruction, is present.","longName":"10231327v1.00:6682528v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DED6273D-0831-221E-E053-731AD00A8FB3","latestVersionIndicator":"Yes","beginDate":"2022-05-17","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-17","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/17/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10235386","version":"1","preferredName":"Nodule Internal Feature Large Pericystic Space Yes No Unknown Data Not Available Indicator","preferredDefinition":"The response indicating the presence of an empty area of relatively great size or extent, adjacent to or surrounding a cyst, within the nodule.","longName":"10231591v1.00:6682528v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DF254FDB-10FC-0788-E053-731AD00A68DE","latestVersionIndicator":"Yes","beginDate":"2022-05-17","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-17","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/17/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10245183","version":"1","preferredName":"Nodule External Feature Pleural Attachment Yes No Unknown Data Not Available Indicator","preferredDefinition":"The response indicating whether the exterior of the nodule is affixed to the pleural surface.","longName":"10245173v1.00:6682528v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DED6273D-21E5-221E-E053-731AD00A8FB3","latestVersionIndicator":"Yes","beginDate":"2022-05-17","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-17","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/17/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10250231","version":"1","preferredName":"Nodule External Feature Paracicatricial Emphysema Yes No Unknown Data Not Available Indicator","preferredDefinition":"The response indicating whether paracicatricial emphysema is present.","longName":"10248354v1.00:6682528v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DF3B7344-930C-078C-E053-731AD00A65A1","latestVersionIndicator":"Yes","beginDate":"2022-05-17","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-17","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/17/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10265883","version":"1","preferredName":"Nodule Environment Type","preferredDefinition":"The text term that describes the conditions immediately surrounding the nodule.","longName":"10261117v1.00:10261134v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DF254000-3223-4E37-E053-731AD00A0E79","latestVersionIndicator":"Yes","beginDate":"2022-05-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-18","modifiedBy":"COLBERTM","dateModified":"2022-06-03","changeNote":null,"administrativeNotes":"6/3/22 mr Added AQT per MCL Lung Imaging Atlas.  \r\n5/18/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10266447","version":"1","preferredName":"Nodule External Feature Pleural Retraction Type","preferredDefinition":"The text term that describes the pleural retraction in the environment immediately surrounding the nodule.","longName":"10265886v1.00:10265925v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DF254FDB-2476-0788-E053-731AD00A68DE","latestVersionIndicator":"Yes","beginDate":"2022-05-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-18","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/18/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10334486","version":"1","preferredName":"Nodule Lung Non-Small Cell Carcinoma Level of Suspicion Finding Range","preferredDefinition":"Describes the level of suspicion for non-small cell lung carcinoma (NSCLC).","longName":"10268441v1.00:10304237v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DF5DF015-9BB2-2A5A-E053-731AD00A8826","latestVersionIndicator":"Yes","beginDate":"2022-05-20","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-20","modifiedBy":"COLBERTM","dateModified":"2022-06-03","changeNote":null,"administrativeNotes":"6/3/22 mr Added AQT per MCL Lung Imaging Atlas CRF.  \r\n5/20/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10341805","version":"1","preferredName":"Nodule Atypical Adenomatous Lung Hyperplasia Or Adenocarcinoma In Situ Level of Confidence Finding Range","preferredDefinition":"Describes the expectation that a nodule is indolent and either AAH or AIS.","longName":"10340711v1.00:10304237v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DF76BCAC-F13E-1C30-E053-731AD00A15B6","latestVersionIndicator":"Yes","beginDate":"2022-05-20","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-20","modifiedBy":"COLBERTM","dateModified":"2022-06-03","changeNote":null,"administrativeNotes":"6/3/22 mr Added AQT per MCL Lung Imaging Atlas CRF.  \r\n5/20/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"10342993","version":"1","preferredName":"Nodule Neuroendocrine Neoplasm Level of Confidence Finding Range","preferredDefinition":"Describes the expectation that a nodule is a neuroendocrine tumor.","longName":"10341807v1.00:10304237v1.00","contextName":"MCL","contextVersion":"1","dataElementConceptPublicId":"6771009","dataElementConceptVersion":"1","valueDomainPublicId":"4213342","valueDomainVersion":"1","origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"DF4FE05A-6401-2A63-E053-731AD00AD131","latestVersionIndicator":"Yes","beginDate":"2022-05-20","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-05-20","modifiedBy":"COLBERTM","dateModified":"2022-05-25","changeNote":null,"administrativeNotes":"5/20/22 mr Created for MCL Lung Imaging Atlas per CRF.","unresolvedIssues":null,"deletedIndicator":"No"}]}